TW201022331A - Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display device - Google Patents

Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display device Download PDF

Info

Publication number
TW201022331A
TW201022331A TW098139996A TW98139996A TW201022331A TW 201022331 A TW201022331 A TW 201022331A TW 098139996 A TW098139996 A TW 098139996A TW 98139996 A TW98139996 A TW 98139996A TW 201022331 A TW201022331 A TW 201022331A
Authority
TW
Taiwan
Prior art keywords
formula
liquid crystal
group
carbon number
structural formula
Prior art date
Application number
TW098139996A
Other languages
Chinese (zh)
Inventor
Yuko Katano
Fumitaka Kondo
Takeshi Fujiwara
Original Assignee
Chisso Corp
Chisso Petrochemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chisso Corp, Chisso Petrochemical Corp filed Critical Chisso Corp
Publication of TW201022331A publication Critical patent/TW201022331A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/52Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
    • C09K19/54Additives having no specific mesophase characterised by their chemical composition
    • C09K19/56Aligning agents
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • C08G73/1057Polyimides containing other atoms than carbon, hydrogen, nitrogen or oxygen in the main chain
    • C08G73/106Polyimides containing other atoms than carbon, hydrogen, nitrogen or oxygen in the main chain containing silicon
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • C08G73/1075Partially aromatic polyimides
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L79/00Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing nitrogen with or without oxygen or carbon only, not provided for in groups C08L61/00 - C08L77/00
    • C08L79/04Polycondensates having nitrogen-containing heterocyclic rings in the main chain; Polyhydrazides; Polyamide acids or similar polyimide precursors
    • C08L79/08Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1337Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
    • G02F1/133711Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by organic films, e.g. polymeric films
    • G02F1/133723Polyimide, polyamide-imide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Health & Medical Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nonlinear Science (AREA)
  • Mathematical Physics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Liquid Crystal (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)

Abstract

This invention provides a liquid crystal display device performing VHR long-term heat reliability as required, a liquid crystal alignment film thereof which performs the required VHR long-term heat reliability, and a liquid crystal alignment agent to form the liquid crystal alignment film. The liquid crystal alignment film is formed by polyamic acid or its derivative using diamine tetraacetic acid dianhydride and aromatic diamine having side chains as raw materials, and the liquid crystal alignment film is used in the liquid crystal display device.

Description

201022331 32945pif.doc 六、發明說明: 【發明所屬之技術領域】 本發明涉及一種含有使二胺(diamine)與四羧酸二酐 (tetracarboxylic dianhydride)反應所獲得的聚醯胺酸 (polyamic acid)或者其衍生物的液晶配向劑、由此液晶配向 劑所獲得的液晶配向膜以及具有此液晶配向膜的液晶顯示 元件,尤其是涉及一種適合於垂直配向(Vertical Alignment,VA)方式的液晶配向劑、由此液晶配向劑所獲 得的液晶配向膜以及具有此液晶配向膜的液晶顯示元件。 【先前技術】 液晶顯示元件被用於以筆記本電腦(note personal computer)或臺式電腦(desktop personal computer)的監視器 (monitor)為代表的攝像機(video camera)的取景器 (viewfinder)、投影式的顯示器(displa>〇等各種液晶顯示裝 置,最近也被用於電視(television)。進而,液晶顯示元件 也被用於光學打印頭(optical printer head)、光學傅裏葉變 換元件(optical Fourier transform device)、光閥(以扮 valve) 等光電子相關元件。 液晶顯示元件中已知有各種元件,而液晶顯示元件的 技術發展不僅可通過對液晶顯示元件的驅動方式或 示元件的結構進行改良來實現的,還可通過對液晶顯=元 件中所使用的構成構件進行改良來實現的。通常,圹 示元件具有絲將液晶層中的液晶組成物配向=南 上的液晶配向膜。液晶配向膜是與液晶顯示元件的^示二 201022331 32945pif.doc 質相關的一個重要的要素,液晶配向膜的作用隨著液 不元件的品質提南而逐年變得重要。 ” 液晶配向膜是由液晶配向劑所製備的。目前,主要使 用的液晶配向劑是將聚醯胺酸或可溶性聚醯亞胺 (polyimide)溶解在有機溶媒中所獲得的溶液。將此種溶液 塗布在基板上之後’利用加熱等方法進行成膜,由此形 液晶配向膜。 ❹ 關於液晶配向膜’例如已知有使用二胺四乙酸二野的 液晶配向膜,且揭示了此液晶配向膜可以改善超扭轉向列 (Super Twisted Nematic,STN)模式、有源矩陣顯示器⑽〜 matrix display)中的電壓保持率(參照專利文獻i)。 另外,揭示有通過使用乙二胺四乙酸二肝的液晶配向 膜來改善串擾(crosstalk)(參照專利文獻2)。 進而’揭示有-種使用使乙二胺四乙酸二針上鍵結光 反絲而成的高分子物質與其他酸酐的共聚物的液晶配向 膜(參照專利文獻3)。 © #一方面,對於液晶配向元件的特性來說,要求長時 間地維持高電壓保持率。當無法長時間地維持高電壓保持 率時,會產生電壓降低、驅動電壓上升、消耗電力上升、 對比度(contrast)下降等問題。在所述專利文獻i中,雖然 初始值的電魏持率制改善,但絲纽善電壓保持率 的長時間的熱可靠性方面進行研究。另外,在所述專利文 獻2、3中,同樣也未在改善電壓保持率的長時間的熱可靠 性方面進行研究。 5 201022331 32945pif.doc [先前技術文獻] [專利文獻] [專利文獻1]美國專利第552〇845號說明書 利文獻2]曰本專利特開平6_7S229號公報 [利文獻3]曰本專利特開2〇〇6_35〇347號公報 【發明内容】 ㈣ίΐ明提供一種可以表現出所需的電壓保持率的長 』熱可祕的液晶顯示科、在此液晶顯示元件中可以表 見出所需的電壓保持率的長期熱可靠性的液晶配向膜、以 及可以形成此液晶配向膜的液晶配向劑。 本發明者等人發現,將含有以特定二胺四乙酸二酐與 /、有側鏈的芳香族二胺作為原料的聚醯胺酸或其衍生物的 組成物用於液晶配向劑’可以對具有由此液晶配向劑所形 成的液晶配向膜的液晶顯示元件賦予所需的電壓保持率的 長期熱可靠性,從而完成本發明。 本發明包含以下的構成。 [1]一種液晶配向劑’其含有作為四羧酸二酐與二胺的 反應生成物的聚酿胺酸或者其衍生物, 所述四羧酸二酐含有以下述通式(TC-i)〜通式(TC-14) 所表示的四羧酸二酐,所述二胺含有以下述通式(VIII)及通 式(X)〜通式(XI)所表示的具有側鏈結構的二胺。 201022331 32945pif.doc201022331 32945pif.doc VI. Description of the Invention: [Technical Field] The present invention relates to a polyamic acid obtained by reacting a diamine with a tetracarboxylic dianhydride or a liquid crystal alignment agent of the derivative thereof, a liquid crystal alignment film obtained by the liquid crystal alignment agent, and a liquid crystal display element having the liquid crystal alignment film, in particular, a liquid crystal alignment agent suitable for a vertical alignment (VA) method, A liquid crystal alignment film obtained by the liquid crystal alignment agent and a liquid crystal display element having the liquid crystal alignment film. [Prior Art] A liquid crystal display element is used for a viewfinder or a projection type of a video camera represented by a monitor of a notebook personal computer or a desktop personal computer. Various liquid crystal display devices, such as displa>, have recently been used for television. Further, liquid crystal display elements are also used for optical printer heads and optical Fourier transform elements (optical Fourier transform elements). Photoelectric-related components such as a light valve (for valve). Various components are known in liquid crystal display elements, and the development of liquid crystal display elements can be improved not only by driving the liquid crystal display element but also by changing the structure of the liquid crystal display element. This can also be achieved by modifying the constituent members used in the liquid crystal display device. Generally, the display member has a liquid crystal alignment film in which the liquid crystal composition in the liquid crystal layer is aligned to the south. It is an important element related to the quality of liquid crystal display elements, 201022331 32945pif.doc, liquid The role of the alignment film becomes important year by year with the quality of the liquid component. ” The liquid crystal alignment film is prepared by a liquid crystal alignment agent. Currently, the liquid crystal alignment agent mainly used is polyglycine or soluble polyfluorene. A solution obtained by dissolving an imide in an organic solvent. After coating such a solution on a substrate, a film is formed by heating or the like to form a liquid crystal alignment film. ❹ For the liquid crystal alignment film, for example, A liquid crystal alignment film of diamine tetraacetic acid is used, and it is revealed that the liquid crystal alignment film can improve the voltage holding ratio in the Super Twisted Nematic (STN) mode and the active matrix display (10) to the matrix display (refer to Patent Document i) Further, crosstalk is improved by using a liquid crystal alignment film of ethylenediaminetetraacetic acid dihepatic (see Patent Document 2). Further, it is disclosed that the use of ethylenediaminetetraacetic acid has two needles. A liquid crystal alignment film of a copolymer of a polymer material and a different acid anhydride which is bonded to a light-bonded wire (see Patent Document 3). © # On the one hand, characteristics of a liquid crystal alignment element In this case, it is required to maintain the high voltage holding ratio for a long period of time. When the high voltage holding ratio cannot be maintained for a long period of time, problems such as voltage drop, driving voltage increase, power consumption increase, and contrast reduction may occur. In the literature i, although the initial value of the electrical maintenance ratio system is improved, the long-term thermal reliability of the wire-good voltage holding ratio is studied. Further, in the above-mentioned Patent Documents 2 and 3, the improvement is also not improved. The long-term thermal reliability of the voltage holding ratio was investigated. 5 201022331 32945pif.doc [Prior Art Document] [Patent Document] [Patent Document 1] U.S. Patent No. 552 845, Pro. 2, Japanese Patent Laid-Open Publication No. Hei 6-7-S229 (Korean Document 3) 〇〇6_35〇347号 [Summary of the Invention] (4) ΐ 提供 提供 提供 提供 提供 提供 提供 提供 提供 提供 提供 提供 提供 提供 提供 提供 提供 提供 提供 提供 提供 提供 提供 提供 提供 提供 提供 提供 提供 提供 提供 提供 提供 提供 提供 提供 提供 提供 提供 提供 提供 提供 提供A liquid crystal alignment film having a long-term thermal reliability, and a liquid crystal alignment agent capable of forming the liquid crystal alignment film. The inventors of the present invention have found that a composition containing polyamine or a derivative thereof having a specific diamine tetraacetic acid dianhydride and/or a side chain aromatic diamine as a raw material can be used for a liquid crystal alignment agent. The liquid crystal display element having the liquid crystal alignment film formed by the liquid crystal alignment agent imparts long-term thermal reliability to a desired voltage holding ratio, thereby completing the present invention. The present invention includes the following constitutions. [1] A liquid crystal alignment agent containing polyamic acid or a derivative thereof as a reaction product of a tetracarboxylic dianhydride and a diamine, the tetracarboxylic dianhydride having the following formula (TC-i) a tetracarboxylic dianhydride represented by the formula (TC-14), which contains a side chain structure represented by the following formula (VIII) and formula (X) to formula (XI) amine. 201022331 32945pif.doc

7 201022331 32945pif.doc [化2]7 201022331 32945pif.doc [Chemical 2]

201022331 32945pif.doc (通式(TC-1)中,X表示-(CH2)n,至多兩個-CH2-可以 獨立地被-0-(此處並非連續)、-S-、-COO-、-OCO-、-CO-、 -CONH,、-CnH2nN(CmH2inCOOH)CnH2n_、-CH(CmH2mOH)-、 -CH(CnH2n+1)_、_CH=CH-或-OC-取代(m 表示 0〜30 的整 數’η獨立地表示1〜30的整數)。通式(TC-4)〜通式(TC-7) 中,Υ獨立地表示單鍵、-0、_s---S-S- ' -S02---CO-、 -CONH-、_NHC0-、-NH-、-N(CH3HCH2)m-N(CH3)-、 ❹ -C(CH3)2- > -C(CF3)2- ^ -(CH2)m- > -0-(CH2)m-0- ' -S-(CH2)m-S-(m表示1〜6的整數)。通式(TC-5)中,Z表示 單鍵或不存在。通式(TC-9)中,R33及R34分別獨立地表示 碳數為1〜3的烧基(alkyl)或苯基(phenyl),A3獨立地表示 亞甲基(methylene)、次苯基(phenylene)或經烧基取代的次 苯基’1表示1〜6的整數,m表示1〜10的整數。通式(TC-2) 〜通式(TC-7)中,鍵結在環己烧(cyclohexane)環或苯 (benzene)環上的氫可以獨立地被_f、-CH3、-CF3、-OH、 -COOH、-S03H、-P〇3H2取代,通式(TC-3)中的鍵結在苯 © 環上的氫可以被节基(benzyl)取代。通式(TC-2)〜通式 (TC-8)中,R1獨立地表示_(CH2)m,至多兩個·〇:Η2-可以獨 立地被-0-(此處並非連續)、-S-、-COO-、-OCO-、-CO-、 —CONH-、,CH(CmH2m〇H)-、-CH(CmH2m+1)-、-CH=CH-或 -OC-取代(m獨立地表示〇〜30的整數)。通式(TC-8)中, A1獨立為碳數為1〜10的烷基,碳數為1〜1〇的烷氧基 (alkoxy)、乙醯胺(acetamide)、氟、氣或溴,A2獨立地表示 石炭數為1〜3的院基,m表示0〜3的整數,η表示0〜4的 201022331 32945pif.doc 整數。通式(TC-10)中,A3 表示單鍵、-〇-、-coo-、-oco·、 -CO-、-CONH-或-(CH2)m-(m表示1〜6的整數pR1表示具 有類固醇(steroid)骨架的基或以下述通式(B)所表示的基, 當鍵結在苯環上的兩個氨基(amino)的位置關係為對位時 R1進一步包含碳數為1〜30的烷基,當此位置關係為間位 時R1進一步包含碳數為1〜30的烷基或苯基,此烷基中任 意的-CH2-可以獨立地被-CF2-、-CHF-、·〇_(此處並非連 續)、_CH=CH-或-〇C_取代,-CH3 可以被-CH2F、-CHF2 或-cf3取代,此苯基的氩可以獨立地被-F、-CH3、-OCH3、 •OCH2F、-OCHF2 或-OCF3 取代。 [化3]201022331 32945pif.doc (In the general formula (TC-1), X represents -(CH2)n, and at most two -CH2- can be independently -0-(here is not continuous), -S-, -COO-, -OCO-, -CO-, -CONH,, -CnH2nN(CmH2inCOOH)CnH2n_, -CH(CmH2mOH)-, -CH(CnH2n+1)_, _CH=CH- or -OC-substitution (m means 0~30 The integer 'n independently represents an integer from 1 to 30.) In the formula (TC-4) to the formula (TC-7), Υ independently represents a single bond, -0, _s---SS-'-S02 ---CO-, -CONH-, _NHC0-, -NH-, -N(CH3HCH2)mN(CH3)-, ❹-C(CH3)2- > -C(CF3)2- ^ -(CH2) M- > -0-(CH2)m-0- '-S-(CH2)mS- (m represents an integer of 1 to 6). In the formula (TC-5), Z represents a single bond or does not exist. In the formula (TC-9), R33 and R34 each independently represent an alkyl group or a phenyl group having a carbon number of 1 to 3, and A3 independently represents a methylene group and a phenyl group (methylene group). Phenylene or a substituted subphenylene group 1 represents an integer of 1 to 6, and m represents an integer of 1 to 10. In the formula (TC-2) to formula (TC-7), the bond is in the ring. The hydrogen on the cyclohexane ring or the benzene ring can be independently _f, -CH3, -CF3, -OH, -COOH, -S03H Substituting -P〇3H2, the hydrogen bonded to the benzene ring in the formula (TC-3) may be substituted by a benzyl group. The formula (TC-2) to the formula (TC-8) R1 independently represents _(CH2)m, at most two 〇: Η2- can be independently -0-(here is not continuous), -S-, -COO-, -OCO-, -CO-, CONH-,, CH(CmH2m〇H)-, -CH(CmH2m+1)-, -CH=CH- or -OC-substitution (m independently represents an integer of 〇30). General formula (TC-8) Wherein A1 is independently an alkyl group having a carbon number of 1 to 10, an alkoxy group having a carbon number of 1 to 1 Å, a acetamide, fluorine, gas or bromine, and A2 independently represents a carbon number of 1 to 3, the m represents an integer of 0 to 3, and η represents an integer of 201022331 32945pif.doc of 0 to 4. In the general formula (TC-10), A3 represents a single bond, -〇-, -coo-,- Oco·, -CO-, -CONH- or -(CH2)m- (m represents an integer pR1 of 1 to 6 represents a group having a steroid skeleton or a group represented by the following formula (B), when a bond When the positional relationship of two amino groups on the benzene ring is a para position, R1 further contains an alkyl group having a carbon number of 1 to 30, and when the positional relationship is meta-position, R1 further contains a carbon number of 1~ An alkyl group or a phenyl group of 30, wherein any -CH2- of the alkyl group may be independently substituted by -CF2-, -CHF-, 〇_(here not continuous), _CH=CH- or -〇C_, -CH3 may be substituted by -CH2F, -CHF2 or -cf3, which may be independently substituted by -F, -CH3, -OCH3, -OCH2F, -OCHF2 or -OCF3. [Chemical 3]

通式(B)中,A4及A5分別獨立地表示單鍵、_〇_(此處 並非連續)、-COO-、-OCO-、-CONH-、-CH=CH-或碳數為 1〜12的烷烯基(alkylene),R2及R3分別獨立地表示_F或 -CH3,環S獨立地表示1,4-次笨基、M_環己稀 (1,4-cyclohexylene) 、 1,3-二惡烷 _2,5-二基 (l,3-dioxane-2,5-diyl) 、 σ密咬 -2 5- 一 美 (Pyrimidine-2,5_diyl)、处唆-1,4-二基(pyridine_14_diyl)、^ -1,5-二基(naphthalene-l,5-diyl)、萘二基或蒽_9,1〇_二^ (anthracene-9,10-diyl),R4 表示_H、、碳數為;」3〇 的^ 基、碳數為1〜30的氟取代烧基、碳數為丨〜3〇的燒氧芙、 -⑽、-〇CH2F、-〇CHF2 t〇CF3,a 及 b 分別表示 〇14 201022331 32945pif.doc 的整數,C、d及e分別表示〇〜3的整數,f及g分別獨立 地表示0〜2的整數,且c + d+e^l。通式(TC-11)及通式 (TC-12)中,R5獨立地表示-H或-CH3,R6表示-H、或者碳 數為1〜20的烷基或碳數為2〜20的烯基(alkenyl),A6獨 立地表示單鍵、-C0-或-CH2·。通式(TC-12)中,R7及R8 分別獨立地表示-H、碳數為1〜20的烷基或苯基。通式 (TC-13)及通式(TC-14)中’A7獨立地表示_〇_或碳數為1〜6 φ 的烷烯基。通式(TC_13)中,R9表示-H或碳數為1〜30的 烷基,此烷基中碳數為2〜30的烷基的任意_ch2-可以被 -0-(此處並非連續)、-CH=CH·或-OC-取代,A8表示單鍵 或碳數為1〜3的烧烯基’環T表示1,4-次苯基或l,4-環己 烯,h表示〇或1。通式(TC-14)中,R10表示碳數為6〜22 的烷基,R11表示-H或碳數為1〜22的烧基)。 [化4]In the general formula (B), A4 and A5 each independently represent a single bond, _〇_ (here is not continuous), -COO-, -OCO-, -CONH-, -CH=CH- or a carbon number of 1~ 12 alkylene, R2 and R3 each independently represent _F or -CH3, and ring S independently represents 1,4-decyl, M-cyclohexylene, 1, 3-dioxane-2,5-diyl (l,3-dioxane-2,5-diyl), σ 密-2 - 5-yy (Pyrimidine-2,5_diyl), 唆-1,4- Bis(pyridine_14_diyl), ^ -1,5-diyl (naphthalene-l, 5-diyl), naphthalene diyl or 蒽_9,1〇_二^ (anthracene-9,10-diyl), R4 represents _ H, carbon number is: "3" base, carbon number 1~30 fluorine-substituted alkyl group, carbon number 丨~3〇, oxygen-oxygen, -(10), -〇CH2F, -〇CHF2 t〇 CF3, a and b respectively represent integers of 〇14 201022331 32945pif.doc, C, d and e respectively represent integers of 〇~3, f and g respectively represent integers of 0~2, respectively, and c + d+e^l . In the formula (TC-11) and the formula (TC-12), R5 independently represents -H or -CH3, R6 represents -H, or an alkyl group having 1 to 20 carbon atoms or a carbon number of 2 to 20 Alkenyl, A6 independently represents a single bond, -C0- or -CH2. In the formula (TC-12), R7 and R8 each independently represent -H, an alkyl group having 1 to 20 carbon atoms or a phenyl group. In the general formula (TC-13) and the general formula (TC-14), 'A7' independently represents _〇_ or an alkenyl group having a carbon number of 1 to 6 φ. In the formula (TC_13), R9 represents -H or an alkyl group having 1 to 30 carbon atoms, and any _ch2- of the alkyl group having 2 to 30 carbon atoms in the alkyl group may be -0- (here is not continuous) , -CH=CH· or -OC-substitution, A8 represents a single bond or an alkylene group having a carbon number of 1 to 3, and the ring T represents 1,4-phenylene or 1,4-cyclohexene, and h represents 〇 or 1. In the formula (TC-14), R10 represents an alkyl group having 6 to 22 carbon atoms, and R11 represents -H or a group having 1 to 22 carbon atoms. [Chemical 4]

(通式(VIII)中 ’ A3 表示單鍵、-0-、_c〇〇-、-0C0-、 -CO-、-CONH-或-(CH2)m-(m表示1〜6的整數),R1表示具 有類固醇骨架的基或以下述通式(IX)所表示的基,當鍵結 在苯環上的兩個氨基的位置關係為對位時R1進一步包含 碳數為1〜30的烧基’當此位置關係為間位時R1進一步包 含碳數為1〜30的烧基或苯基,此烧基中任意的-CH2-可以 獨立地被-CF2_、-CHF-、-〇-(此處並非連續)、_ch=CH-或 -OC-取代,_CH3可以被-CH2F、-CHF2或-CF3取代,此笨 201022331 32945pif.doc 基的氫可以獨立地被-F、ΤΗ;、-〇CH3、_0CH2f、_〇CHF2 或-OCF3取代。其中,當所述四竣酸二酐僅包含以通式 (TC-〗)〜通式(ΊΧΜ4)所表示的四羧酸二酐時,R]進一步包 含的所述烷基的碳數為23〜30)。 [化5] [(f)fl [删 - _ 十A4允 c [〇j 士5V d -R4 (IX) e (通式(IX)中,A4及A5分別獨立地表示單鍵、_〇_(此 ◎ 處並非連續)、-COO-、-OCO-、-CONH-、-CH=CH-或者碳 數為1〜12的烷烯基,尺2及R3分別獨立地表示—F 4_CH3, 環S獨立地表示1,4-次苯基、1,4-環己烯、1,3-二惡烷-2,5-一基、喷咬·2,5·二基、吡咬-1,4·二基、萘-1,5-二基、萘-2,7-一基或惠ΊΟ-二基’ R4表示-Η、-F、碳數為1〜30的烷 基、碳數為1〜30的氟取代烷基、碳數為1〜30的烷氧基、 _ 〇CH2F、-〇CHF2 或-〇CF3,a 及 b 分別表示 0〜4 的整數’ c、d及e分別表示〇〜3的整數,f及g分別獨立 〇 地表二0〜2的整數,且c + d + eg卜其中’當c + d+e=1 時’ R4表示碳數為1〜30的烷基、碳數為1〜30的氟取代 院基或後數為1〜30的烷氧基,通式(VIII)的A3表示碳數 大於等於丨縣)。 12 201022331 32945pif.doc [化6](In the formula (VIII), 'A3 represents a single bond, -0-, _c〇〇-, -0C0-, -CO-, -CONH- or -(CH2)m- (m represents an integer of 1 to 6), R1 represents a group having a steroid skeleton or a group represented by the following formula (IX), and when the positional relationship of two amino groups bonded to the benzene ring is para-position, R1 further contains a group having 1 to 30 carbon atoms. 'When this positional relationship is meta-position, R1 further contains a burnt group or a phenyl group having a carbon number of 1 to 30, and any -CH2- of the alkyl group may be independently -CF2_, -CHF-, -〇- Is not continuous), _ch=CH- or -OC-substitution, _CH3 can be replaced by -CH2F, -CHF2 or -CF3, this stupid 201022331 32945pif.doc-based hydrogen can be independently -F, ΤΗ;, -〇CH3 , _0CH2f, _〇CHF2 or -OCF3, wherein when the tetraphthalic acid dianhydride contains only the tetracarboxylic dianhydride represented by the formula (TC-) to the formula (ΊΧΜ4), R] further The alkyl group contained has a carbon number of 23 to 30). [(5) [[f)fl [Delete - _ Ten A4 Yun c [〇j 士 5V d -R4 (IX) e (In the general formula (IX), A4 and A5 independently represent a single bond, _〇_ (This ◎ is not continuous), -COO-, -OCO-, -CONH-, -CH=CH- or an alkenyl group having a carbon number of 1 to 12, and the scales 2 and R3 independently represent -F 4_CH3, ring S independently represents 1,4-phenylene, 1,4-cyclohexene, 1,3-dioxane-2,5-yl, punctured 2,5·diyl, pyridyl-1. 4·diyl, naphthalene-1,5-diyl, naphthalene-2,7-yl or oxime-diyl' R4 represents -Η, -F, an alkyl group having a carbon number of 1 to 30, and the carbon number is a fluorine-substituted alkyl group of 1 to 30, an alkoxy group having 1 to 30 carbon atoms, _ 〇CH 2 F, -〇CHF 2 or -〇 CF 3 , a and b each represent an integer of 0 to 4 'c, d and e respectively represent An integer of 〇~3, f and g are independent of the integers of the table 2 to 2, and c + d + egb where 'when c + d+e=1' R4 represents an alkyl group having a carbon number of 1 to 30 And a fluorine-substituted yard group having a carbon number of 1 to 30 or an alkoxy group having a rear number of 1 to 30, and A3 of the formula (VIII) means a carbon number of 大于 or more. 12 201022331 32945pif.doc [Chem. 6]

(通式(X)及(XI)中’ R5獨立地表示·H 4_CH3,R6表示 -Η、或者碳數為1〜20的烷基或碳數為2〜20的烯基,A6 獨立地表不单鍵、-CO-或-CH2· ’通式(XI)中,r7及r8分 別獨立地表示-H、碳數為1〜20的烷基或苯基)。 [2]根據[1]所述的液晶配向劑’其特徵在於:所述具有 侧鏈結構的二胺是以所述通式(VIII)K表示的二胺,Rl'是 以所述通式(IX)所表示的基。 & 〇 [3]根據[2]所述的液晶配向劑’其特徵在於:所述具有 側鏈結構的二胺是以通式(VIII)所表示的二胺,Rl 下通式(Rq)〜通式(Ri-7)所表示的基。 疋乂如 13 201022331 32945pif.doc [化7](In the formulae (X) and (XI), 'R5 independently represents ·H 4_CH3, R6 represents -Η, or an alkyl group having 1 to 20 carbon atoms or an alkenyl group having 2 to 20 carbon atoms, and A6 independently represents In the formula (XI), r7 and r8 each independently represent -H, an alkyl group having 1 to 20 carbon atoms or a phenyl group). [2] The liquid crystal alignment agent according to [1] characterized in that the diamine having a side chain structure is a diamine represented by the above formula (VIII) K, and R1' is the above formula The base represented by (IX). [3] The liquid crystal alignment agent according to [2], wherein the diamine having a side chain structure is a diamine represented by the formula (VIII), and R1 is a formula (Rq) a group represented by the formula (Ri-7). For example 13 201022331 32945pif.doc [Chemistry 7]

(R】-3)(R]-3)

1-^ A~~~〈)—R (r1-7) (通式(R^-l)中,R表示後數為1〜30的烧基、碳數為 1〜30的氟取代烷基或碳數為1〜30的烷氧基,當通式 (RLl)的R是碳數為1的基時,通式(VIII)的A3表示碳數 大於等於1的基,通式(R、2)〜通式(R1-?)中,R表示-H、 Q -F、碳數為1〜30的烷基、碳數為1〜30的氟取代烷基、 碳數為 1 〜30 的烷氧基、-CsN、-〇CH2F、-OCHF2 或-OCF3, A表示-Ο-或碳數為1〜6的烷烯基)。 [4]根據[3]所述的液晶配向劑’其特徵在於:所述具有 側鏈結構的二胺是選自以下述通式(VIII-2)〜通式(vn 所表示的化合物中的至少一種。 14 201022331 32945pif.doc [化8]1-^ A~~~<)-R (r1-7) (In the formula (R^-l), R represents a postal number of 1 to 30, a fluoro-substituted alkyl group having a carbon number of 1 to 30 Or an alkoxy group having a carbon number of 1 to 30. When R of the formula (RL1) is a group having a carbon number of 1, the group A3 of the formula (VIII) represents a group having a carbon number of 1 or more, and the formula (R, 2) From the formula (R1-?), R represents -H, Q-F, an alkyl group having 1 to 30 carbon atoms, a fluorine-substituted alkyl group having 1 to 30 carbon atoms, and a carbon number of 1 to 30. Alkoxy, -CsN, -〇CH2F, -OCHF2 or -OCF3, A represents -Ο- or an alkenyl group having 1 to 6 carbon atoms). [4] The liquid crystal alignment agent according to [3], wherein the diamine having a side chain structure is selected from the group consisting of compounds represented by the following formula (VIII-2) to formula (vn) At least one. 14 201022331 32945pif.doc [Chem. 8]

H2N (vm-2)H2N (vm-2)

(所述通式中,R52表示碳數為16〜30的院泰’ 表 示碳數為1〇〜30的烷基,R54表示碳數為4〜30的择基’ R55表示碳數為2〜30的烧基)。 [5]根據[1]所述的液晶配向劑,其特徵在於:所述具有 侧鏈結構的二胺是以所述通式(X)或(XI)所表示的° 0 [6]根據[1]〜[5]中任一項所述的液晶配向劑,其特徵 在於:所述四羧酸二酐包含芳香族四羧酸二酐。 [7]根據[6]所述的液晶配向劑,其特徵在於:所述芳香 族四羧酸二酐是以下述結構式(1)、結構式(2)、結構式(5) 〜結構式(7)、結構式(11)、結構式(12)及結構式(14)所表示 的化合物中的至少一種。 15 201022331 32945pif.doc(In the above formula, R52 represents a hydrocarbon having a carbon number of 16 to 30, represents an alkyl group having a carbon number of 1 to 30, and R54 represents a radical having a carbon number of 4 to 30. R55 represents a carbon number of 2 to 30. 30 bases). [5] The liquid crystal alignment agent according to [1], wherein the diamine having a side chain structure is represented by the above formula (X) or (XI) ° 0 [6] according to [ The liquid crystal alignment agent according to any one of the above aspects, wherein the tetracarboxylic dianhydride comprises an aromatic tetracarboxylic dianhydride. [7] The liquid crystal alignment agent according to [6], wherein the aromatic tetracarboxylic dianhydride is a structural formula (1), a structural formula (2), and a structural formula (5) to a structural formula. (7) At least one of the compounds represented by the structural formula (11), the structural formula (12) and the structural formula (14). 15 201022331 32945pif.doc

[8] 根據[1]〜[7]中任一項所述的液晶配向劑,其特徵 在於:所述四羧酸二酐包含脂環式四羧酸二酐及脂肪族四 叛酸二針中的一方或雙方。 [9] 根據[8]所述的液晶配向劑,其特徵在於:所述脂環 式四羧酸二酐及脂肪族四羧酸二酐是以下述結構式(19)、 結構式(23)、結構式(25)、結構式(35)〜結構式(39)、結構 Q 式(44)及結構式(49)所表示的化合物中的至少一種。 16 201022331 32945pif.doc [化 10][8] The liquid crystal alignment agent according to any one of [1] to [7] wherein the tetracarboxylic dianhydride comprises an alicyclic tetracarboxylic dianhydride and an aliphatic four-reelic acid two-needle One or both of them. [9] The liquid crystal alignment agent according to [8], wherein the alicyclic tetracarboxylic dianhydride and the aliphatic tetracarboxylic dianhydride are the following structural formula (19), structural formula (23) At least one of the compounds represented by Structural Formula (25), Structural Formula (35) to Structural Formula (39), Structural Formula (Formula) (44) and Structural Formula (49). 16 201022331 32945pif.doc [Chem. 10]

(19) (23)(19) (23)

[10]根據[1]〜[9]中任一項所述的液晶配向劑,其特徵 在於:所述二胺進一步包含以下述通式⑴〜通式(VII)、通 式(XV)、通式(N)及通式(a)所表示的不具有侧鏈結構的二[10] The liquid crystal alignment agent according to any one of [1] to [9], wherein the diamine further comprises the following general formula (1) to general formula (VII), general formula (XV), Two of the general formula (N) and the general formula (a) having no side chain structure

胺0 17 201022331 32945pif.doc [化η] h2n-x—nh2 (1)Amine 0 17 201022331 32945pif.doc [化η] h2n-x-nh2 (1)

(通式(I)中,X表示-(CH2)m-(m表示1〜6的整數),通 式(III)及通式(V)〜通式(VII)中,Y獨立地表示單鍵、-Ο-、 -S-、-S-S-、-S02-、-CO-、-CONH-、-NHCO-、-NH-、 -N(CH3)-(CH2)m-N(CH3)-、_C(CH3)2-、-C(CF3)2-、-(CH2)m-、 18 201022331 32945pif.doc 0_(CH2)m-〇-、_s_(CH2)m_s_(m 表示 J〜6 的整數),通式(v) 中’ Z表示單鍵或不存在,通式(χν)中,R33及R34分別獨 立地表示碳數為1〜3的烷基或苯基,A3獨立地表示亞甲 基、次苯基或經烷基取代的次苯基,丨表示1〜6的整數, 示1〜10的整數。通式(11)〜通式(νπ)中,鍵結在環己 烷環或苯環上的氫可以獨立地被-F、-CH3、-CF3、-OH、 &lt;X)〇H、-S〇3H、-ΡΟ#2取代,通式(IV)中的苯環上所鍵 © ㈣氫可以鮮基取代。通式(Ν)中,Α1獨立地表示碳數 為1〜4的烷基、碳數為丨〜4的烷氧基、乙醯胺、氟、氯 或濞,Α2獨立地表示碳數為!〜3的烷基,m表示〇〜3的 整數,η表示〇〜4的整數。通式(a)中,L1表示氫、碳翁系 1〜4的燒基、笨基群基)。 數為 [11]根據[10]所述的液晶配向劑,其特徵在於:所述不 具有側鏈結構的二胺是選自以下述結構式(IV_1}、結構式 (^2)、結構式(IV-15)〜結構式(IV-17)、結構式(vq) Q 構式(V-13)、結構式(ν·33)、結構式(V-35)〜結構式(%37)°、 結構式(VII-2)、結構式(χν-i)、結構式⑼-丨、(Ν)_2、結構 式(Ν)-14、結構式(a-l)及結構式(a_2)所表示的化合物中的 至少一種。 19 201022331 32945pif.doc [化 12-1](In the formula (I), X represents -(CH2)m- (m represents an integer of 1 to 6), and in the formula (III) and the formula (V) to the formula (VII), Y independently represents a single Key, -Ο-, -S-, -SS-, -S02-, -CO-, -CONH-, -NHCO-, -NH-, -N(CH3)-(CH2)mN(CH3)-, _C (CH3)2-, -C(CF3)2-, -(CH2)m-, 18 201022331 32945pif.doc 0_(CH2)m-〇-, _s_(CH2)m_s_(m represents an integer of J~6), In the formula (v), 'Z represents a single bond or does not exist. In the formula (??), R33 and R34 each independently represent an alkyl group or a phenyl group having a carbon number of 1 to 3, and A3 independently represents a methylene group. a phenyl group or an alkyl group-substituted phenyl group, 丨 represents an integer of 1 to 6, and represents an integer of 1 to 10. In the formula (11) to the formula (νπ), a bond is bonded to a cyclohexane ring or a benzene. The hydrogen on the ring may be independently substituted by -F, -CH3, -CF3, -OH, &lt;X)〇H, -S〇3H, -ΡΟ#2, and the bond on the benzene ring in the formula (IV) © (4) Hydrogen can be replaced by fresh base. In the formula (Ν), Α1 independently represents an alkyl group having 1 to 4 carbon atoms, an alkoxy group having a carbon number of 丨4, acetamidine, fluorine, chlorine or hydrazine, and Α2 independently represents a carbon number! An alkyl group of 〜3, m represents an integer of 〇~3, and η represents an integer of 〇~4. In the formula (a), L1 represents hydrogen, a carbon group of 1 to 4, and a styl group. The liquid crystal alignment agent according to [10], wherein the diamine having no side chain structure is selected from the following structural formula (IV_1}, structural formula (^2), structural formula (IV-15)~Structure Formula (IV-17), Structural Formula (vq) Q Configuration (V-13), Structural Formula (ν·33), Structural Formula (V-35)~Structure Formula (%37) °, structural formula (VII-2), structural formula (χν-i), structural formula (9)-丨, (Ν)_2, structural formula (Ν)-14, structural formula (al) and structural formula (a_2) At least one of the compounds. 19 201022331 32945pif.doc [Chem. 12-1]

H2N 分叫 h^-Q- (IV-1.) (IV-2) ⑽Η2ΝΌη〇ΝΗ2 H2NtXi&gt;NH2 (V·*1) (V-2) (V-3)H2N is called h^-Q- (IV-1.) (IV-2) (10)Η2ΝΌη〇ΝΗ2 H2NtXi&gt;NH2 (V·*1) (V-2) (V-3)

(V-10)(V-10)

(V-11)(V-11)

(V-13)(V-13)

h2nhQ^-n-&lt;Q^nh2 h2n-^Q&gt;-n^n-^j^nh2 (V-35) (V-36) 20 201022331 32945pif.doc 12-2]h2nhQ^-n-&lt;Q^nh2 h2n-^Q&gt;-n^n-^j^nh2 (V-35) (V-36) 20 201022331 32945pif.doc 12-2]

(V-37) ?H3 ?h3 H2N-C3H6-?i-〇-Si-C3H6-NH2 CH3 CH3 (XV-1)(V-37) ?H3 ?h3 H2N-C3H6-?i-〇-Si-C3H6-NH2 CH3 CH3 (XV-1)

h2n h2n (a-0 (a-2) ΟH2n h2n (a-0 (a-2) Ο

[12] 根據⑴〜[丨1]中任一項所述的液晶配向劑’其特 徵在於:戶斤述四叛酸二軒包含砍倍半氧烧(silsesquioxane) 二酐衍生物。 [13] 根據[12]所述的液晶配向劑,其特徵在於:所述石夕 倍半氧烷二酐衍生物是以下述結構式(S_1)所表示的化合 物。 21 201022331 32945pif.doc [化 13][12] The liquid crystal alignment agent according to any one of (1) to [1], wherein the bismuth resorcinus bismuth derivative comprises a silsesquioxane dianhydride derivative. [13] The liquid crystal alignment agent according to [12], wherein the sesquiterpene dianhydride derivative is a compound represented by the following structural formula (S_1). 21 201022331 32945pif.doc [Chem. 13]

(S-l) [14] 根據[1]〜[13]中任一項所述的液晶配向劑,其特 徵在於: 所述聚醯胺酸或者其衍生物包含兩種聚醯胺酸或者 其衍生物A及B, 所述聚醯胺酸或者其衍生物A包含所述二胺中的所 述具有側鍵結構的二胺,且所述聚酿胺酸或者其衍生物A 及B的四叛酸二酐的一方或雙方包含以通式(TC1)〜通式 (TC-14)所表示的四叛酸二酐。 [15] 根據[1]〜[14]中任一項所述的液晶配向劑,其特 徵在於.進一步含有選自稀基取代納迪克醢亞胺(nadiimide) 化合物、具有自由基(radical)聚合性不飽和雙鍵的化合物、 惡0秦(oxazine)化合物、惡。坐琳(oxaz〇iine)化合物及環氧 (epoxy)化合物中的一種或一種以上。 [16] —種液晶配向膜,其特徵在於:其是對根據[η〜 [15]中任一項所述的液晶配向劑的塗膜進行加熱而形成。 [17] —種液晶顯示元件,其具有:一對基板;含有液 晶分子並形成于所述一對基板之間的液晶層;對液晶層施 加電壓的電極;以及將所述液晶分子配向在預定的方向上 的液晶配向膜,此液晶顯示元件的特徵在於:所述液晶配 向膜是根據[16]所述的液晶配向膜。 201022331 32945pif.doc 根據本發明,可以提供一種可以表現出電壓保 長期熱可靠性的液晶顯示元件。 、的 為讓本發明之上述特徵和優點能更明顯易懂,下文特 舉實施例,並配合所附圖式作詳細說明如下。 ' 【實施方式】 本發明的液晶配向劑含有作為四羧酸二酐與二胺 反應產物的聚醯胺酸或者其衍生物。所述聚酿胺酸的衍生 〇 物是指,在製成含有溶劑的後述液晶配向劑時溶解于溶劑 中的成分、且在將此液晶配向劑製成後述的液晶配向膜 可以形成以聚醯亞胺作為主成分的液晶配向膜的成分 為此種聚醯胺酸的衍生物,例如可以列舉:可溶性聚醯亞 胺、聚酿胺酸醋(polyamic acid ester)以及聚醯胺酸釀胺 (polyam^c add amide)等’更具體而言可以列舉丨)聚醯胺酸 的所有氨基與絲(eafbGxy 1)騎财騎反應而成的 醯亞胺、2)部分地進行脫水閉環反應而成的部分聚酿亞 ⑮、3)將聚醯胺酸的絲轉化為g旨而成的聚酿胺酸醋 从豸四幾酸二if化合物所含的酸二肝的一部分替換為有機二 羧酸來進行反應而獲得的聚醯胺酸_聚醯胺共聚物,進一 可以列舉5)使此聚醯胺酸-聚醯胺共聚物的一部分或者全 部進行脫水閉環反應而成的聚醯胺醯亞胺 (polyamide-imide)。所述聚醯胺酸或者其衍生物可以是一 種化合物,也可以是兩種或兩種以上的化合物。另外,所 述聚醯胺酸或者其衍生物只要是具有四羧酸二酐與二胺的 反應生成物的結構的化合物,也可以是使用其他原1料並通 23 201022331 32945pif.doc 過四羧酸二酐與二胺的反應以外的其他反應所獲得的反 生成物。 ’ 本發明中所使用的四羧酸二酐包含以所述通式(tc_U 〜通式(TC-14)所表示的四竣酸二酐。 作為以通式(TC-1)所表示的四羧酸二酐,通式中,χ 優選作為主鏈的烷烯基的碳數為〇〜20,例如可二列舉以 下述結構式所表示的酸二酐。 牛 [化 14]The liquid crystal alignment agent according to any one of [1] to [13] wherein the polyamic acid or a derivative thereof comprises two polylysines or derivatives thereof A and B, the polyperuric acid or derivative A thereof comprises the diamine having a side bond structure in the diamine, and the tetrahydro acid of the poly-branched acid or derivatives A and B thereof One or both of the dianhydrides include four ortho-dianhydrides represented by the general formula (TC1) to the general formula (TC-14). [15] The liquid crystal alignment agent according to any one of [1] to [14] further comprising a radically substituted nadiimide compound having a radical polymerization. A compound of a sexually unsaturated double bond, an oxazine compound, or a compound. One or more of an oxaz〇iine compound and an epoxy compound. [16] A liquid crystal alignment film which is formed by heating a coating film of the liquid crystal alignment agent according to any one of [n to [15]. [17] A liquid crystal display element having: a pair of substrates; a liquid crystal layer containing liquid crystal molecules and formed between the pair of substrates; an electrode applying a voltage to the liquid crystal layer; and aligning the liquid crystal molecules at a predetermined The liquid crystal display element in the direction of the liquid crystal display element is characterized in that the liquid crystal alignment film is the liquid crystal alignment film according to [16]. 201022331 32945pif.doc According to the present invention, it is possible to provide a liquid crystal display element which can exhibit voltage long-term thermal reliability. The above described features and advantages of the present invention will become more apparent from the description of the appended claims. [Embodiment] The liquid crystal alignment agent of the present invention contains a polyamic acid or a derivative thereof as a reaction product of a tetracarboxylic dianhydride and a diamine. The derivative of the poly-branched acid is a component which is dissolved in a solvent when a liquid crystal alignment agent described later containing a solvent is prepared, and the liquid crystal alignment film described later can be formed into a liquid crystal alignment film. The component of the liquid crystal alignment film containing the imine as a main component is a derivative of such a polyamic acid, and examples thereof include soluble polyimine, polyamic acid ester, and polyamine glycine ( Polyam^c add amide), etc., more specifically, 丨) all amino groups of poly-proline are reacted with silk (eafbGxy 1), and 2) partially undergo dehydration ring closure reaction. Part of the poly-branches 15 and 3) The poly-branched vinegar obtained by converting the filament of poly-proline to g is replaced by an organic dicarboxylic acid from a part of the acid di-hepatic contained in the tetra-acid diif compound. The polylysine-polyamine copolymer obtained by the reaction is further exemplified by 5) a polyamidoquinone obtained by subjecting a part or all of the polyamido-polyamine copolymer to a dehydration ring-closing reaction. Amine (imamide-imide). The polyamic acid or a derivative thereof may be one compound or two or more compounds. Further, the poly-proline or a derivative thereof may be a compound having a structure of a reaction product of a tetracarboxylic dianhydride and a diamine, or may be a mixture of other raw materials and may be passed through 23 201022331 32945 pif.doc. An inverse product obtained by a reaction other than the reaction of acid dianhydride with a diamine. The tetracarboxylic dianhydride used in the present invention contains tetradecanoic dianhydride represented by the above formula (tc_U to formula (TC-14). As the four represented by the formula (TC-1) In the carboxylic acid dianhydride, in the formula, χ is preferably an alkylene group as a main chain having a carbon number of 〇 20, and for example, an acid dianhydride represented by the following structural formula may be mentioned.

作為以通式(TC-2)所表示的四羧酸二酐,通 ι 樣透作為主鏈的烷烯基的碳數為〇〜10,例如:R 冓式所表示的酸二酐。 丨牛以The tetracarboxylic dianhydride represented by the formula (TC-2) has a carbon number of 烷10 which is a main chain, and is, for example, an acid dianhydride represented by R 冓. Yak

作為以通式(TC-3)所表示的四羧酸二酐, 廣遂作為主鏈眺烯基的碳數為G〜10,^式中’ R] 以列舉以 24 201022331 32945pif.doc 下述結構式所表示的酸二酐。 [化 16]As the tetracarboxylic dianhydride represented by the formula (TC-3), the carbon number of the broad chain as the main chain nonenyl group is G 10, and the formula 'R' is exemplified by 24 201022331 32945 pif.doc. The acid dianhydride represented by the structural formula. [Chemistry 16]

作為以通式(TC-4)所表示的四羧酸二酐,通式中,R1 優選作為主鏈的烷烯基的碳數為0〜10,例如可以列舉以 下述結構式所表示的酸二酐。 [化 17]In the general formula, the number of carbon atoms of the alkenyl group as the main chain is from 0 to 10, and examples of the tetracarboxylic dianhydride represented by the formula (TC-4) include an acid represented by the following structural formula. Diacid anhydride. [Chem. 17]

25 201022331 32945pif.doc 作為以通式(TC-5)所表示的四羧酸二酐,通式中,R1 優選作為主鏈的烷烯基的碳數為0〜10,例如可以列舉以 下述結構式所表示的酸二酐。 [化 18-1]25 201022331 32945pif. doc As a tetracarboxylic dianhydride represented by the formula (TC-5), in the formula, R1 is preferably an alkenyl group as a main chain having a carbon number of 0 to 10, and examples thereof include the following structures. The acid dianhydride represented by the formula. [Chem. 18-1]

ο ο ο ο 26 201022331 32945pif.doc [化 18-2]ο ο ο ο 26 201022331 32945pif.doc [Chem. 18-2]

φ 作為以通式(TC-6)所表示的四羧酸二酐,通式中,Rl 優選作為主鍵的烧稀基的碳數為0〜10,例如可以列舉r 下述結構式所表示的酸二針。 入 [化 19]φ is a tetracarboxylic dianhydride represented by the formula (TC-6), and in the formula, R1 is preferably a carbon atom of the primary group as a primary bond, and the number of carbon atoms is 0 to 10, and examples thereof include r represented by the following structural formula. Two needles. Into [Chemistry 19]

作為以通式(TC-7)所表示的四羧酸二酐,通式 康瘟作為主鏈的烷烯基的碳數為〇〜1〇,例如可二與 γ述結構式所表示的酸二酐。 &amp; 27 201022331 32945pif.doc [化 20]As the tetracarboxylic dianhydride represented by the formula (TC-7), the carbon number of the alkenyl group having a main chain of the formula is 〇~1〇, for example, the acid represented by the structural formula of γ and γ Diacid anhydride. &amp; 27 201022331 32945pif.doc [Chem. 20]

作為以通式(TC-8)所表示的四緩酸二 樣遂作為主鏈的烷烯基的碳數為〇〜1〇, f述結構式所表示的酸二野。 酐,通式中,R1 例如可以列舉以The number of carbon atoms of the alkenyl group which is a main chain of the tetrazoic acid dihydrazide represented by the formula (TC-8) is 〇~1〇, and f is an acid field represented by the structural formula. Anhydride, in the formula, R1 can be exemplified by

28 201022331 32945pif.doc [化*21_1]28 201022331 32945pif.doc [化*21_1]

29 201022331 32945pif.doc [化 21-2]29 201022331 32945pif.doc [Chem. 21-2]

作為以通式(TC-9)所表示的四羧酸二酐,例如可以列 舉以下述結構式所表示的酸二酐。The tetracarboxylic dianhydride represented by the formula (TC-9) may, for example, be an acid dianhydride represented by the following structural formula.

[化 22] 〇. 〇 、 ?h3 ?h3 t N一—Si—O一Si—C3H6—N、 ch3 ch3 o 0 1 作為以通式(TC-10)所表示的四羧酸二酐,例如可以列 舉以下述通式或結構式所表示的酸二酐。[化22] 〇. 〇 , ? H3 ?h3 t N-Si-O-Si-C3H6-N, ch3 ch3 o 0 1 The tetracarboxylic dianhydride represented by the formula (TC-10), for example, may be exemplified by the following formula or structural formula The acid dianhydride represented.

30 201022331 32945pif.doc [化 23-1]30 201022331 32945pif.doc [Chem. 23-1]

31 201022331 32945pif.doc [化 23-2]31 201022331 32945pif.doc [Chem. 23-2]

Ο R*Ο R*

❹ (所述通式中,R23、R24、R25、R26分別表示碳數為 30的烷基、或者碳數為1〜30的烷氧基)。 32 201022331 32945pif.doc [化 24]❹ (In the above formula, R23, R24, R25 and R26 each represent an alkyl group having 30 carbon atoms or an alkoxy group having 1 to 30 carbon atoms). 32 201022331 32945pif.doc [Chem. 24]

作為以通式(T C -11)所表示的四羧酸二酐,例如可以列 舉以下述結構式所表示的酸二酐。 33 201022331 32945pif.doc [化 25]The tetracarboxylic dianhydride represented by the formula (T C -11) may, for example, be an acid dianhydride represented by the following structural formula. 33 201022331 32945pif.doc [Chem. 25]

作為以通式(TC-12)所表示的四羧酸二酐,例如可以列 舉以下述結構式所表示的酸二酐。The tetracarboxylic dianhydride represented by the formula (TC-12) may, for example, be an acid dianhydride represented by the following structural formula.

34 201022331 32945pif.doc [化 26]34 201022331 32945pif.doc [Chem. 26]

35 201022331 32945pif.doc 作為以通式(TC-13)所表示的四羧酸二酐,例如可以列 舉以下述通式所表示的酸二酐。 [化 27]35 201022331 32945pif.doc The tetracarboxylic dianhydride represented by the formula (TC-13) may, for example, be an acid dianhydride represented by the following formula. [化27]

36 201022331 32945pif.doc (R29表示-Η、碳數為1〜30的烷基或碳數為1〜30的 烷氧基,更優選表示碳數為3〜30的烷基或碳數為3〜30 的烧氧基)。 作為以通式(T C -14)所表示的四羧酸二酐,例如可以列 舉以下述通式所表示的酸二酐。 [化 28]36 201022331 32945pif.doc (R29 represents - an anthracene, an alkyl group having a carbon number of 1 to 30 or an alkoxy group having a carbon number of 1 to 30, more preferably an alkyl group having a carbon number of 3 to 30 or a carbon number of 3 to 30. 30 alkoxy groups). The tetracarboxylic dianhydride represented by the formula (T C -14) may, for example, be an acid dianhydride represented by the following formula. [化 28]

(R29表示碳數為6〜22的烷基,更優選表示碳數為6 〜10的烷基。R3Q表示-Η或碳數為1〜22的烷基,更優選 表示-H或碳數為1〜10的烷基)。 作為其他四羧酸二酐,例如可以列舉以下述通式所表 示的酸二酐。 37 201022331 32945pif.doc [化 29](R29 represents an alkyl group having 6 to 22 carbon atoms, more preferably an alkyl group having 6 to 10 carbon atoms. R3Q represents an anthracene or an alkyl group having 1 to 22 carbon atoms, more preferably -H or a carbon number is 1 to 10 alkyl groups). Examples of the other tetracarboxylic dianhydride include acid dianhydride represented by the following formula. 37 201022331 32945pif.doc [Chem. 29]

特別適用于本發明的四羧酸二酐是以通式(TC-1)〜通 式(TC-7)所表示的四羧酸二酐,其中特別優選以如下結構 式所表示的四羧酸二酐。 [化 30]The tetracarboxylic dianhydride which is particularly suitable for use in the present invention is a tetracarboxylic dianhydride represented by the general formula (TC-1) to the general formula (TC-7), and among them, a tetracarboxylic acid represented by the following structural formula is particularly preferable. Diacid anhydride. [化30]

38 201022331 32945pif.doc 另外,就在液晶顯示元件中表現出所需的電壓保持 率’並且實現電壓保持率的長期熱可靠性的觀點而言,子 構成本發明的液晶配向劑中的聚醯胺酸的酸二酐中,以莫 爾比計優選含有10%〜100%的以所述(Td)〜所述(TO!4) 所表示的四羧酸二酐,更優選含有2〇%〜1〇〇%的以所述 (TC-1)〜所述(TC_14)所表示的四羧酸二酐。 、#本發明的四羧酸二酐優選包含芳香族四羧酸二酐,所 0 述芳香族四叛酸二針是指兩個酸酐中的至少一個是由鍵結 2芳香族化合物上的兩個羧基(carb0xy)所形成的酸酐的化 σ物。作為所述芳香族四羧酸二酐,例如可列棗下述 結構式⑴〜結構式⑽所表示的化合物。鱗 ❿ 39 201022331 32945pif.doc [化 31]38 201022331 32945pif.doc In addition, the polyamine which constitutes the liquid crystal alignment agent of the present invention is formed from the viewpoint of exhibiting a desired voltage holding ratio in the liquid crystal display element and achieving long-term thermal reliability of the voltage holding ratio. The acid dianhydride of the acid preferably contains 10% to 100% of the tetracarboxylic dianhydride represented by the above (Td) to the above (TO! 4) in a molar ratio, and more preferably contains 2% by weight. 1% by mass of tetracarboxylic dianhydride represented by the above (TC-1) to (TC_14). The tetracarboxylic dianhydride of the present invention preferably contains an aromatic tetracarboxylic dianhydride, and the aromatic tetracarboxylic acid bisphenol refers to at least one of the two anhydrides which are bonded by the aromatic compound on the two A sigma of an acid anhydride formed by a carboxyl group (carb0xy). The aromatic tetracarboxylic dianhydride may, for example, be a compound represented by the following structural formula (1) to structural formula (10). Scales 39 201022331 32945pif.doc [Chem. 31]

(7) (8) ⑼(7) (8) (9)

40 201022331 32945pif.doc 所述芳香族四叛酸二肝優選以所述t構式⑴結構式 (2)、結構式(5)〜結構式⑺、結構式(⑴、結構式(12)及結 構式(14)所表示的化合物,更優選以所述結構式(1)所表示 的化合物。另外,就在液晶顯示元件中表現出電壓保持率 等所需的電性能的觀點而言,優選于構成本發明的液晶配 向劑中的聚醯胺酸的酸二針中,以莫爾比汁優選含有1〇/〇 〜98%的所述芳香族四羧酸二酐,更優選含有10%〜95% 的所述芳香族四叛酸二針。 本發明的四叛酸二針優選包含如下的脂環式四緩酸二 酐及脂肪族四羧酸二酐中的一方或雙方,所述脂環式四羧 酸二酐是兩個酸酐中的至少一個是由鍵結在脂環式化合物 上的兩個叛基所形成的酸酐的化合物,所述脂肪族四缓酸 是具有兩個由鍵結在脂肪族化合物上的兩個羧基所形成的 酸酐的化合物。作為所述脂環式四羧酸二酐,例如可以列 舉以下述結構式(19)〜結構式(22)、結構式(24)〜結構式(44) 及結構式(49)〜結構式(65)所表示的化合物。 41 201022331 32945pif.doc40 201022331 32945pif.doc The aromatic tetra-rebel acid liver is preferably in the t configuration (1) structural formula (2), structural formula (5) - structural formula (7), structural formula ((1), structural formula (12) and structure The compound represented by the formula (14) is more preferably a compound represented by the structural formula (1), and is preferably a viewpoint that the liquid crystal display element exhibits electrical properties required for a voltage holding ratio or the like. In the acid two needles constituting the polyproline in the liquid crystal alignment agent of the present invention, the aromatic carboxylic acid dianhydride is preferably contained in an amount of from 1% to 98 to 98%, more preferably 10% by weight. 95% of the aromatic tetra-retensive acid two-needle. The four-poisonic acid two-needle of the present invention preferably contains one or both of the following alicyclic tetra-acid dianhydride and aliphatic tetracarboxylic dianhydride. The cyclic tetracarboxylic dianhydride is a compound in which at least one of the two acid anhydrides is an acid anhydride formed by two rebel groups bonded to an alicyclic compound having two bonds a compound of an acid anhydride formed by two carboxyl groups bonded to an aliphatic compound as the alicyclic tetracarboxylic acid Examples of the anhydride include compounds represented by the following structural formula (19) to structural formula (22), structural formula (24) to structural formula (44), and structural formula (49) to structural formula (65). 41 201022331 32945pif .doc

42 201022331 32945pif.doc42 201022331 32945pif.doc

43 201022331 32945pif.doc [化 32-3]43 201022331 32945pif.doc [Chem. 32-3]

(60) (61)(60) (61)

作為所述脂肪族四羧酸二酐,例如可以列舉以下述結 構式(23)、結構式(45)〜結構式(48)、結構式(66)及結構式 (67)所表示的化合物。Examples of the aliphatic tetracarboxylic dianhydride include compounds represented by the following structural formula (23), structural formula (45) to structural formula (48), structural formula (66), and structural formula (67).

44 201022331 32945pif.doc44 201022331 32945pif.doc

[化 33][化33]

所述脂環式四羧酸二酐及所述脂肪族四羧酸二酐優 選以所述結構式(19)、結構式(23)、結構式(25)、結構式(35) 〜結構式(39)、結構式(44)及結構式(49)所表示的化合物, 更優選以所述結構式(19)、結構式(23)所表示的化合物。另 外,就在液晶顯示元件中表現出電壓保持率等所需的電性 能的觀點而言,于構成本發明的液晶配向劑中的聚醯胺酸 的酸一酐中,以莫爾比計優選含有1%〜98%的所述脂環式 四敌酸二軒及所述脂職四賊二針,更優選含有跳〜 95%的所述脂環式四紐二酐及所述脂_四魏二肝。 本發明巾所使_四舰二野優選包切倍 氧燒由於是高度的交聯體且不會被水 解,因此搞対德半尬可讀化作魏晶配向劑的 45 201022331 32945pif.doc 保存穩定性。料,即使過量地使帛, f牛的顯雜能等帶來不良雜,因此可以軸 南的液晶配向膜。 本發明中所使用㈣倍半氧院二軒衍生物例如可以 使用w〇〇3_2487〇號手冊中所記載的梦倍半氧烧二肝衍生 物,此矽倍半氧烷二酐衍生物以如下通式表示。 [化 34]The alicyclic tetracarboxylic dianhydride and the aliphatic tetracarboxylic dianhydride preferably have the structural formula (19), the structural formula (23), the structural formula (25), and the structural formula (35) to the structural formula. (39) The compound represented by the structural formula (44) and the structural formula (49), more preferably the compound represented by the structural formula (19) or the structural formula (23). In addition, from the viewpoint of exhibiting electrical properties required for a voltage holding ratio and the like in the liquid crystal display element, it is preferable to use a molar ratio in the acid anhydride of the poly-proline which constitutes the liquid crystal alignment agent of the present invention. Containing 1% to 98% of the alicyclic tetrahydro acid dixanthine and the lipid thief two needles, more preferably containing 〜95% of the alicyclic tetranic dianhydride and the lipid _four Wei Er liver. The invention of the invention makes the _ four ships and the second field preferably octave oxy-combustion because it is a highly cross-linked body and will not be hydrolyzed, so it can be read as a Weijing alignment agent 45 201022331 32945pif.doc stability. In addition, even if the enthalpy of the yttrium, f cattle is excessively mixed, the liquid crystal alignment film can be used. The (tetra) sesquioxin derivative used in the present invention may be, for example, a dreamy hemoxytetraacetate derivative as described in the manual of the 〇〇3 2 〇 〇 , , , , , , Expressed by the general formula. [34]

所述式(S)中’ R分別獨立地選自氫、礙數為1〜45的 烷基、經取代或未經取代的芳基(aiyl)及經取代或未經取代 的芳基烷基’ Y獨立地以下述(a)或(b)表示。 [化 35]In the formula (S), R is independently selected from hydrogen, an alkyl group having a hindrance of 1 to 45, a substituted or unsubstituted aryl group, and a substituted or unsubstituted arylalkyl group. 'Y is independently represented by the following (a) or (b). [化35]

(b) 所述式(a)及式(b)中的X中,一個或兩個X表示酸酐 基’剩餘的X分別獨立為氫、鹵素(halogen)、羥基(hydroxyl) 46 201022331 32945pif.doc 或一價有機基,Z為-ο-、-CH2-或單鍵。其中,於碳數為J 〜45的烷基中,任意的氫可以被氟取代,任意的CH2-可 以被-〇·、-CH=CH-、環烷烯基(cycl〇alkyiene)或環烯撐 (cycloalkenylene)取代。於經取代或未經取代的芳基烷基中 的烷烯基中,任意的氫可以被氟取代,任意的_CH2·可以被 -0- ’ -CH=CH-或環烧稀基取代。(b) In the formula (a) and the formula (b), one or two X represents an acid anhydride group. The remaining X is independently hydrogen, halogen, or hydroxyl. 46 201022331 32945pif.doc Or a monovalent organic group, Z is -ο-, -CH2- or a single bond. Wherein, in the alkyl group having a carbon number of from J to 45, any hydrogen may be substituted by fluorine, and any CH2- may be -〇·, -CH=CH-, cycloalkenyl (cyclic) or cycloalkenyl Replacement with cycloalkenylene. In the alkenyl group in the substituted or unsubstituted arylalkyl group, any hydrogen may be substituted by fluorine, and any _CH2. may be substituted by -0-'-CH=CH- or a ring-burning group.

所述通式中,特別優選的矽倍半氧烷二酐衍生物是以 如下結構式(S-1)所表示的化合物。 [化 36] (S-1) p0h-si-°〇?sr-°Ph 0) 气 另外,就在液晶顯示元件中表現出電壓保持率等所需 的電性能,並表現出長期熱可靠性的觀點而言,于構成本 發明的液晶配向劑中的聚酿胺酸的酸二軒中,以莫爾比計 優選含有1%〜60%的所述石夕倍半氧烧二酐衍生物,更優選 含有10%〜40%的所述&gt;5夕倍半氧烧二酐衍生物。 本發明中所使用的四羧酸二酐,可以在實現本發明的 効果的範圍内,任意地使用它的種類或調配量。另外,于 本發明中,優選使用將以所述通式(TCM)〜通式(TC_14)所 表示的四羧酸二酐與一種或一種以上的其他四羧酸二酐共 聚而成的共聚物。通過使用四鲮酸二酐,會提高配向劑的 保存穩定性,因此優選使用四竣酸二酐。 也可以將所述四叛酸二酐的一部分替換成叛酸酐 47 201022331 32945pif.doc (carboxylic anhydri岭此種替換可以引起生成聚酿胺酸時 的聚合,應的終止(tenninatiGn)’何財卩制聚合反應使其 不再進行下去。因此,通過此種替換,可以容易地控制所 獲得=聚合物(聚醯魏或者其衍絲)的分子量,例如可 以不抽及本發明的效果而改善液晶配向劑的塗布特性。羧 ,相對於四銳二_比率只要在残及本發明效果的 範圍内即可’作為基準’優選為小於等於四叛酸二針總量 Θ 的1〇莫_ /。。只要不損及本發明的效果,那麼替換成叛酸 ^的^酸二肝可以是—種,也可以是兩種或者兩種以 上。作為所錢酸單酐,例如可以列舉:馬來酸針(maleic anhydnde) . ^ (phthalic anhydride) ^ (=嶋acid anhydride)、正癸基琥站酸軒㈣㈣職响 acnd anhydnde)、正十二烷基琥珀酸軒 断、正十六錄琥賴㈣及環己酸針。十絲琥拍 〇 =四紐二肝可以在二㈣相對於_酸 率小於等於H)莫爾%的範_,將吨酸二針的 ,成二幾酸。只要不損及本發明的效果 酸的:舰二—是-種,也可以是兩種或=之竣 本發明中所使用的二胺是具有側鏈結構的。 側鏈結構的二胺是指具有如下取代基(顯)的二胺,ς 代基在將連結兩個氨基的取代基作為主鏈時自主鏈八 並且可以表現出所需的預傾角(Pretilt ang丨e)。具有: f的二胺中的側鏈只要根據所要求的預傾角而適當地選^ Ρ可,例如此側鏈可以列舉礙數大於等於8的基。所述且 48 201022331 32945pif.doc 有侧鏈結構的二胺可以列舉以下述通式(VIII)及通式(X)〜 通式(XI)所表示的化合物。 [化 37] R1Among the above formulas, a particularly preferred sesquinal dianhydride derivative is a compound represented by the following structural formula (S-1). (S-1) p0h-si-°〇?sr-°Ph 0) Gas additionally exhibits electrical properties such as voltage holding ratio in liquid crystal display elements, and exhibits long-term thermal reliability. In view of the above, in the acid succinic acid constituting the polyacrylic acid in the liquid crystal alignment agent of the present invention, it is preferable to contain 1% to 60% of the sesame sesquiterpoxide dianhydride derivative in terms of a molar ratio. More preferably, it contains 10% to 40% of the &gt;5 sesquioxide dianhydride derivative. The tetracarboxylic dianhydride used in the present invention may be arbitrarily used in its kind or blending amount within the range in which the effects of the present invention are achieved. Further, in the present invention, a copolymer obtained by copolymerizing a tetracarboxylic dianhydride represented by the above formula (TCM) to formula (TC-14) with one or more other tetracarboxylic dianhydrides is preferably used. . The use of tetradecanoic dianhydride improves the storage stability of the alignment agent, and therefore it is preferred to use tetradecanoic dianhydride. It is also possible to replace a part of the four resorcinic dianhydrides with a tickic acid anhydride. 47 201022331 32945pif.doc (This kind of substitution of carboxylic anhydriling can cause polymerization when polylactoic acid is formed, and should be terminated (tenninatiGn)' The polymerization reaction is prevented from proceeding. Therefore, by such substitution, the molecular weight of the obtained polymer (polyfluorene or its filament) can be easily controlled, for example, the liquid crystal alignment can be improved without extracting the effects of the present invention. The coating property of the agent. The ratio of the carboxy group to the tetra-ruthenium ratio is preferably 'as a reference' in the range of the effect of the present invention and is preferably equal to or less than 1 〇 of the total amount of the four-poisonous two-needle. As long as the effects of the present invention are not impaired, the diacids of the acid which are replaced with the tickose may be of the same type, or may be two or more. As the monoacid anhydride, for example, a maleic acid needle may be mentioned. (maleic anhydnde) . ^ (phthalic anhydride) ^ (=嶋acid anhydride), Zhengyijihuzhanxuan (4) (4) occupational acnd anhydnde), n-dodecyl succinic acid Xuan, Zheng 16 Lu Hu (4) and Cyclohexanoic acid needle. Ten silk shot 〇 = four new liver can be in the second (four) relative to the _ acid rate is less than or equal to H) Mohr% of the _, will be two needles of acid, into two acids. As long as the effects of the present invention are not impaired, the acid: ship II - is - type, or both or = 竣 The diamine used in the present invention has a side chain structure. The diamine of the side chain structure means a diamine having a substituent (display) which is an autonomous chain when the substituent linking the two amino groups is used as a main chain and can exhibit a desired pretilt angle (Pretilt ang)丨e). The side chain of the diamine having: f may be appropriately selected according to the desired pretilt angle. For example, the side chain may include a group having a hindrance of 8 or more. The above-mentioned diamine having a side chain structure may, for example, be a compound represented by the following formula (VIII) and formula (X) to formula (XI). [化37] R1

(VIII) ❹(VIII) ❹

(通式(VIII)中,A3 表示單鍵、-〇·、_c〇〇_、-OCO-、 -CO-、-CONH-或-(CH2)m-(m表示1〜6的整數),R!表示具 有類固醇骨架的基或以下述通式(IX)所表示的基,當鍵結 在苯環上的兩個氨基的位置關係為對位時R]進一步包含 碳數為1〜30的燒基’當此位置關係為間位時r1進一步包 含碳數為1〜30的烧基或苯基,於此院基中,任意的_〇^2_ 可以獨立地被-CF2-、-CHF·、-0-(此處並非連續)、_ch=CH-或-〇C·取代 ’ -CH3 可以被-CHyF、-chf2 或-cf3 取代,-ch3 可以被-CHJ、-CHF2或-CF3取代,此苯基的氫可以獨立地 被-F、-CH3、-OCH3、-OCH2F、-〇CHF2 或-〇CF3 取代。其 中’當所述四叛酸二酐僅包含以通式(TC-1)〜通式(TC-14) 所表示的四羧酸二酐時,R1進一步包含的所述烷基的碳數 為23〜30)。 [化 38](In the formula (VIII), A3 represents a single bond, -〇·, _c〇〇_, -OCO-, -CO-, -CONH- or -(CH2)m- (m represents an integer of 1 to 6), R! represents a group having a steroid skeleton or a group represented by the following formula (IX), and when the positional relationship of two amino groups bonded to the benzene ring is para-position, R) further contains a carbon number of 1 to 30. When the positional relationship is meta-position, r1 further contains a burning group or a phenyl group having a carbon number of 1 to 30. In this hospital base, any _〇^2_ may be independently -CF2-, -CHF· , -0-(here is not continuous), _ch=CH- or -〇C·substitution '-CH3 may be substituted by -CHyF, -chf2 or -cf3, and -ch3 may be substituted by -CHJ, -CHF2 or -CF3, The hydrogen of the phenyl group may be independently substituted by -F, -CH3, -OCH3, -OCH2F, -〇CHF2 or -〇CF3. wherein 'when the four-rebel dianhydride contains only the general formula (TC-1) When the tetracarboxylic dianhydride represented by the formula (TC-14) is used, the alkyl group further contained in R1 has a carbon number of 23 to 30). [化38]

JdJd

(通式(IX)中’_A及A分別獨立地表示單鍵、_〇_(此 處並非連續)、-COO-、-OCO-、-CONH-、-CH=CH-或者碳 49 201022331 32945pif.doc =為1〜12的烷烯基,!^及R3分別獨立地表示_F或七%, 環s獨立地表示M.次苯基、M_環己稀、u_二惡燒上 一基、鳴咬_2,5·二基、β比咬心,4_二基、萘],5_二基蔡力 一基,蒽-9,10·二基’ R4表示_H、_F、碳數為ι〜3〇的浐 基二碳數為1〜30的氟取代烷基、碳數為1〜30的烷氣基^ ON、视秘、-〇CHF2或_0(^3,a及b分別表示〇〜: 的整數’ c、d及e分別表示〇〜3的整數,(及§分別獨立 地表示0〜2的整數,且c + d+egl。其中,當c + d + e=l 時,R4表示碳數為1〜30的烷基、碳數為丨〜孙的氟取代 燒基或碳數為1〜30的烷氧基,通式(VIII)的A3表示碳數 大於等於1的基)。 [化 39](In the general formula (IX), '_A and A each independently represent a single bond, _〇_ (here is not continuous), -COO-, -OCO-, -CONH-, -CH=CH- or carbon 49 201022331 32945pif .doc = alkenyl group of 1 to 12, !^ and R3 each independently represent _F or seven%, and ring s independently represents M. phenylene, M_cyclohexene, and u_dioxin. Base, biting _2,5·diyl, β-biting, 4_diyl, naphthalene], 5_diyl-Cali-based, 蒽-9,10·diyl' R4 means _H, _F, a fluoro-substituted alkyl group having a carbon number of 1 to 30 and a carbon group having a carbon number of 1 to 30, ON, a secret, -〇CHF2 or _0 (^3, a And b denote 〇~: the integers 'c, d, and e respectively represent integers of 〇~3, (and § independently represent integers of 0~2, respectively, and c + d+egl. Where, when c + d + When e=l, R4 represents an alkyl group having a carbon number of 1 to 30, a fluorine-substituted alkyl group having a carbon number of 丨~sun or an alkoxy group having a carbon number of 1 to 30, and A3 of the formula (VIII) represents a carbon number. A base greater than or equal to 1.)

(通式(X)及(XI)中,R5獨立地表示_H或^出,R6表示 或者碳數為1〜2〇的烷基或碳數為2〜20的烯基,A6 立地表不單鍵、-C0·或-CH2-,通式(XI)中,R7及R8分 】獨立地表示-H、碳數為1〜20的烷基或苯基)。 50 201022331 32945pif.doc 本發明中所使用的二胺優選以通式(V111;1所表示的二 胺·,且式中R]包含以如下通式(R1-1)〜通式(RL7)所表示的 化合物。 [化 40](In the general formulae (X) and (XI), R5 independently represents _H or ^, and R6 represents an alkyl group having a carbon number of 1 to 2 fluorene or an alkenyl group having a carbon number of 2 to 20, and the A6 site is not only A bond, -C0. or -CH2-, in the formula (XI), R7 and R8 each independently represent -H, an alkyl group having 1 to 20 carbon atoms or a phenyl group). 50 201022331 32945pif.doc The diamine used in the present invention is preferably a diamine represented by the formula (V111; 1 and wherein R) is represented by the following formula (R1-1) to (RL7). The compound represented. [Chem. 40]

(通式(RL!)中,R表示碳數為1〜30的烷基、碳數為 1〜3〇的氟取代絲或碳數為卜3G的魏基,當通式 (W-l)的R是碳數為1的基時,通式(VIII)的A3表示碳數 i於ί於、1的基,通式(Ri-2)〜通式(r1-7)中,R表示-H、 數為1〜30的烷基、碳數為1〜3〇的氟取代烷基、 :1 〜30 的烷氧基、-c=n、-och2f、-ochf2 或-〇CF3, 表不_〇•或碳數為1〜6的烷烯基)。 J&amp; 百 、一 一而言,優選含有選自以下述通式(VIIK2)〜通式 51 201022331 32945pif.doc (VIII_8)所表示的化合物中的炙少一種。 [化 41](In the formula (RL!), R represents an alkyl group having a carbon number of 1 to 30, a fluorine-substituted silk having a carbon number of 1 to 3 fluorene, or a fluorenyl group having a carbon number of 3G, as R of the formula (Wl) When it is a group having a carbon number of 1, the A3 of the formula (VIII) represents a group having a carbon number i in the range of 1, wherein, in the formula (Ri-2) to the formula (r1-7), R represents -H, An alkyl group having 1 to 30 carbon atoms, a fluorine-substituted alkyl group having 1 to 3 carbon atoms, an alkoxy group having 1 to 30, -c=n, -och2f, -ochf2 or -〇CF3, not shown. • or an alkenyl group having a carbon number of 1 to 6). In the case of J&amp;, it is preferred to contain one selected from the group consisting of compounds represented by the following formula (VIIK2) to formula 51 201022331 32945 pif.doc (VIII_8). [化41]

〇 (所述通式中,R52表示旅數為16〜30的炫基’R表 示碳數為1G〜30的絲,#表示碳數Μ〜Μ的烧基, R55表示碳數為2〜30躲基452優選雜為16〜25的烧 基,R53優選碳數為10〜25的嫁基,R54優選礙數為4〜25 的烧基,R55優選碳數為2〜%的烷基)。 以所述通式(VIII)所表系的二胺可以使用幕所周知的 方法來製造。作為此種製造方法,例如可以列舉在:使1,2_ 笨二胺與鄰笨二甲酸軒在氣環境下反應,將反應物溶解於 /農硫酸並與發煙俩混合’再使祕、歸料原劑的售 ^的還原2下’將所獲得之化合物 還原成氨基的方法。 52 201022331 32945pif.doc 以所所表示的二胺優選在通式,兩個 “戰.A A的一個鍵結在類固醇骨架的3位,另-個 鍵結在6位^外,優選兩個氨基分別鍵結在苯環的碳上, 且鍵結在A的鍵結仇置的間位或對位上。 作為以通式(X)所表示的二胺,例如可以列舉以下述結 構式(X-1)〜結構式(X_4)所表示的二胺。 [化 42]〇 (In the above formula, R52 represents a radix of 16 to 30, and R represents a filament having a carbon number of 1 G to 30, # represents a carbon number of Μ Μ Μ, and R 55 represents a carbon number of 2 to 30. The radical 452 is preferably a halogen group of 16 to 25, R53 is preferably a graft having a carbon number of 10 to 25, R54 is preferably a group having a hindrance of 4 to 25, and R55 is preferably an alkyl group having a carbon number of 2 to 5%. The diamine represented by the above formula (VIII) can be produced by a method known in the art. As such a production method, for example, a reaction of 1,2_stanediamine and o-dibenzoic acid in an air environment is carried out, and the reactant is dissolved in / sulphuric acid and mixed with the smog. A method of reducing the compound obtained by reduction of the obtained compound to an amino group. 52 201022331 32945pif.doc The diamine represented by the formula is preferably in the general formula, one of the two "war.AA bonds at the 3 position of the steroid skeleton, and the other bond is at the 6 position, preferably the two amino groups respectively. The bond is bonded to the carbon of the benzene ring, and the bond is in the meta or para position of the bonding of A. As the diamine represented by the formula (X), for example, the following structural formula (X-1) can be cited. ) to a diamine represented by the structural formula (X_4).

“作為以所述通式(ΧΙ)所表示的二胺,在通式(χι)中雨 個“NH2-(R6_)ph_A6_〇_,,分別鍵結在苯環上的碳上,但褫遂 鍵結在類固醇骨架所鍵結的碳的間位或對位的碳上σ为 外兩個我基分別鍵結在苯環的礙上,但優選鍵結在A 鍵的間位或對位上。 作為以通式(XI)所表示的二胺,例如可以列舉以f逑 53 201022331 32945pif.doc 結構式(XI-1)〜結構式(XI-8)所表示的二胺。 [化 43-1]"As a diamine represented by the above formula (ΧΙ), in the formula (χι), a "NH2-(R6_)ph_A6_〇_, which is bonded to the carbon on the benzene ring, respectively, but 褫The 遂 bond is in the meta or para carbon of the carbon bonded by the steroid skeleton. The σ is the outer two ke groups respectively bonded to the benzene ring, but preferably the bond is in the meta or alignment of the A bond. on. The diamine represented by the formula (XI) is, for example, a diamine represented by the structural formula (XI-1) to the structural formula (XI-8) of f逑 53 201022331 32945 pif.doc. [Chem. 43-1]

54 201022331 32945pif.doc [&gt;[匕 43-2]54 201022331 32945pif.doc [&gt;[匕 43-2]

55 201022331 32945pif.doc 就在液晶顯示元件中表現出所需的預傾角的觀點而 言,于構成本發明的液晶配向劑中的聚醢胺酸的二胺中, 以莫爾比計優選含有1%〜90%的所述具有側鏈結構的二 胺,更優選含有5%〜70%的所述具有側鏈結構的二胺。 另外’本發明中所使用的二胺也可以進一步包含不具 有侧鏈結構的二胺。不具有側鏈結構的二胺是指不具有如 下取代基(側鏈)的二胺,此取代基在將連結兩個氨基的取 代基作為主鏈時自主鏈分支,並且可以表現出所需的預傾 角。所述不具有侧鏈結構的二胺可以列舉以下述通式⑴〜 Θ 通式(νπ)、通式(XV)、通式(N)及通式(a)所表示的化合物。 56 (I) 201022331 32945pif.doc55 201022331 32945pif.doc From the viewpoint of exhibiting a desired pretilt angle in the liquid crystal display element, the diamine of the polylysine which constitutes the liquid crystal alignment agent of the present invention preferably contains 1 in a molar ratio. From 0.01 to 90% of the diamine having a side chain structure, more preferably from 5% to 70% of the diamine having a side chain structure. Further, the diamine used in the present invention may further contain a diamine having no side chain structure. A diamine having no side chain structure means a diamine having no substituent (side chain) which branches autonomously when a substituent linking two amino groups is used as a main chain, and can exhibit desired Pretilt angle. The diamine having no side chain structure may, for example, be a compound represented by the following formula (1) to formula (νπ), formula (XV), formula (N) and formula (a). 56 (I) 201022331 32945pif.doc

[化 44] H2N—X—NH2 η η2ν^—^·νη2Η2Ν〇-γ-〇 h2nC^nh2 νη2H2N—X—NH2 η η2ν^—^·νη2Η2Ν〇-γ-〇 h2nC^nh2 νη2

η2ν〇·ΥΌΥΌνη2Η2ν〇·ΥΌΥΌνη2

(II) (Hi) (IV) (V) (VI) (νιι) (个1)m (个2)η (个”丨 νη2 (Ν) η2ν(II) (Hi) (IV) (V) (VI) (νιι) (1) m (2) η (“” 丨 νη2 (Ν) η2ν

-ΝΗ, Ν η2ν 通式⑴中,X表示-(CH2)m-(m表示1〜6的整數),通 式(III)及通式(V)〜通式(VII)中,Y獨立地表示單鍵、·〇-、 S-、_S-S-、-S02-、-CO-、-CONH-、-NHCO-、-NH-、 -N(CH3HCH2)m-N(CH3)-、-C(CH3)2-、-C(CF3)2-、-(CH2)m-、 57 201022331 32945pif.doc -0-(0¾)^、-S-(CH2)m-S-(m 表示卜6 的整數),通式(v) 中’ Z表示單鍵或不存在,通式(χν)中,r33及r34分別獨 立地表示碳數為1〜3的錄絲基,A3獨立地表示亞f 基、次苯基或域基取代的次苯基,丨表示丨〜6的整數, m表示1〜10的整數。通式(11)〜通式(νπ)中, 烷環或苯環上的氫可以獨立地被_F、_CH3、 Θ Γ的〇==其卿2取代’通式(IV)中的苯環上所鍵 。通綱巾’A1社地表示破 ϊί'Γ為1〜4的烧氧基、乙酿胺、氟、 i n 數為1〜3狀基,m表示0〜3 cm的整數。通式⑷中,L!表示氳、破數 為1〜4的烷基、笨基或苄基。 作為以通式(I)所表示的二胺,例如可以以下述结 構式(1-1)〜結構式(1_3)所表示的二胺。 [化 45] Ο H2N(CH2)2NH2 H2N(CH2)4NH2 H2N(CH2)eNH2 (M) d-2) (1-3) 作為以通式(II)所表示的二胺’例如可以 卞述鍺 構式(II-1)、結構式(11_2)所表示的二胺。 [化 46] Ί~|^ρΝΗ2 η2ν-(^)-νη2 Η2Ν~ (ΙΙ-2) (11-1) 結構二=可以列舉β 58 201022331 32945pif.doc [化 47]-ΝΗ, Ν η2ν In the formula (1), X represents -(CH2)m- (m represents an integer of 1 to 6), and in the formula (III) and the formula (V) to the formula (VII), Y independently Represents a single bond, 〇-, S-, _S-S-, -S02-, -CO-, -CONH-, -NHCO-, -NH-, -N(CH3HCH2)mN(CH3)-, -C( CH3)2-, -C(CF3)2-, -(CH2)m-, 57 201022331 32945pif.doc -0-(03⁄4)^, -S-(CH2)mS-(m represents an integer of 卜6), In the general formula (v), 'Z represents a single bond or does not exist. In the general formula (χν), r33 and r34 each independently represent a carbon number of 1 to 3, and A3 independently represents a sub-f group and a benzene. A subphenyl group substituted with a base or a domain group, 丨 represents an integer of 丨~6, and m represents an integer of 1 to 10. In the general formula (11) to the general formula (νπ), the hydrogen on the alkane ring or the benzene ring may be independently substituted by _F, _CH3, Θ = == 卿2, and the benzene ring in the formula (IV) On the key. The general-purpose towel 'A1' indicates that the alkyl group, the ethylamine, the fluorine, and the n n number are 1 to 3 groups, and m represents an integer of 0 to 3 cm. In the formula (4), L! represents an anthracene, an alkyl group having a number of 1 to 4, a strepyl group or a benzyl group. The diamine represented by the formula (I) may, for example, be a diamine represented by the following structural formula (1-1) to structural formula (1_3). Ο H2N(CH2)2NH2 H2N(CH2)4NH2 H2N(CH2)eNH2 (M) d-2) (1-3) As the diamine represented by the formula (II), for example, the 锗 configuration can be described. (II-1), a diamine represented by the structural formula (11-2).化~|^ρΝΗ2 η2ν-(^)-νη2 Η2Ν~ (ΙΙ-2) (11-1) Structure 2 = can be cited as β 58 201022331 32945pif.doc [Chem. 47]

作為以通式(IV)所表示的二胺,例如可以列舉以下述 結構式(IV-1)〜結構式(IV-17)所表示的二胺。The diamine represented by the formula (IV) is, for example, a diamine represented by the following structural formula (IV-1) to structural formula (IV-17).

[化 48] h2nhQ-nh2 h2n-Q-nh2h2nhQ-nh2 h2n-Q-nh2

(IV-1) (IV-2)(IV-1) (IV-2)

HOHO

COOHCOOH

H2N,v、NH2 (!V-8)H2N, v, NH2 (!V-8)

59 201022331 32945pif.doc 作為以通式(V)所表示的二胺,例如可以列舉以下述結 構式(V-1)〜結構式(V-37)所表示的二胺。 [化 49-1]In the case of the diamine represented by the formula (V), for example, a diamine represented by the following structural formula (V-1) to structural formula (V-37) can be mentioned. [化 49-1]

(V-13) (V-14) (V-15) ^-〇&quot;°^0Ό-νη2 η2νη〇κ°—〇λ_τνΗ2 (V-16) (V-17) h2n-^°—°^k-nh2 h2n-Qk°——o^-NH2 (V-18) (V-19) 60 201022331 32945pif.doc [化 49-2] h2n Ο (V-21) (V-20) h2N~~C~^~s~~s~C~^~nh2 HzN~HC~^s^s&gt;'sC~^~NH2 (V-22) (V-23)(V-13) (V-14) (V-15) ^-〇&quot;°^0Ό-νη2 η2νη〇κ°—〇λ_τνΗ2 (V-16) (V-17) h2n-^°—°^k -nh2 h2n-Qk°——o^-NH2 (V-18) (V-19) 60 201022331 32945pif.doc [化49-2] h2n Ο (V-21) (V-20) h2N~~C~ ^~s~~s~C~^~nh2 HzN~HC~^s^s&gt;'sC~^~NH2 (V-22) (V-23)

h2n^Q-S—s-〇-NH^ h2n-^ks—s-Q-nh2 (V-24) (V-25) h2n-^Ks'-^^s^J^NH2 (V-26) h2n-〇^S—-S^h2 (V-27)H2n^QS—s-〇-NH^ h2n-^ks—sQ-nh2 (V-24) (V-25) h2n-^Ks'-^^s^J^NH2 (V-26) h2n-〇^ S—-S^h2 (V-27)

OH OHOH OH

HQHQ

(V-33)(V-33)

(V-34) h2n(V-34) h2n

(V-35) nh2 (V-36) 61 201022331 32945pif.doc(V-35) nh2 (V-36) 61 201022331 32945pif.doc

(V-37) [化 49-3] h2n 作為以通式(VI)所表示的二胺,例如可以列舉以下述 結構式(VI-1)〜結構式(VI-6)所表示的二胺。 [化 50] ^ ^ -nh2(V-37) [Chem. 49-3] h2n The diamine represented by the formula (VI), for example, a diamine represented by the following structural formula (VI-1) to structural formula (VI-6) . [化 50] ^ ^ -nh2

(VI-1) (v|-2) 吵❹。分0分叫Η2Ν^^〇γ々ΝΗ2 (VI-4)(VI-1) (v|-2) Noisy. 0 points are called Η2Ν^^〇γ々ΝΗ2 (VI-4)

/-ΝΗ2 (VI-6) (VI-3) η2ν (VI-5) 作為以通式(vii)所表示的二胺,例如可以列舉以下述 〇 結構式(VII-1)〜結構式(VII-16)所表示的二胺。 62 201022331 32945pif.doc [化 51]ΝΗ2 (VI-5) (VI-5) η2ν (VI-5) Examples of the diamine represented by the formula (vii) include the following formula (VII-1) to (VII). -16) The diamine represented. 62 201022331 32945pif.doc [Chem. 51]

h2nH2n

NH2 h2n (Vtl-1) h2nNH2 h2n (Vtl-1) h2n

ch2Ch2

(VU-3)(VU-3)

(VH-5)(VH-5)

(VII-7)(VII-7)

NH2 (VH-2)NH2 (VH-2)

nh2 (VIM) h2nNh2 (VIM) h2n

nh2 (VII-6)Nh2 (VII-6)

H2NH2N

NH (VII-8) nh2 (VII-9) (VI MO) H2N_^^°'vC^ch2V〇k〇nC)k&quot;nh2 hzn'^C^0'vO^ch2^O^0&quot;O_nh2 (VII-11) (VII-12)NH (VII-8) nh2 (VII-9) (VI MO) H2N_^^°'vC^ch2V〇k〇nC)k&quot;nh2 hzn'^C^0'vO^ch2^O^0&quot;O_nh2 (VII -11) (VII-12)

(VH-15) (Vll-ΐβ) 作為以通式(XV)所表示的二胺,例如可以列舉以下述 結構式(XV-1)所表示的化合物。 63 201022331 32945pif.doc [化 52] ?h3 ch3 H2N*C3H6~Si—〇-Si-C3H6_NH2 CH3 ch3 (XV-1) 作為以通式(N)所表示的二胺,例如可以列舉以下述結 構式(N)-l〜結構式(N)-2、結構式(N)-5〜結構式(N)-7、結 構式(N)-9〜結構式(N)-10、結構式(N)-14、結構式(N)-17 〜結構式(N)-18、結構式(N)-21〜結構式(N)-23、結構式 (N)-26及結構式(N)-28所表示的化合物。 201022331 32945pif.doc [化 53] η2ν- η2ν(VH-15) (Vll-ΐβ) The diamine represented by the formula (XV) is, for example, a compound represented by the following formula (XV-1). And the like. (N)-l~Structure Formula (N)-2, Structural Formula (N)-5~Structure Formula (N)-7, Structural Formula (N)-9~Structure Formula (N)-10, Structural Formula (N -14, Structural Formula (N)-17~Structure Formula (N)-18, Structural Formula (N)-21~Structure Formula (N)-23, Structural Formula (N)-26 and Structural Formula (N)- Compound represented by 28. 201022331 32945pif.doc [化53] η2ν- η2ν

/ν~0^νη2 (Ν)-1 (Ν)-2/ν~0^νη2 (Ν)-1 (Ν)-2

CI η2νCI η2ν

CICI

Ν Ν—^ jj~~ΝΗ2 (Ν)-6 ΟΝ Ν—^ jj~~ΝΗ2 (Ν)-6 Ο

Br、 Η2ΝBr, Η2Ν

H3cq η2νH3cq η2ν

(Ν)-7 Ν^~~^Ν (Ν)-10(Ν)-7 Ν^~~^Ν (Ν)-10

Br H3COCHN ΗΗmC^'nh2 h2n-^^nC/n_&lt;Cj&gt;_i NHCOCH3 νη2Br H3COCHN ΗΗmC^'nh2 h2n-^^nC/n_&lt;Cj&gt;_i NHCOCH3 νη2

〇ch3 &gt;-νη2 (Ν)-9 Η2Ν—Ν'^/ν~^~&quot;^~~νη2 (Ν)-14 η2ν〇ch3 &gt;-νη2 (Ν)-9 Η2Ν—Ν'^/ν~^~&quot;^~~νη2 (Ν)-14 η2ν

Ν Ν \f (Ν)-17Ν Ν \f (Ν)-17

ΝΗ2ΝΗ2

η2ν·Η2ν·

NHCOCH3 NHCOCH3〇-^^ΝΗ2 (Ν)-21 η2νNHCOCH3 NHCOCH3〇-^^ΝΗ2 (Ν)-21 η2ν

(Ν)-18 och3 h3covN^fsl (Ν)-22(Ν)-18 och3 h3covN^fsl (Ν)-22

νη2Ηη2

Cl η2νCl η2ν

Ν Ν Ν_/ (Ν)-23Ν Ν Ν_/ (Ν)-23

νη2 JHL 厂' HsN \_ν~Ν\_/Ν.Νη2 JHL Factory ' HsN \_ν~Ν\_/Ν.

/^ΝΗ2 (Ν)-26/^ΝΗ2 (Ν)-26

Hgcq η2νHgcq η2ν

och3 H3cq&lt;DCH3 ΝΗζ (Ν)-28 65 201022331 32945pif.doc 作為以通式(a)所表示的二胺,例如可以列舉以下述結 構式(a-Ι)及結構式(a-2)所表示的化合物。 [化 54] h2nOch3 H3cq &lt;DCH3 ΝΗζ (Ν)-28 65 201022331 32945pif.doc The diamine represented by the formula (a) is, for example, represented by the following structural formula (a-Ι) and structural formula (a-2). compound of. [化54] h2n

(a-1)(a-1)

NH2 這些二胺中,所述不具有側鏈結構的二胺優選以結構 式(IV-1)〜結構式(IV-5)、結構式(IV-15)〜結構式(IV-17)、 結構式(V-1)〜結構式(V-13)、結構式(V-26)、結構式 (V-27)、結構式(V-31)、結構式(V-33)、結構式(V-35)〜結 構式(V-37)、結構式(VI-1)、結構式(VI-2)、結構式(VI-6)、 結構式(VII-1)〜結構式(VII-5)及結構式(XV-1)所表示的二 胺,更優選以結構式(IV-1)、結構式(IV-2)、結構式(IV-15) 〜結構式(IV-17)、結構式(V-1)〜結構式(V-13)、結構式 (V-33)、結構式(V-35)〜結構式(V-37)、結構式(VII-2)、結 構式(XV-1)、結構式(N)-l、結構式(N)-2、結構式(N)-14及 結構式(a-Ι)所表示的二胺。 就在液晶顯示元件中表現出離子密度(ion density)等 所需的電性能的觀點而言,于構成本發明的液晶配向劑中 的聚醯胺酸的二胺中,以莫爾比計優選含有1〇/。〜98%的所 述不具有侧鏈結構的二胺,更優選含有10%〜95%的所述 不具有側鏈結構的二胺。 本發明中的二胺可以使用所述的以通式⑴〜通式 (VIII)、通式(X)〜通式(XI)、通式(XV)及通式(N)所表斧的 201022331 32945pif.doc 二胺以外的其他二胺。作為此種其他二胺’例如可以列舉· 具有萘結構的萘系二胺,具有芴(fluorene)結構的努系_ 胺,以下述通式(XII)、(XIII)所表示的二胺,以及除通Z (VIII)及通式(X)〜通式(XI)以外的具有側鏈結構的二胺: [化 55]Among these diamines, the diamine having no side chain structure preferably has the structural formula (IV-1) to the structural formula (IV-5), the structural formula (IV-15) to the structural formula (IV-17), Structural formula (V-1) to structural formula (V-13), structural formula (V-26), structural formula (V-27), structural formula (V-31), structural formula (V-33), structural formula (V-35)~Structure Formula (V-37), Structural Formula (VI-1), Structural Formula (VI-2), Structural Formula (VI-6), Structural Formula (VII-1)~Structure Formula (VII) -5) and the diamine represented by the structural formula (XV-1), more preferably structural formula (IV-1), structural formula (IV-2), structural formula (IV-15) - structural formula (IV-17) ), structural formula (V-1) to structural formula (V-13), structural formula (V-33), structural formula (V-35) to structural formula (V-37), structural formula (VII-2), A diamine represented by the structural formula (XV-1), the structural formula (N)-1, the structural formula (N)-2, the structural formula (N)-14, and the structural formula (a-Ι). From the viewpoint of exhibiting electrical properties required for ion density or the like in the liquid crystal display element, it is preferable to use a molar ratio in the diamine of the poly-proline which constitutes the liquid crystal alignment agent of the present invention. Contains 1〇/. ~98% of the diamine having no side chain structure, more preferably 10% to 95% of the diamine having no side chain structure. The diamine in the present invention can be used as described in the formula (1) to the formula (VIII), the formula (X) to the formula (XI), the formula (XV) and the formula (N) 201022331 32945pif.doc Other diamines other than diamines. Examples of the other diamines include naphthyl diamines having a naphthalene structure, fluorene-containing amides, diamines represented by the following general formulae (XII) and (XIII), and a diamine having a side chain structure other than Z (VIII) and formula (X) to formula (XI): [Chem. 55]

r10 r11 通式(XII)及(XIII)中,Α7獨立地表示_〇_或碳數為 的烷烯基。另外,通式(XII)中,R9表示_H或碳數為%〜3〇 的烷基,此烷基中,碳數為2〜30的烷基的任意_CH 以 瘳 被-〇-(此處並非連續)、-CH=CH-或-OC-取代二A8 ^乔單 鍵或碳數為1〜3的烷烯基,環T表示丨,舡次苯基或i,‘ 環己烯,h表示〇或卜進而,通式(ΧΙΠ)中,r1g&amp;示破數 為6〜22的烧基,R11表示碳數為〗〜22的燒武。 以所述通式(XII)所表示的二胺中,在通 雨 個氨基分繼結在苯環的碳上,但魏鱗在a7的間位威 對位上。 作為以通式(XII)所表示的二胺,例 述 通式ραι-υ〜通式(ΧΠ-8)所絲的二胺。Μ舉以下 67 201022331 32945pif.doc [化 56-1]R10 r11 In the formulae (XII) and (XIII), Α7 independently represents _〇_ or an alkenyl group having a carbon number of . Further, in the formula (XII), R9 represents _H or an alkyl group having a carbon number of from 3% to 3 Å, and in the alkyl group, any _CH of an alkyl group having a carbon number of from 2 to 30 is 瘳-〇-( Here, it is not continuous), -CH=CH- or -OC-substitutes two A8^Joe single bonds or alkenyl groups having a carbon number of 1 to 3, and ring T represents fluorene, fluorenyl or i, 'cyclohexene, h Further, in the formula (ΧΙΠ), r1g&amp; shows a burnt group having a number of breaks of 6 to 22, and R11 represents a burnt ring having a carbon number of 〜22. In the diamine represented by the above formula (XII), the amino group in the rain is successively attached to the carbon of the benzene ring, but the Wei scale is in the meta position of the a7. The diamine represented by the formula (XII) is exemplified by a diamine of the formula ραι-υ to the formula (ΧΠ-8). Μ举 following 67 201022331 32945pif.doc [Chem. 56-1]

R29 R29R29 R29

R30R30

68 201022331 32945pif.doc68 201022331 32945pif.doc

[化 56-2] R3〇[化56-2] R3〇

以所述通式(xiii)所表示的二胺中,在通式(xm)中, ::氨,別鍵結在苯環上的碳上,但優選相對於八7鍵結 於間位或對位上 不的 作為以通式(χιπ)所表示的二胺,〇 述通式(XJiJ-】)〜通式(ΧΙΠ-3)所表s u $如可以列舉以τ 69 201022331 32945pif.doc [化 57]In the diamine represented by the above formula (xiii), in the formula (xm), :: ammonia is bonded to the carbon on the benzene ring, but is preferably bonded to the meta position relative to the octa 7 or The diamine represented by the formula (χιπ) in the para position is described in the formula (XJiJ-) to the formula (ΧΙΠ-3). Su $ can be enumerated as τ 69 201022331 32945pif.doc [ 57]

通式(XIII-1)〜(XIII_3)中,R31優選表示碳數為6〜22 的烷基,更優選表示碳數為6〜20的烷基。R32優選表示-H 或碳數為1〜22的烷基,更優選表示碳數為1〜10的烷基。 作為其他二胺,例如可以列舉以下述通式(Γ)〜通式 (8')所表示的化合物。 201022331 32945pif.docIn the general formulae (XIII-1) to (XIII_3), R31 preferably represents an alkyl group having 6 to 22 carbon atoms, and more preferably an alkyl group having 6 to 20 carbon atoms. R32 preferably represents -H or an alkyl group having 1 to 22 carbon atoms, and more preferably represents an alkyl group having 1 to 10 carbon atoms. Examples of the other diamines include compounds represented by the following formula (Γ) to (8'). 201022331 32945pif.doc

[化 58][化58]

R36分別獨立地表示碳數R36 independently represents the carbon number

通式(Γ)〜通式(8,)中,R35及 為3〜30的烷基。 在構成本發明的液晶配向劑中的聚醯 ^以在不損及本發顿果的程㈣ 對於所述二胺來說, C_ine)相對於二胺的比率小於^-胺中,在單胺 内’將二胺的―部分替換 、等、莫爾%的範圍 聚醢胺酸時的聚合反應的终止,=種替換可以引起生成 不再進行下去1此,通軸種叫難合反應使其 、可以容易地控制所 71 201022331 32945pif.doc 獲得的聚合(聚醯胺酸或者其衍生物)的分子量,例如可以 不損及本發明的效果而改善液晶配向劑的塗布特性。只要 不損及本發明的效果,那麼替換成單胺的二胺可以是一 種I也Γ是兩種或兩種以上。作為所述單胺,例如可以 列舉:本胺(―)、4,基苯胺(4_hydr〇xyanmne)、環己 胺(Cyd〇heXylamine)、正丁胺(n_butylamine)、正戊胺、正 己胺、正庚胺、正辛胺、正壬胺、正癸胺、正十一胺、正 十二胺、正十三胺、正十四胺、正十五胺、正十六胺、正 十七胺、正十八胺以及正二十胺。 0 、所述聚st胺酸或者其衍生物❸單體巾也可 =進步包含單異氰酸酯(monoisocyanate)化合物。通過使 單體中包含單異氰酸醋化合物,可以修飾所獲得的聚酿胺 酸或者其衍生物的末端,而調節分子量。通過使用此末端 修飾型的聚醯胺酸或者其衍生物,例如可以不損及本發明 的效果而改善液晶配向劑的塗布特性。就所述的觀點而 5,單體中的單異氰酸酯化合物的含量優選相對於單體中 的二胺及四羧酸二酐的總量為丨莫爾%〜10莫爾0/〇。作為 〇 所述單異氰酸酯化合物,例如可以列舉異氰酸苯酯及異氰 酸萘酯。 ~ 除使用以通式(TC-1)〜通式(TC_14)所表示的四鲮酸 一野、以通式(VIII)及通式(X)〜通式(XI)所表示的二胺以 外,所述聚醯胺酸或者其衍生物可以通過與聚醯亞胺的膜 的形成中所使用的眾所周知的聚醯胺酸或者其衍生物相同 的方式製造。四叛酸二酐的總添加量優選與二胺的總莫爾 72 201022331 32945pif.doc 數大致等莫爾(莫爾比為0.9〜1.1左右)。 所述聚醯胺酸或者其衍生物的分子量以聚苯乙烯 (polystyrene)換算的重量平均分子量(Mw)計優選為 10,000〜5GG,GGG,更優選為2〇,_〜2⑻。所述聚酿胺 酸或者其衍生物的分子量可以通過利用凝膠滲透色譜(㈤In the formula (Γ) to the formula (8,), R35 and an alkyl group of 3 to 30 are used. In the liquid crystal alignment agent constituting the present invention, the ratio of C_ine) to diamine is less than that of the diamine in the process of not damaging the present invention (IV) for the diamine, in the monoamine The termination of the polymerization reaction when the 'partial replacement of the diamine, the equimolar range of polyamine, and the substitution of the valinate, the substitution of the species can cause the formation to no longer proceed, and the through-axis species is called a difficult reaction. The molecular weight of the polymerization (polyglycine or a derivative thereof) obtained by the method of 2010 201031 31 32945 pif. doc can be easily controlled, and for example, the coating property of the liquid crystal alignment agent can be improved without impairing the effects of the present invention. The diamine substituted with a monoamine may be one type I or two or more types as long as the effects of the present invention are not impaired. The monoamine may, for example, be a present amine (-), 4, phenylaniline (4_hydr〇xyanmne), cyclohexylamine (Cyd〇heXylamine), n-butylamine (n-butylamine), n-pentylamine, n-hexylamine, or Heptamine, n-octylamine, n-decylamine, n-decylamine, n-undecylamine, n-dodecylamine, n-tridecylamine, n-tetradecylamine, n-pentadecylamine, n-hexadecylamine, n-heptadecaneamine, N-octadecylamine and n-dodecylamine. 0. The polystamic acid or a derivative thereof, the monomeric towel, may also be improved to include a monoisocyanate compound. By including a monoisocyanate compound in the monomer, the terminal of the obtained polyacrylic acid or a derivative thereof can be modified to adjust the molecular weight. By using this terminally modified polylysine or a derivative thereof, for example, the coating properties of the liquid crystal alignment agent can be improved without impairing the effects of the present invention. In view of the above, 5, the content of the monoisocyanate compound in the monomer is preferably 丨 mol% to 10 mol%/〇 with respect to the total amount of the diamine and the tetracarboxylic dianhydride in the monomer. Examples of the monoisocyanate compound include phenyl isocyanate and naphthyl isocyanate. ~ In addition to the tetralinic acid represented by the general formula (TC-1) to the general formula (TC_14), and the diamine represented by the general formula (VIII) and the general formula (X) to the general formula (XI) The polyaminic acid or a derivative thereof can be produced in the same manner as the well-known polyaminic acid or a derivative thereof used in the formation of a film of a polyimide. The total addition amount of the four resorcinic dianhydrides is preferably equal to the total mole of the diamines, such as the molar ratio of 0.9 to 1.1. The molecular weight of the polyamic acid or a derivative thereof is preferably 10,000 to 5 GG, GGG, more preferably 2 Å, _2 to 2 (8), based on the weight average molecular weight (Mw) in terms of polystyrene. The molecular weight of the polyacrylic acid or its derivative can be determined by using gel permeation chromatography ((5)

Permeation Chromatography,GPC)法進行測定而求出。 所述聚醯胺酸或者其衍生物可以通過如下方式來確 參 認其存在,即通過紅外光譜(Infrared spectr〇sc〇py,ir)、核 磁共振(Nuclear Magnetic Resonance,NMR)對利用大量的 不良溶劑進行沉澱而獲得的固體成分進行分析。另外,可 以通過如下方式來確認所使用的單體,即利用KOH或 NaOH等強鹼的水溶液將所述聚醯胺酸或者其衍生物分 解’並利用氣相色譜(Gas Chromatography,GC)、高效液 相色譜(High Performance Liquid Chromatography,HPLC) 或者氣相色言普-質譜(Gas Chromatograph-Mass Spectrometer ’ GC-MS)對利用有機溶劑自此分解混合物中 ® 獲得的萃取物進行分析。 本發明的液晶配向劑可以進一步含有所述聚醯胺酸 或者其衍生物以外的其他成分。其他成分可以是一種,也 可以是兩種或兩種以上。 例如,就使液晶顯示元件的電性能長期穩定的觀點而 言,本發明的液晶配向劑可以進一步含有烯基取代納迪克 酿亞胺化合物。所述烯基取代納迪克酿亞胺化合物可以是 一種化合物,也可以是兩種或兩種以上的化合物。就所述 73 201022331 32945pif.doc 的觀點而言,所述烯基取代納迪克醯亞胺化合物的含量以 相對于液晶配向劑中的聚醯胺酸或者其衍生物的重量比 計,優選為0.01〜1.00,更優選為0.01〜〇·7〇,進—步i 選為0.01〜0.50。 所述烯基取代納迪克醯亞胺化合物優選可以在溶解 本發明中所使用的聚醯胺酸或者其衍生物的溶劑中溶解的 化合物。此種細基取代納迪克酿亞胺化合物的例子可以列 舉以下述通式(Ina)所表示的化合物。 [化 59]The Permeation Chromatography (GPC) method was measured and determined. The polyaminic acid or a derivative thereof can be confirmed by the presence of a large amount of defects by infrared spectroscopy (Infrared spectr〇sc〇py, ir) and nuclear magnetic resonance (NMR). The solid component obtained by precipitation of the solvent was analyzed. In addition, the monomer to be used can be confirmed by decomposing the polyamic acid or a derivative thereof with an aqueous solution of a strong alkali such as KOH or NaOH and using gas chromatography (GC), which is highly efficient. High Performance Liquid Chromatography (HPLC) or Gas Chromatograph-Mass Spectrometer 'GC-MS is used to analyze the extract obtained from the decomposition mixture using an organic solvent. The liquid crystal alignment agent of the present invention may further contain the polypyridic acid or other components other than the derivative thereof. The other ingredients may be one type or two or more types. For example, the liquid crystal alignment agent of the present invention may further contain an alkenyl group-substituted nadicki-imine compound from the viewpoint of stabilizing the electrical properties of the liquid crystal display element for a long period of time. The alkenyl-substituted nadick-yourmine compound may be one compound or two or more compounds. The content of the alkenyl-substituted nadicylimine compound is preferably 0.01 in terms of the weight ratio of the poly-proline or the derivative thereof in the liquid crystal alignment agent, from the viewpoint of the above-mentioned 73 201022331 32945 pif. 〜1.00, more preferably 0.01~〇·7〇, and step i is selected from 0.01 to 0.50. The alkenyl-substituted nadicylimine compound is preferably a compound which can be dissolved in a solvent which dissolves the poly-proline or the derivative thereof used in the present invention. Examples of such a fine group-substituted Nadick-based imine compound can be exemplified by the compound represented by the following formula (Ina). [化59]

通式(Ina)中,L1及L2分別獨立地表示氫、碳數為1 〜12的烷基、碳數為3〜6的烯基、碳數為5〜8的環烷基 (cycloalkyl)、芳基或节基,n表示1或2。 土 當n=l時,W表示碳數為i〜12的烷基、碳數為2 〜6的烯基、碳數為5〜8的環烷基、碳數為6〜12的芳美、 节基、以』(〇)#〇)名H(zl、Z2及z3獨立地表示碳土數 為2〜6的輯基,q表示〇或卜而且r表示卜孙的敕 數)所麵、〜(zVb_z5_h(z4及立地表示碳二 為1〜4的輯基或碳數為5〜8的環輯基,Β表示次笨 ,,而且s表不0或〗)所表示的基、以-Β-Τ-Β-Η(Β表示次 苯基’而且 τ 表示_CH2_、_c(CH3)2_、_〇_、携_、^_或 SCV)所表㈣基、或者這絲的丨個〜3個氫被羥基取代 201022331 32945pif.doc 而成的基。 此時,優選的W是碳數為1〜8的烧基、碳數為3〜4 的烯基、環己基(cyclohexyl)、苯基、苄基、碳數為4〜1〇 的聚(乙烯氧基)乙基(poly(ethyleneoxy)ethyl)、苯氧基苯基 (phenyloxy phenyl)、苯基曱基苯基(phenyl methyl phenyl)、 苯基異亞丙基苯基(phenyl isopropylidene phenyl)、以及這 些基的1個或2個氳被羥基取代而成的基。In the general formula (Ina), L1 and L2 each independently represent hydrogen, an alkyl group having 1 to 12 carbon atoms, an alkenyl group having 3 to 6 carbon atoms, a cycloalkyl group having 5 to 8 carbon atoms, and An aryl or a benzyl group, n represents 1 or 2. When n=l, W represents an alkyl group having a carbon number of i to 12, an alkenyl group having a carbon number of 2 to 6, a cycloalkyl group having a carbon number of 5 to 8, and a merma, a carbon having a carbon number of 6 to 12. Base, with 』(〇)#〇)Name H (zl, Z2, and z3 independently represent the base of carbon tolls 2 to 6, q is 〇 or 卜 and r is the number of 卜孙), ~ (zVb_z5_h (z4 and the standing indicates that the carbon two is a ring of 1 to 4 or a ring with a carbon number of 5 to 8, and Β represents a second stupid, and the s table is not 0 or 〗)) -Τ-Β-Η(Β denotes subphenylene' and τ denotes _CH2_, _c(CH3)2_, _〇_, carry _, ^_ or SCV) (4) base, or one of the wires ~3 The hydrogen is substituted by a hydroxyl group by a group of 201022331 32945pif.doc. In this case, preferred W is a carbon group having a carbon number of 1 to 8, an alkenyl group having a carbon number of 3 to 4, a cyclohexyl group, a phenyl group, or the like. a benzyl group, a poly(ethyleneoxy)ethyl group having a carbon number of 4 to 1 Å, a phenyloxy phenyl group, a phenyl methyl phenyl group, and a benzene group. Phenyl isopropylidene phenyl, and one or two of these hydrazines are replaced by hydroxy groups Into groups.

當通式(Ina)中的n=2時,W表示碳數為2〜20的烷 烯基、碳數為5〜8的環烷烯基、碳數為6〜12的亞芳基 (arylene)、以-Ζ^Ο-θονζ3#1〜Z3以及r的含義如上所 述)所表示的基、以-Z4_B-Z5-(Z4、Z5及B的含義如上所述) 所表示的基、以-B-(0-B)s-T-(B-0)s-B-(B表示次苯基,τ表 示碳數為1〜3的烷烯基、或_S〇2_,s表示〇或丨)所表 示的基、或者這些基的1個〜3個氫被羥基取代而成的基。 ^此時’優選的冒是碳數為2〜12的烷烯基、環己烯、 次苯基、甲苯烯(tolylene)、苯二甲基(xylylene)、以 -C^-O-^OVO-CKZ2表示碳數為2〜6的烷烯基、r 表示1或2)所表示的基、以_Β_Τ_Β_(Β表示次苯基,而且τ 表示-Ον、_〇-或·δ〇2_)所表示的基、以 f-〇_B-C3H6_B-0-B-(B表示次苯基)所表示的基、以及這些 基的1個或2個氫被羥基取代而成的基。 — 此種烯基取代納迪克醯亞胺化合物例如可以使用:如 第2729565號公報中所記載般’通過將稀基 納适克酸if衍生物與二胺在崎〜2抓的溫度下保持 201022331 32945pif.doc 小時〜20小時進行合成而獲得的化合物、或者 物。作為歸基取代納迪克醯亞胺化合物的具 的化合 舉以下所示的化合物。 可以歹 N-甲基·稀丙基雙環[2 21]庚_5•烯-2,3·二 Ν·甲基-婦丙基甲基雙環[2.2.1]庚-5-烯-2,3-二甲酼亞胺、 甲基-甲基烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯、队 甲基-甲基烯丙基甲基雙環[221]庚_5-烯义夂—胺、队 胺、Ν-(2-乙基己基)_烯丙基雙環[2 21]庚_ :甲隨亞 亞胺、 岬乂3'二甲醯 g丞己暴)_婦丙基(曱基)雙環[2 2a 二甲醯亞胺、N-烯丙基-烯丙基雙環[2·21]庚·5· 、j,3 醯亞胺、Ν·烯丙基-婦丙基甲基雙環[2 21]庚·,3-^ 醯亞胺、Ν_稀丙基-曱基稀丙基雙環[2.2.1]庚_5嫌,, 醯亞胺、Ν·異丙縣,丙基雙環[2·21]庚_ _,3_-二〒 亞胺、Ν•異丙烯基-烯丙基(甲基)雙環[2.2.1]庚_5:二甲雖 曱醯亞胺、Ν·異丙稀基_甲基烯丙基雙環[2 祕,3-二When n=2 in the general formula (Ina), W represents an alkenyl group having 2 to 20 carbon atoms, a cycloalkenyl group having 5 to 8 carbon atoms, and an arylene group having 6 to 12 carbon atoms. ), the base represented by -Ζ^Ο-θονζ3#1 to Z3 and r as described above, and the base represented by -Z4_B-Z5- (the meaning of Z4, Z5, and B are as described above) -B-(0-B)sT-(B-0)sB-(B represents a subphenyl group, τ represents an alkenyl group having a carbon number of 1 to 3, or _S〇2_, s represents 〇 or 丨) The group represented by the group or a group in which one to three hydrogens of these groups are substituted with a hydroxyl group. ^At this time, 'the preferred one is an alkenyl group having 2 to 12 carbon atoms, cyclohexene, phenylene, tolylene, xylylene, and -C^-O-^OVO. -CKZ2 represents an alkenyl group having 2 to 6 carbon atoms, r represents a group represented by 1 or 2), _Β_Τ_Β_ (Β represents a subphenyl group, and τ represents -Ον, _〇- or ·δ〇2_) The group represented by the group represented by f-〇_B-C3H6_B-0-B-(B represents a phenyl group) and a group in which one or two hydrogens of these groups are substituted with a hydroxyl group. — such an alkenyl-substituted nadicylimine compound can be used, for example, as described in Japanese Patent No. 2729565, by maintaining a dilute quinamic acid if derivative and a diamine at a temperature of 2, 2, 2 32945 pif.doc A compound or substance obtained by synthesis in an hour to 20 hours. The compound shown below is a compound which is a substituting group of a nadic ylidene imine compound. It can be N-methyl-dilylbicyclo[2 21]hept-5-ene-2,3·diindolemethyl-propylpropylmethylbicyclo[2.2.1]hept-5-ene-2, 3-dimethylimine, methyl-methylallylbicyclo[2.2.1]hept-5-ene-2,3-dimethylhydrazine, benzyl-methylallylmethylbicyclo[221 Geng _5-ethylidene-amine, amide, Ν-(2-ethylhexyl)-allylbicyclo[2 21]g _ : methyl imidate, 岬乂 3 dimethyl hydrazine暴暴) _ propyl (indenyl) bicyclo [2 2a dimethyl sulfoximine, N-allyl-allyl bicyclo [2 · 21] g · 5 ·, j, 3 quinone imine, Ν · Allyl-propylpropylmethylbicyclo[2 21]g,3-^ quinone imine, Ν-propyl-decyl propyl bicyclo[2.2.1]g _5 ,, 醯imino , Ν·isopropyl County, propyl bicyclo [2·21] g _ _, 3 _ di quinone imine, Ν • isopropenyl-allyl (methyl) bicyclo [2.2.1] g _ 5: two A 曱醯 曱醯 imine, Ν · isopropyl _ methallyl bicyclo [2 secret, 3- two

二甲醯亞胺、Ν_環己基,丙基雙環[2 2.丨]庚 酿亞胺、Ν·環己基·烯丙基(曱基)雙環[,’ ^甲 甲醢亞胺、Ν·環己基_甲基稀丙基雙雖21]庚=’3-二 -曱醯亞胺、Ν-苯基-烯丙基雙環 烯义3_ 亞胺、 ^2,3_二甲酿 Ν-苯基-烯丙基(甲基)雙環[2 亞胺、Ν_节基,丙基雙環似狀 W甲3酿二甲酿 N-节基-稀丙基甲基雙環[2.2 亞胺、 π ,一笮醯亞胺、N- 76 201022331 32945pif.doc 节基-曱基稀丙基雙環[2.2.1]庚·5·稀_2,3_二甲酿亞胺-羥基乙基)·娣丙基雙環[2.2.1]庚_5_烯-2,3-二曱醯亞胺、 Ν-(2-羥基乙基)-烯丙基(曱基)雙環[22」]庚烯·-二 醯亞胺、Ν-(2_羥基乙基)_甲基烯丙基雙環[m]庚· -2,3-二曱酿亞胺、 Ν-(2,2-二f基-3-經基丙基)_烯丙基雙環[2 21]庚· ❹Dimethyl imine, Ν-cyclohexyl, propyl bicyclo [2 2. 丨] heptanimide, Ν·cyclohexyl·allyl (indenyl) bicyclo [, '^-methionine, Ν· Cyclohexyl-methyl-propyl propyl double 21]hept='3-di-indenine, fluorenyl-phenyl-allyl bicycloalkenene 3_imine, ^2,3-dimethyl hydrazine-benzene -Allyl (methyl) bicyclo [2 imine, Ν 节 , , propyl bicyclic like W A 3 broth N-pyringyl - propyl methyl bicyclo [2.2 imine, π, Imine imine, N-76 201022331 32945pif.doc benzyl-decyl propyl bicyclo [2.2.1] g · 5 · dilute _2, 3 dimethyl anilide - hydroxyethyl) 娣 娣Bicyclo[2.2.1]hept-5-ene-2,3-diimineimine, Ν-(2-hydroxyethyl)-allyl (indolyl)bicyclo[22]]heptene·- Yttrium imine, Ν-(2-hydroxyethyl)-methylallylbicyclo[m]heptane-2,3-diindole, imine-(2,2-di-f--3- Propyl)-allylbicyclo[2 21]heptane

-2,3-二甲醯亞胺、N-(2,2-二甲基_3_羥基丙基)_烯丙基(甲基 雙環[2.Z1]庚-5-烯-2,3-二甲醯亞胺、叫2,3_二羥基丙 烯丙基雙環[2·2.1]庚-5-烯_2,3-二曱醯亞胺、N-(2,3_二羥基 丙基)-烯丙基(曱基)雙環[2.2.1]庚_5_烯_2,3·二曱醯亞胺t N-(3-羥基-i_丙烯基)-烯丙基雙環[221]庚_5_烯_2,3_二甲醯 亞胺、N-(4-羥基環己基)-烯丙基(甲基)雙環[2 2丨]庚_5_烯 -2,3-二曱醯亞胺、 n-(4-經基苯基)-婦丙基雙環[22.η庚_5_婦_2,3_二甲醢 亞胺、Ν-(4-羥基苯基)_烯丙基(甲基)雙環[2.2.1]庚-5-烯-2,3- 二曱醯亞胺、Ν-(4-羥基苯基)-甲基烯丙基雙環[2.21]庚_5_ 烯-2,3-二甲醯亞胺、Ν-(4-羥基苯基)-甲基烯丙基曱基雙環 [2.2.1]庚-5-烯-2,3-二甲醯亞胺、Ν-(3-羥基苯基)_烯丙基雙 環[2.2.1]庚_5_烯_2,3_二甲醯亞胺、ν_(3_羥基苯基)_烯丙基 (曱基)雙環[2.2.1]庚_5_蝉-2,3-二甲醯亞胺、Ν•(對羥基苄 基)-婦丙基雙環[2.2.1]庚-5·烯-2,3-二甲醯亞胺、Ν·{2_(2_羥 基乙氧基)乙基}-烯丙基雙環卩.2.1]庚_5-烯_2,3- 二甲酿亞 胺、 Ν-{2-(2·羥基乙氧基)乙基}•烯丙基(甲基)雙環[2 21] 77 201022331 32945pif.doc 庚-5-烯-2,3-二曱醯亞胺、Ν·{2-(2-羥基乙氧基)乙基}-曱基 烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺、Ν-{2-(2-羥基乙 氧基)乙基}-曱基烯丙基曱基雙環[2.2.1]庚-5·烯-2,3·二曱 酿亞胺、Ν_[2-{2-(2-經基乙乳基)乙氣基}乙基]-稀丙基雙ί衷 [2.2.1] 庚-5-烯-2,3-二曱醯亞胺、沁[2-{2_(2-羥基乙氧基)乙 氧基}乙基]-烯丙基(甲基)雙環[2.2.1]庚-5-烯-2,3-二甲醯亞 胺、Ν-[2-{2-(2-羥基乙氧基)乙氧基}乙基]-曱基烯丙基雙環 [2.2.1] 庚-5-烯-2,3-二甲醯亞胺、Ν-{4-(4-羥基苯基異亞丙基) 苯基}-烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺、Ν-{4-(4-羥基苯基異亞丙基)苯基烯丙基(曱基)雙環Ρ.2.1]庚_5_烯 -2,3_二曱醯亞胺、Ν-{4-(4-羥基苯基異亞丙基)苯基}-曱基 烯丙基雙環[2.2.1]庚-5-烯-2,3_二曱醯亞胺、以及這些的低 聚物(oligomer)、 Ν,Ν'-乙烯雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二曱醯亞 胺)、Ν,Ν'-乙烯-雙(烯丙基曱基雙環[2.2.1]庚-5-烯-2,3-二曱 醯亞胺)、Ν,Ν’-乙烯-雙(曱基烯丙基雙環[2.2.1]庚-5-烯-2,3-二曱醯亞胺)、Ν,Μ-三亞曱基-雙(烯丙基雙環[2.2.1]庚-5·烯 -2,3-二曱醯亞胺)、Ν,Ν'-六亞曱基-雙(烯丙基雙環[2.2.1]庚 -5-烯-2,3·二曱醯亞胺)、Ν,Ν’-六亞曱基-雙(烯丙基曱基雙環 [2.2.1] 庚-5-烯-2,3-二曱醯亞胺)、Ν,Ν'-十二亞曱基-雙(烯丙 基雙環[2.2.1]庚-5-烯-2,3-二曱醯亞胺)、1^^-十二亞曱基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯-2,3-二曱醯亞胺)、Ν,Ν’-環己烯-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二曱醯亞胺)、 Ν,Μ-環己烯-雙(烯丙基曱基雙環[2.2.1]庚-5-烯-2,3-二曱醯 201022331 32945pif.doc 亞胺)、 1.2- 雙{3’-(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺) 丙氧基}乙烷、1,2-雙{3'-(烯丙基甲基雙環[2.2.1]庚-5-烯 -2,3-二曱醯亞胺)丙氧基}乙烷、1,2-雙{3'-(曱基烯丙基雙環 [2.2.1] 庚-5-烯-2,3-二甲醯亞胺)丙氧基}乙烷、雙[2匕{3’_(烯 丙基雙環[2.2.1]庚-5-烯-2,3-二曱醯亞胺)丙氧基}乙基] 醚、雙[2’-{3'-(烯丙基曱基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞 @ 胺)丙氧基}乙基]醚、1,4-雙{3’-(烯丙基雙環[2.2.1]庚-5-烯 -2,3-二甲醯亞胺)丙氧基}丁烷、1,4_雙{3’-(烯丙基甲基雙環 [2.2.1] 庚-5-烯-2,3-二曱醯亞胺)丙氧基} 丁烷、 ]^,:^-對次苯基-雙(烯丙基雙環卩.2.1]庚-5-烯-2,3-二曱 醯亞胺)、N,N'_對次苯基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯 •2,3-二甲醯亞胺)、Ν,Ν’-間次苯基-雙(烯丙基雙環[2.2.1]庚 -5-烯-2,3-二曱醯亞胺)、Ν,Ν’-間次苯基-雙(烯丙基曱基雙環 [2.2.1] 庚-5-烯-2,3-二曱醯亞胺)、:^,:^'-{(1-曱基)-2,4-次苯 基}-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、Ν,Ν’- 〇 對二曱苯基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞 胺)、Ν,Ν1ί二曱苯基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯 -2,3-二曱醯亞胺)、Ν,Ν’-間苯二曱基-雙(烯丙基雙環[2.2.1] 庚-5-烯-2,3-二曱醯亞胺)、Ν,Ν’-間苯二甲基-雙(烯丙基曱基 雙環[2.2.1]庚-5-烯-2,3-二曱醯亞胺)、 2.2- 雙[4-{4-(烯丙基雙環[2.2.1]庚-5-烯-2,3-二曱醯亞 胺)苯氧基}苯基]丙烷、2,2-雙[4-{4-(烯丙基曱基雙環[2.2.1] 庚-5-烯-2,3-二甲醯亞胺)苯氧基}苯基]丙烷、2,2-雙 79 201022331 .32945pif.doc [4爷(曱基烯丙基雙環[2.21]庚_5_稀_2,3 氧基}苯基]丙燒、雙{4-(稀丙基雙環[221]庚_5稀23胺= 醯亞胺)苯基}曱烷、雙{4_(烯丙基甲基雙 庚 -2,3-二曱醯亞胺)苯基}甲烷、 邓 “雙{4-(甲基烯丙基雙環[2.2.lm_5务2,3•二甲酿亞胺) 本基}甲炫、雙{4-(曱基烯丙基曱基雙環[2 21]庚_5_稀_2,3_ 二曱酿亞胺)苯基}代、雙{4_(烯丙基雙環[2.21]庚_5_稀 -2,3-二曱醯亞胺)苯基}醚、雙{4_(烯丙基甲基雙環[2 2 -5鲁2,3·二曱醯亞胺)笨基}醚、雙卜(曱基婦丙基雙環 [2_2·1]庚-5-烯-2,3-二甲酿亞胺)苯基鴻、雙Μ侦丙基雙環 [2.2.1] 庚·5_烯_2,3-二甲酿亞胺)苯基}職、雙&amp;(稀丙基甲基 雙環[2.2.1]庚_5_烯_2,3_二曱醯亞胺)苯基}砜、 雙(4_(甲基烯丙基雙環[2·2·1]庚稀办工曱醯亞 苯基}礙、1,6·雙(烯丙基雙環[2.2 η庚·5_烯_2&gt;二甲酿亞 胺)-3-經基己⑨、ι,ΐ2·雙(曱基烯丙基雙環[2 21]庚_5•稀 -2,3-二曱醯亞胺)-3,6·二經基十二&amp;、u_雙(烯丙基雙環 [2.2.1] 庚-5·稀_2,3·二甲醯亞胺)_5·經基環己烧、】5_雙 {34烯丙基雙環[2.2.^-5•烯办二甲醯亞胺)丙氧基}各 羥基戊烷、1,4·雙(烯丙基雙環[2.21]庚_5_烯_2,3_二曱醯亞 胺)-2-經基苯、 1,4-雙(稀丙基甲基雙環[2.2.lm_5,_2n_ 胺)-2,5-二羥基苯、N,N’_對(2_羥基)苯二曱基-雙(烯丙基雙 環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、'沖_對(2_羥基)笨二曱 基·雙(烯丙基甲基環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、 201022331 32945pif.doc 間(2_羥基)苯二曱基_雙(烯丙基雙環[2 21]庚_5•烯二 曱醯亞胺)、N,N,-間(2-經基)苯二甲基_雙(甲基_基雙環 [2.2.1] 庚_5_烯-2,3·二甲酿亞胺)、N,N’_對(2,3_二經基)笨二 甲基-雙(烯丙基雙環[2.2.1]庚_5·烯_2,3_二甲醯亞胺)、 2,2-雙[4-{4-(烯丙基雙環[2 21]庚·5_烯_2,3_二甲醯亞 胺)_2_羥基-苯氧基}苯基]丙烷、雙(4_(烯丙基曱基雙環 [2.2.1] 庚-5-烯-2,3-二甲醯亞胺)_2_羥基苯基}甲烷、$ 〇 {3_(烯丙基雙環卩.2.1]庚-5-烯-2,3·二曱醯亞胺)-4-羥基苯 基}醚、雙{3-(曱基烯丙基雙環[2 21]庚_5_稀_2,3_二甲^亞 胺)·5_經基苯基μ風、1,1,1_三{4_(烯丙基曱基雙環[221]庚 -5-烯-2,3·二甲醯亞胺)}苯氧基曱基丙烷、Ν,Ν,,Ν、三(乙 曱基烯丙基雙環Ρ.2.1]庚-5-烯-2,3-二甲醯亞胺)異氰尿萨 酯、以及這些的低聚物等。 夂 進而,本發明中所使用的烯基取代納迪克醯亞胺化人 物也可以是非對稱的含有烷烯基、次苯基的以下述鈐 所表示的化合物。 、、、°傳式 ❹ 81 201022331 32945pif.doc [化 60]-2,3-dimethylimine, N-(2,2-dimethyl-3-hydroxypropyl)-allyl (methylbicyclo[2.Z1]hept-5-ene-2,3 -dimethylimine, called 2,3-dihydroxypropylpropylbicyclo[2.2.1]hept-5-ene-2,3-diindoleimine, N-(2,3-dihydroxypropyl )-allyl (indenyl)bicyclo[2.2.1]hept-5-ene-2,3·diimine imine t N-(3-hydroxy-i-propenyl)-allylbicyclo[221 G?___ene_2,3_dimethylimine, N-(4-hydroxycyclohexyl)-allyl (methyl)bicyclo[2 2丨]hept-5-ene-2,3- Diquinone imine, n-(4-phenylphenyl)-propylpropyl bicyclo [22.ηg_5_wo-2,3-dimethylenimine, anthracene-(4-hydroxyphenyl) _Allyl (methyl)bicyclo[2.2.1]hept-5-ene-2,3-diimineimine, Ν-(4-hydroxyphenyl)-methylallylbicyclo[2.21]g _5_ ene-2,3-dimethylimine, Ν-(4-hydroxyphenyl)-methylallylhydrazinobicyclo[2.2.1]hept-5-ene-2,3-dimethylhydrazine Imine, Ν-(3-hydroxyphenyl)-allylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine, ν_(3-hydroxyphenyl)-allyl (fluorenyl)bicyclo[2.2.1]hepta-5_蝉-2,3-dimethylimine, Ν•(p-hydroxybenzyl)-propylpropylbicyclo[2.2.1]hept-5-ene- 2,3-dimethyl醯iamine, Ν·{2_(2-hydroxyethoxy)ethyl}-allylbicyclic hydrazine.2.1]gly-5-ene-2,3-dimethylanimine, Ν-{2-( 2·Hydroxyethoxy)ethyl}•allyl (methyl)bicyclo[2 21] 77 201022331 32945pif.doc Hept-5-ene-2,3-diimine, Ν·{2-( 2-hydroxyethoxy)ethyl}-mercaptopropylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine, Ν-{2-(2-hydroxyethoxy) Ethyl}-mercaptopropyl fluorenylbicyclo[2.2.1]hept-5-ene-2,3·diindole imine, Ν[[2-{2-(2-ylethylethyl) Ethyl]ethyl]-dilyl bis-[2.2.1]hept-5-ene-2,3-diimine, 沁[2-{2_(2-hydroxyethoxy)B Oxy}ethyl]-allyl (methyl)bicyclo[2.2.1]hept-5-ene-2,3-dimethylimine, Ν-[2-{2-(2-hydroxyethoxy) Ethyl}ethyl]-mercaptopropyl bicyclo [2.2.1] hept-5-ene-2,3-dimethylimine, Ν-{4-(4-hydroxyphenyl iso- Propyl)phenyl}-allylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine, fluorene-{4-(4-hydroxyphenylisopropylidene)phenyl Allyl (fluorenyl)bicyclic guanidine .2.1]g-5-ene-2,3-diimine, Ν-{4-(4-hydroxyphenyl isopropylidene Phenyl}-mercaptopropylbicyclo[2.2.1]hept-5-ene-2,3-diimine, and oligomers thereof, oxime, Ν'-ethylene bis ( Allyl bicyclo [2.2.1] hept-5-ene-2,3-diimide imine), hydrazine, Ν'-ethylene-bis(allylhydrazinobicyclo[2.2.1]hept-5- Alkene-2,3-diimineimine), hydrazine, Ν'-ethylene-bis(mercaptopropylbicyclo[2.2.1]hept-5-ene-2,3-diimineimine), Ν,Μ-trimethylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-diimineimine), anthracene, Ν'-hexamethylene-bis(allyl Bicyclo[2.2.1]hept-5-ene-2,3·diimide), hydrazine, Ν'-hexamethylene-bis(allylhydrylbicyclo[2.2.1]g-5 -ene-2,3-diimineimine), anthracene, Ν'-dodedecyl-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-diazide Amine), 1^^-dodedecyl-bis(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-diimineimine), anthracene, Ν'-cyclohexene Alkene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-diimineimine), anthracene, fluorene-cyclohexene-bis(allylhydrazinobicyclo[2.2.1 ]hept-5-ene-2,3-dioxime 201022331 32945pif.doc imine), 1.2-double {3'-( Propyl bicyclo [2.2.1] hept-5-ene-2,3-dimethylimine imine) propoxy}ethane, 1,2-bis{3'-(allylmethylbicyclo[2.2. 1]hept-5-ene-2,3-diimideimine)propoxy}ethane, 1,2-bis{3'-(nonylallylbicyclo[2.2.1]hept-5- Alkene-2,3-dimethylimine imine)propoxy}ethane, bis[2匕{3'_(allylbicyclo[2.2.1]hept-5-ene-2,3-diindole Imine)propoxy}ethyl]ether, bis[2'-{3'-(allylhydrazinobicyclo[2.2.1]hept-5-ene-2,3-dimethylidene@amine) Propoxy}ethyl]ether, 1,4-bis{3'-(allylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimineimine)propoxy}butane 1,4_bis{3'-(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-diimineimine)propoxy}butane, ]^,:^ - p-Phenyl-bis(allylbicycloindole.2.1)hept-5-ene-2,3-diimineimine), N,N'_p-phenylene-bis(allylmethyl) Bicyclo[2.2.1]hept-5-ene•2,3-dimethylimine), hydrazine, Ν'-m-phenylene-bis(allylbicyclo[2.2.1]hept-5-ene- 2,3-diimine), hydrazine, Ν'-m-phenylene-bis(allylhydrazinobicyclo[2.2.1]hept-5-ene-2,3-diimineimine) , :^, ^'-{(1-indolyl)-2,4-phenylene}-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine), hydrazine, Ν'- 〇 p-Diphenyl-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-carboximine), hydrazine, Ν1ί 曱 phenyl-bis(allyl Methylbicyclo[2.2.1]hept-5-ene-2,3-diimideimine), hydrazine, Ν'-m-phenylenedifluoryl-bis(allylbicyclo[2.2.1] g- 5-ene-2,3-diimineimine), hydrazine, Ν'-m-xylylene-bis(allylhydrazinobicyclo[2.2.1]hept-5-ene-2,3-di曱醯imino), 2.2-bis[4-{4-(allylbicyclo[2.2.1]hept-5-ene-2,3-diimineimine)phenoxy}phenyl]propane, 2,2-bis[4-{4-(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine)phenoxy}phenyl]propane, 2, 2-double 79 201022331 .32945pif.doc [4 曱 (mercaptopropyl double ring [2.21] g _5_ dilute _2, 3 oxy} phenyl] propyl, double {4- (dilyl bis bicyclo [ 221] Gg_5 dil 23 amine = quinone imine) phenyl} decane, bis {4_(allylmethyl bis heptane-2,3-diimideimine) phenyl} methane, Deng "double { 4-(Methylallylbicyclo[2.2.lm_52,3•Diennimine) Benki}A Hyun, Double {4-(曱Allyl fluorenylbicyclo[2 21]g _5_diluted _2,3_ diimineimine)phenyl}, bis{4_(allylbicyclo[2.21]g _5_rare-2, 3-diimineimine)phenyl}ether, bis{4_(allylmethylbicyclo[2 2 -5 ru 2,3 bis quinone imine) phenyl) ether, double bud Propylbicyclo[2_2·1]hept-5-ene-2,3-dimethylenimine)phenylhong, biguanide propyl bicyclo[2.2.1] g-5·ene-2,3-di甲 亚 ) ) 苯基 苯基 苯基 苯基 苯基 苯基 苯基 苯基 苯基 苯基 苯基 苯基 苯基 苯基 苯基 苯基 苯基 苯基 苯基 苯基 苯基 苯基 苯基 苯基 苯基 苯基 苯基 苯基 苯基 苯基 苯基 苯基 苯基 苯基 苯基 苯基 苯基 苯基 苯基 苯基 苯基 苯基 苯基Methylallyl bicyclo [2·2·1] Geng 办 曱醯 phenylene] hind, 1,6 · bis (allyl bicyclo [2.2 η g · 5 _ _ _2 gt; Amine)-3-carbyl 9, ι, ΐ 2 · bis (nonylallyl biscyclo[2 21]hept-5 sulphate-2,3-diimine)-3,6·di-based Twelve &amp;, u_ bis (allyl bicyclo [2.2.1] hept-5 · dilute _2, 3 · dimethyl quinone imine) _5 · via base ring hexane, 5_ bis {34 ally Bicyclo[2.2.^-5• olefinic dimethyl quinone imine] propoxy} hydroxypentane, 1,4 bis (allylbicyclo[2.21]hept-5-ene-2,3_2曱醯imino)-2-phenylbenzene, 1,4-bis(dilylmethylbicyclo[2 .2.lm_5,_2n_amine)-2,5-dihydroxybenzene, N,N'_p-(2-hydroxy)benzodiazepine-bis(allylbicyclo[2.2.1]hept-5-ene- 2,3-dimethylimine), '冲_对对(2_hydroxy) 笨 曱 · · bis (allylmethylcyclo[2.2.1]hept-5-ene-2,3-dimethyl醯imine), 201022331 32945pif.doc (2-hydroxy) benzodiazepine _ bis (allylbicyclo [2 21] hept-5 ene diimide), N, N, - (2 -transmethyl) benzylidene-bis(methyl-ylbicyclo[2.2.1]hept-5-ene-2,3-dimethylanimine), N,N'_pair (2,3_2 Styrene dimethyl-bis(allylbicyclo[2.2.1]hept-5ene-2-,3-dimethylimine), 2,2-bis[4-{4-(allyl Bicyclo[2 21]hept-5-ene_2,3-dimethylimine)_2_hydroxy-phenoxy}phenyl]propane, bis(4_(allylhydrazinobicyclo[2.2.1] Hg-5-ene-2,3-dimethylimine imine)_2_hydroxyphenyl}methane, 〇{3_(allylbicycloindole.2.1)hept-5-ene-2,3·diindole Imine)-4-hydroxyphenyl}ether, bis{3-(mercaptopropylbicyclo[2 21]hept-5-diuretic 2,3-dimethylimine)·5_ylphenyl μ wind, 1,1,1_three {4_(allylhydrazinobicyclo [221]hept-5-ene-2,3.dimethylanilide)} phenoxy Propyl propyl, hydrazine, hydrazine, hydrazine, tris(ethenylallylbicyclopurine .2.1]hept-5-ene-2,3-dimethylimine)isocyanurate, and these Oligomers, etc. Further, the alkenyl-substituted nadicil imidized human used in the present invention may be an asymmetric alkynyl group or a phenylene group-containing compound represented by the following hydrazine. , ,,°传式❹ 81 201022331 32945pif.doc [化60]

以下列舉所述烯基取代納迪克醯亞胺化合物之中優 選的化合物。 N,N’-乙烯-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二曱醯亞 〇 胺)、N,N’-乙烯雙(烯丙基曱基雙環P.2.1]庚-5-烯-2,3-二曱 醯亞胺)、N,N'-乙烯-雙(曱基烯丙基雙環[2.2.1]庚-5-烯-2,3-二曱醯亞胺)、Ν,Ν'-三亞曱基-雙(烯丙基雙環[2.2.1]庚-5-烯 -2,3-二曱醯亞胺)、Ν,Ν'-六亞曱基-雙(烯丙基雙環[2.2.1]庚 -5-烯-2,3-二曱醯亞胺)、Ν,Ν'-六亞甲基-雙(烯丙基曱基雙環 [2.2.1]庚-5-烯-2,3-二曱醯亞胺)、Ν,Ν’-十二亞曱基-雙(烯丙 基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、Ν,Ν’-十二亞曱基- 82 201022331 32945pif.doc 雙(烯丙基曱基雙環[2.2.1]庚-5-烯-2,3-二甲酿亞胺)、ν,Ν,- 環己稀-雙(烯丙基雙環Ρ.2.1]庚-5-埽_2,3-二甲酿亞胺)、 Ν,Ν’-環己烯-雙(烯丙基曱基雙環[2.2.1]庚_5_烯_2,3·二甲醯 亞胺)、 Ν,Ν'-對次苯基-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二曱 醯亞胺)、Ν,Ν'-對次苯基-雙(烯丙基甲基雙環[2.2.1]庚-5·稀 -2,3-二甲醯亞胺)、Ν,Ν'·間次苯基-雙(烯丙基雙環[2.2.1]庚 -5-烯-2,3-二甲醯亞胺)、Ν,ϊνΓ-間次苯基_雙(烯丙基甲基雙環 [2.2.1]庚-5-稀-2,3-二甲醯亞胺)、1^,1&lt;[’-{(1-甲基)-2,4-次苯 基}-雙(烯丙基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)、Ν,Ν'-對二曱苯基·雙(烯丙基雙環[2.2.1]庚_5_烯_2,3-二甲醯亞 胺)、Ν,Ν·-對二曱苯基-雙(烯丙基甲基雙環[2.2.1]庚-5-烯 -2,3-二曱醯亞胺)、Ν,&gt;Γ-間苯二甲基雙(烯丙基雙環[2.2.1] 庚-5-烯-2,3-二甲醯亞胺)、Ν,Ν·-間苯二甲基-雙(稀丙基甲基 雙環[2.2.1]庚-5-稀—甲酿亞胺)、2,2·雙[4-{4-(稀丙基 雙環Ρ.2.1]庚-5-烯-2,3-二曱醯亞胺)苯氧基}苯基]丙烷、 _ 2,2-雙[4-{4·(烯丙基曱基雙環[2.2.1]庚-5-烯-2,3·二曱醯亞 胺)苯氧基}苯基]丙烷、2,2-雙[4-{4-(曱基烯丙基雙環[2.2.1] 庚-5-烯-2,3·二甲醯亞胺)苯氧基}苯基]丙烷、雙{4-(烯丙基 雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)苯基}曱烷、雙{4_(烯丙 基甲基雙環[2.2.1]庚-5-烯-2,3-二甲醯亞胺)苯基}甲烧、 雙{4-(甲基烯丙基雙環[2.2.1]庚-5-稀-2,3-二甲醢亞胺) 苯基}曱烷、雙{4-(曱基烯丙基甲基雙環[2·2.1:^_5^-2,3_ 二曱醯亞胺)苯基}曱烧、雙{4-(稀丙基雙環[2.2.1]庚-5·稀 83 201022331 32945pif.doc -2,3-二甲酿亞胺)笨基㈣、雙{4_(稀丙基甲基雙環[2 21]庚 -5-烯-2,3-二甲醯亞胺)苯基}醚、雙{4_(甲基烯丙基雙環 [2·2.1]庚-5_晞-2,3-二甲醯亞胺)笨基㈣、雙㈣烯丙基雙環 [2.2y]庚_5-稀-2,3-二甲醯亞胺)笨基μ風、雙{4_(稀丙基甲基 雙%[2.2.1]庚-5-稀-2,3-二曱醯亞胺)笨基}颯、雙(4_(曱基烯 丙基雙環[2.2.1]庚-5-烯-2,3-二曱醯亞胺)苯基}硪。Preferred compounds among the alkenyl-substituted nadic quinone imine compounds are listed below. N,N'-ethylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dioximine), N,N'-ethylene bis(allylhydrazinobicyclo) P.2.1]hept-5-ene-2,3-diimineimine), N,N'-ethylene-bis(nonylallylbicyclo[2.2.1]hept-5-ene-2,3 - Dimethyleneimine), hydrazine, Ν'-trimethylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-diimineimine), hydrazine, Ν'- Hexamethylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-diimineimine), anthracene, Ν'-hexamethylene-bis(allylhydrazino) Bicyclo[2.2.1]hept-5-ene-2,3-diimineimine), fluorene, Ν'-dodedecyl-bis(allylbicyclo[2.2.1]hept-5-ene -2,3-dimethylimine), hydrazine, Ν'-taudecyl-82 201022331 32945pif.doc bis(allylhydrylbicyclo[2.2.1]hept-5-ene-2,3 - xylenimide), ν, Ν, - cycloheximide - bis (allyl bicyclopurine .2.1] hept-5-oxime 2, 3-dimethylanimine), hydrazine, Ν'-ring Hexene-bis(allylhydrazinobicyclo[2.2.1]hept-5-ene-2,3.dimethylanilide), hydrazine, Ν'-p-phenylene-bis(allylbicyclo[ 2.2.1]hept-5-ene-2,3-diimineimine), hydrazine, Ν'-p-phenylene-bis ( Propylmethylbicyclo[2.2.1]hept-5·lean-2,3-carboximine), hydrazine, Ν'·m-phenylene-bis(allylbicyclo[2.2.1]heptane- 5-ene-2,3-dimethylimine), hydrazine, ϊνΓ-m-phenylene-bis(allylmethylbicyclo[2.2.1]hept-5-lean-2,3-dimethylhydrazine Imine), 1^,1&lt;['-{(1-methyl)-2,4-phenylene}-bis(allylbicyclo[2.2.1]hept-5-ene-2,3- Dimethyl imine), hydrazine, Ν'-p-diphenylene bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine), hydrazine, hydrazine - p-Phenylphenyl-bis(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-diimineimine), hydrazine, &gt; fluorene-m-xylylene bis ( Allyl bicyclo [2.2.1] hept-5-ene-2,3-dimethylimine), hydrazine, hydrazine--m-xylylene-bis (dilylpropyl bicyclo [2.2.1] Geng-5-diluted-yield imine), 2,2·bis[4-{4-(l-propylbicycloindole.2.1)hept-5-ene-2,3-diimineimine)phenoxy Phenyl]propane, _ 2,2-bis[4-{4·(allylhydrazinobicyclo[2.2.1]hept-5-ene-2,3·diimide) phenoxy }phenyl]propane, 2,2-bis[4-{4-(nonylallylbicyclo[2.2.1]hept-5-ene-2,3.dimethylanilide)phenoxy}benzene Base] , bis{4-(allylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimineimine)phenyl}decane, bis{4_(allylmethylbicyclo[2.2. 1]hept-5-ene-2,3-carboximine)phenyl}methane, bis{4-(methylallylbicyclo[2.2.1]hept-5-rare-2,3- Dimethyl imine) phenyl} decane, bis{4-(mercaptoallylmethylbicyclo[2.2.1:^_5^-2,3_diimideimine)phenyl} fluorene, double {4-(Ledylbicyclo[2.2.1]hept-5·rare 83 201022331 32945pif.doc -2,3-dimethylanimine) Stupid (four), double {4_(dilylmethylbicyclo[2] 21]hept-5-ene-2,3-dimethylimine)phenyl}ether, bis{4_(methylallylbicyclo[2·2.1]hept-5-晞-2,3-dimethyl醯imino) stupid (tetra), bis(tetra)allylbicyclo[2.2y]glycol-5-diluted-2,3-dimethylimine imine) stupid μ wind, double {4_(dilylpropyl bis-% [2.2.1]Hept-5-rare-2,3-diimineimine) Stupid}飒, bis(4_(mercaptopropylbicyclo[2.2.1]hept-5-ene-2,3 - Diimine imine) Phenyl} oxime.

以下列舉更優選的烯基取代納迪克醯亞胺化合物。 ν,ν’_乙烯-雙(烯丙基雙環[221]庚_5_烯_2,3_二甲醯亞 、ΗΝ’-乙烯·雙(烯丙基f基雙環[221]庚_5•稀n Q =ΪΞ)、Ν,Ν,·叫雙㈣柄基雙環阳制-稀办 Τ 亞胺)、卿’_三亞甲基-雙(婦丙基雙環[2·2·1]庚-5-烯 ,-二曱醯亞胺)、Ν,Ν,-六亞曱基_雙(烯丙基雙 -;-2=二甲酿亞胺)、·六”基销丙基;= k雙酿亞胺)、N’NL十二亞甲基-雙(缔丙 土雙辰[2.2.1]庚-5-烯-2,3-二曱醯亞胺)、N,N,_十二亞 雙(烯丙基曱基雙環[2.2.1]庚_5_稀_2,3_二曱酿亞胺)、Nf =婦-雙(烯丙基雙環[2.21]庚_5_稀_2,3_二甲酿亞胺卜 取,環己烯-雙(稀丙基甲基雙環[2 21]庚_5_烯_2,3_ 亞胺)、 τ職 ν,ν’_對次苯基-雙(烯丙基雙環卩.21]庚_5_烯乂3_二 醯亞胺)、Ν,Ν’-對:欠苯基雙(烯丙基曱基雙環[221]庚_5_稀 _2,3-二甲醯亞胺)、Ν,Ν,-間次苯基·雙(烯丙基雙環 -5-烯-2,3-二曱醯亞胺)、Ν,Ν,_間次笨基-雙(烯丙基曱基雙環 [2.2.1]庚-5-烯-2,3-二曱醯亞胺)、取.](1_甲基)_2、4_次以 84 201022331 32945pif.doc 基卜雙(烯丙基雙環[2.2.1]庚-5-晞-2,3-二甲醯亞胺)、N,N’-對二甲笨基-雙(烯丙基雙環[2.2.1]庚_5_烯_2,3-二甲醯亞 胺)、n,n'-對二曱笨基-雙(烯丙基甲基雙環[m]庚_5_烯 _2,3·二曱醯亞胺)、N,N’-間苯二甲基-雙(烯丙基雙環[2.2.1] 庚_5_烯-2,3-二甲醯亞胺)、N,N,_間笨二曱基_雙(烯丙基甲基 雙環[2.2.1]庚-5-烯-2,3-二曱醯亞胺)、 +2,2-雙[4-{4-(烯丙基雙環[2 21]庚_5_烯_2,3_二曱醯亞 φ 胺)苯氧基丨苯基]丙烷、2,2_雙[4-{4-(烯丙基甲基雙環P.2.1] 庚-5-烯-2,3-二曱醯亞胺)笨氧基}苯基]丙烷、2,2_雙 甲基烯丙基雙環[2.2.1]庚-5_烯_2,3_二曱醯亞胺)苯 氧基}苯基]丙烧、雙(4-⑽丙基雙環[2 2 1;]庚_5鲁2,3_二曱 醯亞胺)笨基}曱烷、雙烯丙基曱基雙環[221]庚_5-烯 _2,3-二甲醯亞胺)苯基}甲烷、雙{4-(甲基烯丙基雙環[2.2.1] 庚-5-烯-2,3-二曱醯亞胺)笨基}甲烷、雙{4_(甲基烯丙基甲 基雙環[2.2.1]庚·5-稀_2,3_二甲醢亞胺)苯基}甲烷。 而且’作為特別優選的烯基取代納迪克醯亞胺化合 物,可以列舉如下所示的以結構式(Ina-Ι)所表示的雙{4-(烯 丙基雙環[2.2.1]庚_5-烯-2,3-二曱醯亞胺)苯基}甲烷、以結 構式(Ina-2)所表示的n,N,-間苯二甲基-雙(烯丙基雙環 [2.2.1]庚-5-烯·2,3-二甲醯亞胺)、以及以結構式(Ina_3)所表 示的N,N’·六亞曱基-雙(稀丙基雙環[2.2.1]庚-5-稀-2,3-二曱 醯亞胺)。 85 201022331 32945pif.doc [化 61]More preferred alkenyl substituted nadic quinone imine compounds are listed below. ν,ν'_ethylene-bis(allylbicyclo[221]hept-5-ene-2,3_dimethylhydrazine, ΗΝ'-ethylene·bis(allyl-f-cyclobicyclo[221]hept-5 • Rare n Q = ΪΞ), Ν, Ν, 叫 ( (4) stalk base double ring yang system - rare Τ Τ Τ 、 卿 卿 卿 卿 _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ -5-ene,-diimineimine), hydrazine, hydrazine, -hexamethylene fluorenyl-bis(allylbis-;-2=dimethylanilide), ·hexa-propyl pin; k bis-imine), N'NL dodecamethylene-bis (dipropyl bis-bis[2.2.1]hept-5-ene-2,3-diimine), N, N, _ Twelve bis (allyl fluorenylbicyclo[2.2.1]g _5_diluted _2,3 bis quinone imine), Nf = banister-bis(allylbicyclo[2.21]g _5_ Dilute _2,3_dimethylenimine, cyclohexene-bis(dipylmethylbicyclo[2 21]hept-5-ene-2,3_imine), τ occupation ν, ν'_ p-Phenyl-bis(allylbicycloindole.21]hept-5-eneindole 3_diimine), hydrazine, Ν'-pair: under-phenyl bis(allyl-decylbicyclo[221] Geng_5_diluted 2,3-dimethyl quinone imine), hydrazine, hydrazine, -m-phenyl bis(allylbiscyclo-5-ene-2,3-diimineimine), hydrazine , Ν, _ interstitial-bis(allyl hydrazine Bicyclo[2.2.1]hept-5-ene-2,3-diimineimine), taken.](1_methyl)_2, 4_times to 84 201022331 32945pif.doc bis(allyl) Bicyclo[2.2.1]hept-5-oxime-2,3-carboximine), N,N'-p-dimethylphenyl-bis(allylbicyclo[2.2.1]hept-5-ene _2,3-dimethylimine), n,n'-p-diphenylphenyl-bis(allylmethylbicyclo[m]hept-5-ene-2,3·diimide) , N, N'-m-xylylene-bis(allylbicyclo[2.2.1]hept-5-ene-2,3-dimethylimine), N,N,_ stupid _Bis(allylmethylbicyclo[2.2.1]hept-5-ene-2,3-diimineimine), +2,2-bis[4-{4-(allylbicyclo[2] 21]g-___ene_2,3_diindole φ amine)phenoxypurine phenyl]propane, 2,2_bis[4-{4-(allylmethylbicyclophene P.2.1) Hg-5-ene-2,3-diimineimine) phenyloxy}phenyl]propane, 2,2- bismethylallylbicyclo[2.2.1]hept-5-ene-2,3 _ Diimine imine) phenoxy}phenyl]propane, bis(4-(10)propylbicyclo[2 2 1;]g-5 ruthenium 2,3-diimine) , bisallylhydrazinobicyclo[221]hept-5-ene-2,3-dimethylimine)phenyl}methane, double {4-(methallyl) Bicyclo[2.2.1]hept-5-ene-2,3-diimineimine) stupid}methane, double {4_(methylallylmethylbicyclo[2.2.1]hept-5-lean_ 2,3_dimethylimine imine)phenyl}methane. Further, 'as a particularly preferred alkenyl-substituted nadicylimine compound, a double {4-(allylbicyclo[2.2.1]hept-5 represented by the structural formula (Ina-Ι) shown below can be cited. -ene-2,3-diimineimine)phenyl}methane, n,N,-m-xylylene-bis(allylbicyclo) represented by the formula (Ina-2) [2.2.1 ]hept-5-ene·2,3-dimethylimine), and N,N′·hexamethylene-bis(dipropylbicyclo[2.2.1]g, represented by the structural formula (Ina_3) -5-rare-2,3-diimine). 85 201022331 32945pif.doc [Chem. 61]

另外,例如就使液晶顯示元件的電性能長期穩定的觀 點而言’本發明的液晶配向劑可以進一步含有具有自由基 聚合性不飽和雙鍵的化合物。所述具有自由基聚合性不飽 和雙鍵的化合物可以是一種化合物,也可以是兩種或兩種 以上的化合物。此外,所述具有自由基聚合性不飽和雙鍵 的化合物中不包括所述烯基取代納迪克醯亞胺化合物。就 所述的觀點而言,所述具有自由基聚合性不飽和雙鍵的化 合物的含量以相對於聚醯胺酸或者其衍生物的重量比計, 優選為0.01〜1.00,更優選為0 01〜0 70,進一步優選為 〇.〇1 〜0·50。 此外,就降低液晶顯示元件的離子密度,抑制離子密 度隨時間增加,進而抑制殘像的觀點而言,具有自由基聚 合性不飽和雙鍵的化合物相對於烯基取代納迪克醯亞胺化 合物的比率以重量比計,優選為0.1〜10 ,更優選為0.5〜 201022331 32945pif.doc 、作為所述具有自由基聚合性不飽和雙鍵的化合物,可 以列舉.(甲基)丙烯酸醋、(甲基)丙烯醯胺等 衍生物以及雙馬來醯亞胺⑽maleimide)。所述具有)自^ 聚合性不飽和雙鍵的化合物更優選具有兩個或兩個以上自 由基聚合性不飽和雙鍵的(甲基)丙烯酸衍生物。 作為(甲基)丙烯酸酯的具體例,例如可以列舉:(曱基) φ 丙烯酸環己酯、(曱基)丙烯酸_2·甲基環己酯、(甲基)丙烯 酸二環戊酯、(曱基)丙烯酸二環戊氧基乙酯、(甲基)丙烯酸 異冰片酯、(曱基)丙烯酸苯酯、(曱基)丙烯酸苄酯 '(曱基) 丙烯酸-2-羥基乙酯以及(甲基)丙烯酸_2_羥基丙酯。 作為雙官能(甲基)丙稀酸酯的具體例,例如可以列 舉:二丙烯酸乙二酷,東亞合成(股)的產品Ar〇nixM_21〇、 Aromx M-240及Aronix M-6200,日本化藥(股)的產品 KAYARAD HDDA、KAYARAD HX-220、KAYARAD R-604 及KAYARAD R-684,大阪有機化學工業(股)的產品 © V260、V312及V335HP,以及共榮社化學(股)的產品LightIn addition, for example, the liquid crystal alignment agent of the present invention may further contain a compound having a radical polymerizable unsaturated double bond, for example, in order to stabilize the electrical properties of the liquid crystal display device for a long period of time. The compound having a radical polymerizable unsaturated double bond may be one compound or two or more compounds. Further, the alkenyl-substituted nadic quinone imine compound is not included in the compound having a radical polymerizable unsaturated double bond. In view of the above, the content of the compound having a radical polymerizable unsaturated double bond is preferably 0.01 to 1.00, more preferably 0 01, based on the weight ratio of the polyglycine or a derivative thereof. ~0 70, further preferably 〇.〇1 ~0·50. Further, in terms of reducing the ion density of the liquid crystal display element, suppressing the increase in the ion density with time, and further suppressing the afterimage, the compound having a radical polymerizable unsaturated double bond is substituted with the alkenyl group in place of the nadic ylidene compound. The ratio is preferably 0.1 to 10, more preferably 0.5 to 201022331 32945 pif. doc, and the compound having a radical polymerizable unsaturated double bond may, for example, be a (meth)acrylic acid vinegar or a methyl group. a derivative such as acrylamide or a bismaleimide (10) maleimide). The compound having a self-polymerizable unsaturated double bond is more preferably a (meth)acrylic acid derivative having two or more free radically polymerizable unsaturated double bonds. Specific examples of the (meth) acrylate include (fluorenyl) φ cyclohexyl acrylate, (mercapto)acrylic acid 2·methylcyclohexyl ester, and dicyclopentanyl (meth)acrylate. Mercapto)dicyclopentyloxyethyl acrylate, isobornyl (meth)acrylate, phenyl (meth) acrylate, benzyl (mercapto) acrylate (nonyl) 2-hydroxyethyl acrylate and 2-hydroxypropyl acrylate. Specific examples of the difunctional (meth) acrylate include, for example, Ethylene diacrylate, East Asia Synthetic Co., Ltd. products Ar〇nix M_21〇, Aromx M-240, and Aronix M-6200, Japanese chemical Products of KAYARAD HDDA, KAYARAD HX-220, KAYARAD R-604 and KAYARAD R-684, products of Osaka Organic Chemical Industry Co., Ltd. © V260, V312 and V335HP, and products of Kyoeisha Chemical Co., Ltd.

Acrylate BA-4EA、Light Acrylate BP-4PA 及 Light Acrylate BP-2PA。 作為三官能或三官能以上的多官能(甲基)丙烯酸酯的 具體例,例如可以列舉:4,4,-亞甲基雙(Ν,Ν·二羥基乙烯丙 烯酸酯基苯胺)、Aronix Μ-400、Aronix Μ-405、AronixAcrylate BA-4EA, Light Acrylate BP-4PA and Light Acrylate BP-2PA. Specific examples of the trifunctional or trifunctional or higher polyfunctional (meth) acrylate include, for example, 4,4,-methylenebis(indene, fluorene dihydroxyethylene acrylate aniline), Aronix Μ- 400, Aronix Μ-405, Aronix

M-450、Aronix M-7100、Aronix M-8030、Aronix M-8060、 KAYARAD TMPTA、KAYARAD DPCA-20、KAYARAD 87 201022331 32945pif.doc DPCA-30、KAYARAD DPCA-60、KAYARAD DPCA-120 以及大阪有機化學工業(股)的產品VGPT。 作為(曱基)丙烯醯胺衍生物的具體例,例如可以列 舉:N-異丙基丙烯醯胺、N-異丙基甲基丙烯醯胺、N-正丙 基丙烯醯胺、N-正丙基曱基丙烯醯胺、N-環丙基丙烯醯 胺、N-環丙基曱基丙烯醯胺、N—乙氧基乙基丙烯醯胺、&amp; 乙氧基乙基曱基丙烯醯胺、Ν·四氫糠基丙烯醯胺、Ν·四氫 糠基甲基丙烯醯胺、Ν-乙基丙烯醯胺、Ν-乙基-Ν-曱基丙烯 醯胺、Ν,Ν-二乙基丙烯醯胺、Ν-甲基-Ν-正丙基丙烯醯胺、 ⑩ Ν-甲基-Ν-異丙基丙稀醯胺、Ν-丙烯醯基狐唆、Ν-丙烯醯 基°比咯烷、Ν,Ν’-亞甲基雙丙烯醯胺、Ν,Ν,-乙烯雙丙烯醯 胺、Ν,Ν·-二羥基乙烯雙丙烯醯胺、ν-(4-羥基苯基)曱基丙 烯酿胺、Ν_苯基曱基丙烯醯胺、Ν-丁基甲基丙烯醯胺、Ν-(異 丁氧基甲基)甲基丙烯醯胺、Ν-[2-(Ν,Ν·二曱基氨基)乙基] 曱基丙烯醯胺、Ν,Ν_二甲基甲基丙烯醯胺、Ν-[3-(二曱基 IL基)丙基]曱基丙烯醯胺、Ν-(曱氧基曱基)曱基丙烯醯胺、 N-(經基甲基)_2_甲基丙烯醯胺、ν-苄基-2·甲基丙烯醯胺以 〇 及N,N’-亞甲基雙曱基丙烯醯胺。 所述的(甲基)丙烯酸衍生物中,特別優選亞曱基 雙丙烯醯胺、Ν,Ν'-二羥基乙烯雙丙烯醯胺、二丙烯酸乙二 醋以及4,4’-亞曱基雙(Ν,Ν-二羥基乙烯丙烯酸酯基苯胺)。 作為雙馬來醯亞胺,例如可以列舉:ΚΙ CHEMICAL INDUSTRY(股)製造的ΒΜΙ·7〇及BMI-80,以及大和化成 工業(股)製造的 BMI-1000、BMI-3000、BMI-4000、 88 201022331 32945pif.doc BMI-5000 及 BMI-7000。 另外,例如就液晶顯示元件中的電性能的長期穩定性 的觀點而言’本發明的液晶配向劑可以進一步含有惡嗪化 合物。所述惡嘻化合物可以是一種化合物,也可以是兩種 或兩種以上的化合物。就所述的觀點而言,所述惡嗪化合 物的含量相對於所述聚醯胺酸或者其衍生物,優選為0.1 重量%〜50重量%,更優選為1重量%〜40重量%,進一 ^ 步優選為1重量%〜20重量%。 所述惡嗪化合物優選可溶於可以溶解聚醯胺酸或者 其衍生物的溶媒並且具有開環聚合性的惡嗪化合物。 另外’所述惡嗪化合物中的惡嗪結構的數量沒有特別 限定。 惡嗪的結構已知有各種結構。于本發明中,惡嘻的結 構沒有特別限定,所述惡嗪化合物中的惡嗪結構可以列舉 苯並惡嗪(benzoxazine)或萘並惡嗪(naphthoxazine)等具有 包含縮合多環芳香族基的芳香族基的惡嗪的結構。 作為所述惡嗪化合物,例如可以列舉下述通式(a)〜通 式(f)所表示的化合物。此外,下述通式中,朝向環的中心 所表示的鍵表示鍵結在構成環並且可以鍵結取代基的任奄 碳上。 w 89 201022331 32945pif.docM-450, Aronix M-7100, Aronix M-8030, Aronix M-8060, KAYARAD TMPTA, KAYARAD DPCA-20, KAYARAD 87 201022331 32945pif.doc DPCA-30, KAYARAD DPCA-60, KAYARAD DPCA-120 and Osaka Organic Chemistry Industrial (share) product VGPT. Specific examples of the (fluorenyl) acrylamide derivative include, for example, N-isopropylacrylamide, N-isopropylmethacrylamide, N-n-propylpropenylamine, and N-positive Propylmercapto acrylamide, N-cyclopropyl acrylamide, N-cyclopropyl decyl acrylamide, N-ethoxyethyl acrylamide, &amp; ethoxyethyl decyl propylene oxime Amine, hydrazine, tetrahydrofurfuryl acrylamide, hydrazine, tetrahydrofurfuryl methacrylamide, hydrazine-ethyl acrylamide, hydrazine-ethyl-fluorenyl hydrazide, hydrazine, hydrazine Ethyl acrylamide, hydrazine-methyl-hydrazine-n-propyl acrylamide, 10 Ν-methyl-hydrazine-isopropyl acrylamide, hydrazine-acrylonitrile fluorene, hydrazine-acrylonitrile Pyrrolidine, anthracene, Ν'-methylenebis acrylamide, hydrazine, hydrazine, -ethylene bis acrylamide, hydrazine, hydrazine-dihydroxyethylene bis acrylamide, ν-(4-hydroxyphenyl) Mercapto acrylamide, Ν-phenylmercapto acrylamide, Ν-butyl methacrylamide, Ν-(isobutoxymethyl)methacrylamide, Ν-[2-(Ν,Ν· Dimercaptoamino)ethyl]decyl acrylamide, hydrazine, hydrazine dimethyl methacryl decylamine, hydrazine-[3-(dioxin IL-based) propyl] mercapto acrylamide, hydrazine-(decyloxy) decyl acrylamide, N-(methylidene)-2-methacrylamide, ν-benzyl-2 Methyl acrylamide is hydrazine and N, N'-methylenebismercapto acrylamide. Among the (meth)acrylic acid derivatives, particularly preferably, anthracene bis acrylamide, hydrazine, Ν'-dihydroxyethylene bis acrylamide, ethylene diacetate, and 4,4'-fluorenylene (Ν, Ν-dihydroxyethylene acrylate aniline). Examples of the bismaleimide include ΒΜΙ·7〇 and BMI-80 manufactured by INDUSTRY CHEMICAL INDUSTRY, and BMI-1000, BMI-3000, and BMI-4000 manufactured by Daiwa Kasei Kogyo Co., Ltd. 88 201022331 32945pif.doc BMI-5000 and BMI-7000. Further, for example, the liquid crystal alignment agent of the present invention may further contain an oxazine compound from the viewpoint of long-term stability of electrical properties in the liquid crystal display element. The oxindole compound may be one compound or two or more compounds. In view of the above, the content of the oxazine compound is preferably from 0.1% by weight to 50% by weight, more preferably from 1% by weight to 40% by weight, based on the polyamic acid or a derivative thereof. The step is preferably from 1% by weight to 20% by weight. The oxazine compound is preferably soluble in an oxazine compound which can dissolve a solvent of poly-proline or a derivative thereof and has ring-opening polymerizability. Further, the number of the oxazine structure in the oxazine compound is not particularly limited. The structure of the oxazine is known in various structures. In the present invention, the structure of the oxindole is not particularly limited, and the oxazine structure in the oxazine compound may be exemplified by a benzoxazine or a naphthoxazine having a condensed polycyclic aromatic group. The structure of an aromatic oxazine. Examples of the oxazine compound include compounds represented by the following formula (a) to formula (f). Further, in the following formula, a bond represented toward the center of the ring means that the bond is bonded to any of the carbon constituting the ring and which may bond the substituent. w 89 201022331 32945pif.doc

所述通式(a)〜通式(c)中,Rl&amp;R2表示碳數為1〜30 的有機基。另外,所述通式⑻〜通式(0中,R3至R6表示 氫或碳數為1〜6的煙基。另外’所述通式(c)、通式(幻及 通式(f)中,X 表不早鍵、、_S-S-、-S〇2-、-CO-、 -CONH-、_NHCO_、_C(CH3)2-、_C(CF3)2-、-(CH2)m、 -0-(CH2)m〇-、-S-(CH2)mS-。此處 ’ m 為 1〜6 的整數。另 外,所述通式0)及通式(f)中,Y獨立地表示單鍵、-〇-、-S-、 -CO-、-C(CH3)2-、-C(CF3)2_或碳數為1〜3的烧浠基。所 述γ中的鍵結於苯環、萘環的氫可以獨立地被_F、_CIi3、 -OH、-COOH、-S03H、·Ρ〇3Η2 取代。 另外,所述惡嗪化合物包括侧鏈上具有惡嗪結構的低 聚物或聚合物、續巾射祕結構的錄物或聚合物。· 作為以通式(a)所表示的惡嗪化合物,例如可以列舉以 201022331 32945pif.doc 下的惡11 秦化合物。 [化 63]In the above formula (a) to formula (c), R1 &amp; R2 represents an organic group having 1 to 30 carbon atoms. Further, in the above formula (8) to the formula (0, R3 to R6 represent hydrogen or a ketone having a carbon number of 1 to 6. Further, the above formula (c), formula (phantom and formula (f)) In the X table, the early key, _S-S-, -S〇2-, -CO-, -CONH-, _NHCO_, _C(CH3)2-, _C(CF3)2-, -(CH2)m, -0-(CH2)m〇-, -S-(CH2)mS-. Here, 'm is an integer of 1 to 6. Further, in the above formula 0) and formula (f), Y independently represents a single bond, -〇-, -S-, -CO-, -C(CH3)2-, -C(CF3)2_ or a ruthenium group having a carbon number of 1 to 3. The bond in the γ is The hydrogen of the benzene ring or the naphthalene ring may be independently substituted by _F, _CIi3, -OH, -COOH, -S03H, ·Ρ〇3Η2. In addition, the oxazine compound includes an oligomer having an oxazine structure in a side chain. In the case of the oxazine compound represented by the formula (a), for example, the oxoxine compound of 201022331 32945pif.doc can be cited.

(a-1) (a-2) 式中,R1優選碳數為1〜30的烷基,更優選碳數為1 〜20的院基。 作為以通式(b)所表示的惡嗪化合物,例如可以列舉以 下的惡嗓化合物。 91 201022331 32945pif.doc [化 64](a-1) (a-2) In the formula, R1 is preferably an alkyl group having 1 to 30 carbon atoms, and more preferably a hospital group having 1 to 20 carbon atoms. Examples of the oxazine compound represented by the formula (b) include the following oxime compounds. 91 201022331 32945pif.doc [Chem. 64]

式中,R1優選碳數為1〜30的烷基,更優選碳數為1 92 201022331 32945pif.doc 〜20的烧基。 作為以通式(C)所表示的惡嗪化合物,可以列舉以下述 通式(c-I)所表示的惡嗪化合物。 [化 65]In the formula, R1 is preferably an alkyl group having a carbon number of 1 to 30, and more preferably a alkyl group having a carbon number of 1 92 201022331 32945 pif.doc 〜20. The oxazine compound represented by the following formula (c-I) is exemplified by the oxazine compound represented by the following formula (C). [Chem. 65]

(c—I)(c-I)

所述通式(c-I)中,R1及R2表示碳數為1〜30的有機 基,R3至R6表示氳或碳數為1〜6的烴基,X表示單鍵、 -CH〗·、-C(CH3)2_、-CO-、-0-、-S〇2·或_C(CF3)2_。作為以 所述通式(c-I)所表示的惡嗪化合物,例如可以列舉以下的 惡唤化合物。 93 201022331 32945pif.doc [化 66·1]In the above formula (cI), R1 and R2 represent an organic group having a carbon number of 1 to 30, R3 to R6 represent an anthracene or a hydrocarbon group having 1 to 6 carbon atoms, and X represents a single bond, -CH, ·, -C (CH3) 2_, -CO-, -0-, -S〇2· or _C(CF3)2_. The oxazine compound represented by the above formula (c-I) may, for example, be the following acetonide compound. 93 201022331 32945pif.doc [Chem. 66·1]

94 201022331 32945pif.doc94 201022331 32945pif.doc

[化 66-2][Chem. 66-2]

(c-15)(c-15)

(〇14) ©式中,R1優選碳數為1〜30的烷基,更優選碳數為1 〜20的烷基。 作為以通式(d)所表示的惡嗪化合物,例如可以列舉以 下的惡嗪化合物。 95 201022331 32945pif.doc [化 67](〇14) In the formula, R1 is preferably an alkyl group having 1 to 30 carbon atoms, more preferably an alkyl group having 1 to 20 carbon atoms. The oxazine compound represented by the formula (d) may, for example, be the following oxazine compound. 95 201022331 32945pif.doc [Chem. 67]

(d-9)(d-9)

(d-10)(d-10)

作為以通式(e)所表示的惡嗪化合物,例如可以列舉以 下的惡唤化合物。 96 201022331 32945pif.doc [化 68]The oxazine compound represented by the formula (e) may, for example, be the following acetonide compound. 96 201022331 32945pif.doc [Chem. 68]

Φ 作為以通式(f)所表示的惡嗓化合物,例如可以列舉以 下的惡嗪化合物。 97 201022331 32945pif.doc [化 69]Φ As the oxime compound represented by the formula (f), for example, the following oxazine compounds can be mentioned. 97 201022331 32945pif.doc [Chem. 69]

98 201022331 32945pif.doc 這些惡嗪化合物中,更優選以式(b-1)、式(c_i)、式 ㈣、式㈣、式㈣、式㈣、式㈣〜式㈣)、式(Μ)、 式(e-4)、式(f-2)〜式(f-4)所表示的惡嗪化合物。 所述惡嗪化合物可以利用與國際公開2〇〇4/〇〇97〇8號 手冊、日本專利特開平n_12258號公報、日本專利特開 2〇〇4·35267〇號公報中所記載的方法相同的方法來製造。 例如以通式(a)所表示的惡嗪化合物可以通過使苯酚 ❹ _ηο1)化合物、伯胺(Primary amine)以及醛(aidehyde)反應 而獲得(參照國際公開2004/009708號手冊)。 另外,以通式(b)所表示的惡嗪化合物可以通過如下方 式獲得,即利用將伯胺緩慢添加到甲师_a融yde)中的 方法進行反應之後,添加具有萘紛(naphth〇1)系減的化合 物進行反應(參照國際公開20〇4/〇〇97〇8號手冊)。 另外,以通式(c)所表示的惡嗪化合物可以通過如下方 式獲得’即在有機溶媒中,使丄莫爾的笨紛化合物、相對 Q 於其一個苯紛性經基至少為2莫爾或2莫爾以上的搭、以 莫爾的伯胺于脂肪族仲胺(aliphatic sec〇ndary μ es)月曰肪知叔胺(aHphatic tertiary amines)或驗性含氮 化合物的存在下進行反應(參照國際公開2004/009708 號手冊及日本專利特開平1M2258號公報)。 另外,以通式(d)〜通式(f)所表示的惡嗪化合物可以通 ,如下方式獲得,即在正丁醇中,使4,4,·二氨基二苯基甲 具有多個苯環與鍵結這些苯環的有機基的二胺、福馬 ormahn)等醛以及苯酚在大於等於9〇〇c的溫度下進行 99 201022331 32945pif.doc 脫水縮合反應(參照日本專利特開2004-352670號公報)。 另外,例如就液晶顯示元件中的電性能的長期穩定性 的觀點而言,本發明的液晶配向劑可以進一步含有惡β坐琳 化合物。所述惡唑啉化合物是具有惡唑啉結構的化合物。 所述惡峻琳化合物可以是一種化合物,也可以是兩種或兩 種以上的化合物。就所述的觀點而言,所述惡嗤琳化合物 的含量相對於所述聚醢胺酸或者其衍生物,優選為〇.1重 責〇/〇〜5〇重量% ’更優選為1重量%〜4〇重量%,進一步 樣選為1重量%〜20重量%。或者,就所述的觀點而言, 所述惡唑啉化合物的含量優選於將惡唑啉化合物中的惡嗤 砵結構換算為惡唑啉時,相對於所述聚醢胺酸或者其衍生 物為0.1重量%〜40重量%。 所述惡唑啉化合物可以在一個化合物中僅具有一種 惡唑啉結構,也可以在一個化合物中具有兩種或兩種以上 的惡咬琳結構。另外’所述惡嗤琳化合物只要在一個化合 物中具有一個所述惡唑啉結構即可,但優選具有兩個或兩 侗以上的惡唑啉結構。另外,所述惡唑啉化合物可以是側 健上具有惡唑啉環結構的聚合物,也可以是共聚物。側鏈 上具有惡唾琳結構的聚合物可以是側鏈上具有惡哇琳結構 的單體的均聚物’也可以是側鏈上具有惡。坐琳結構的單體 與不具有惡唑啉結構的單體的共聚物。側鏈上具有惡唑啉 結構的共聚物可以是侧鏈上具有惡唑啉結構的兩種或兩種 以上的早體的共聚物’也可以是側鍵上具有惡唾琳結構的 雨種或兩種以上的單體與不具有惡唑啉結構的單體的共聚 201022331 32945pif.doc 物 所述惡唾傭構優選讀惡料結構巾 可以與聚酸胺酸的絲(Car—)發生反= 方式存在於惡唑啉化合物中的結構。 作為所述惡唾琳化合物,例如可以 :=?;(2·惡棘2_基)·笨、‘咬鳴-2-基亞 本基惡嗤_5_酮、M,(4,5_二氣_2_惡絲)苯、^ (4,5_一虱_2'惡°坐基)苯、2,3-雙(4-異丙稀基_2_惡唾^ 雙娜-2-惡㈣、2,6-雙(異丙基 基)比疋、2,2-異亞丙基雙(4-叔丁基_2惡峻琳)、2 2 =基雙(4-苯基_2_惡姆)、2,2’_亞甲基雙(4_叔丁基惡唾 以及2,2 -亞甲基雙苯基。b :物以外,還可以列舉如Ep_s(商品名,日 限么司製造)之類的具有惡唑基的聚合物或低聚物: 一另外,例如就液晶顯示元件中的電性能的長期穩定性 峨點而言’本發明的液晶配向劑可以進 : ❺合物。所述環氧化合物可以是,合物,也可 或兩種以上的化合物。就所述的觀點而言,所述環氧化合 物的含量相對於所述聚醯胺酸或者其衍生物, σ 重量%〜5G重量%,更優選為〗重量%〜4Q進^ 步優選為1重量%〜20重量%。 作為環氧化合物,可以列舉分子内具有一個或者兩個 或=個以上環氧環的各種化合物。作為分子内具有一個環 氧環的化合物,例如可以列舉:苯基縮水甘油醚(phenyi 101 201022331 32945pif.doc §1&gt;^办〗611^)、丁基縮水甘油醚、3,3,3-三氟甲基環氧丙烷 (3,3,3-trifluoro propylene oxide)、氧化苯乙烯(styrene oxide)、六氟環氧丙烷、氧化環己烯、3_縮水甘油氧基丙基 二甲氧基石夕炫(3-glycidoxy propyl trimethoxysilane)、2-(3,4- 環氧環己基)乙基三甲氧基石夕烧、N-縮水甘油基鄰苯二甲醯 亞胺(N-glycidyl phthalimide)、(九氟-N· 丁基)環氧化物 ((nonafluoro-N-butyl)epoxide)、全氟乙基縮水甘油醚、表氯 ❹ 醇(epichlorohydrin)、表漠醇(epibr〇mohydrin)、Ν,Ν-二縮水 甘油基苯胺以及3·[2-(全氟己基)乙氧基環氧丙烷。 作為分子内具有兩個環氧環的化合物,例如可以列 舉.乙一醇二縮水甘油醚(ethylene glycol diglycidyl ether):聚乙二醇二縮水甘油醚、丙二醇二縮水甘油醚、三 丙=醇二縮水甘油喊、聚丙二醇二縮水甘㈣、新戊二醇 -縮水甘’㈣、丨,6己二醇二縮水甘油醚、甘油二縮水甘 /由醚2,2 臭新戊二醇二縮水甘油醚、π環氧環己稀甲 〇 環氧5衣己缔基曱酿以及3_(N,N_二縮水甘油基)胺 基丙基二甲氧基矽烷。 iSi . λ r/i為刀子内具有二個環氧環的化合物,例如可以列 二·美1 環氧两氧基)笨基]-2件[1,1-雙[4_([2,3_環氧丙 vr^1〇1 ,)]乙基]苯基]丙烷(商品名“Techmore VG31〇1L/三井化學(股)製造)。 =广子内具有四個環氧環的化合物,例如可以列 i:縮水甘油基·2,4-己二醇、n,n,軍-四縮水甘 油基間本二曱胺、丨,3·雙(取二縮水甘油基氨基曱基)環己 102 201022331 32945pif.doc 苯基甲烷以及 除所述化合物以外,作為分子内呈 有二=舉具有環氧環的低聚物或Si的= ==:例如可以列舉:⑽)丙稀酸縮Π: 烷、况况;^,1^四縮水甘油基_4,4,_二氨基 3_(Ν·婦丙基-Ν'縮水甘油基)胺基丙基三;::卷甲 险所诫务札,、,Μ J石夕炫 的例 酯㈣ddy! (meth)aCrylate)、(甲基)丙_ 以及(甲基)丙烯酸甲基縮水甘油酯。 衣氧%己酉曰 作為與具有環氧環的單體進行共聚合的其他 如可以列舉:(甲基)丙烯酸、(甲基)丙烯酸甲酯、(丙 N- 基\丙烯5丁酉日、(甲基)丙婦酸叔丁醋、(¥基}丙_環 己函曰、(甲基)丙稀酸节醋、(甲基)丙稀酸·2老基乙醋、(甲 基)丙烯酸·2·經基丙S旨、苯乙烯(styrene)、甲基笨乙^、氯 曱基苯乙稀、(甲基)丙烯酸(3_乙基_3_環氧丙基)甲醋 環己基馬來醢亞胺以及N-苯基馬來醯亞胺。98 201022331 32945pif.doc Among these oxazine compounds, more preferably, the formula (b-1), the formula (c_i), the formula (IV), the formula (IV), the formula (IV), the formula (IV), the formula (4) to the formula (IV), the formula (Μ), An oxazine compound represented by the formula (e-4) and the formula (f-2) to the formula (f-4). The oxazine compound can be used in the same manner as described in the International Publication No. 4〇〇4/〇〇97〇8, the Japanese Patent Laid-Open No. Hei. No. 12-258, and the Japanese Patent Laid-Open Publication No. Hei. The way to manufacture. For example, the oxazine compound represented by the formula (a) can be obtained by reacting a phenol __ηο1) compound, a primary amine, and an aldehyde (aidehyde) (refer to International Publication No. 2004/009708). Further, the oxazine compound represented by the general formula (b) can be obtained by a method in which a primary amine is slowly added to a method of adding a primary amine to a yde, and a naphth〇1 is added. The compound is reduced by reaction (refer to International Publication No. 20〇4/〇〇97〇8). Further, the oxazine compound represented by the general formula (c) can be obtained by - in the organic solvent, the sullen compound of the oxime, relative to Q, is at least 2 moles per benzene. Or 2 molars or more, reacting with a primary amine of moir in the presence of an aliphatic sec〇ndary μ es, aHphatic tertiary amines or an inert nitrogen-containing compound ( Reference is made to the International Publication No. 2004/009708 and Japanese Patent Laid-Open No. 1M2258. Further, the oxazine compound represented by the general formula (d) to the general formula (f) can be obtained by having 4, 4, diaminodiphenylmethyl having a plurality of benzenes in n-butanol. The ring and the aldehyde of the organic group of the benzene ring, the aldehyde such as Foma or the like, and the phenol are subjected to a dehydration condensation reaction of 99 201022331 32945 pif.doc at a temperature of 9 〇〇c or more (refer to Japanese Patent Laid-Open No. 2004-352670) Bulletin). Further, for example, from the viewpoint of long-term stability of electrical properties in the liquid crystal display element, the liquid crystal alignment agent of the present invention may further contain an oxalate-based compound. The oxazoline compound is a compound having an oxazoline structure. The stagnation compound may be one compound or two or more compounds. In view of the above, the content of the ruthenium compound is preferably 〇.1 heavy 〇 / 〇 〜 5 〇 wt% 'more preferably 1% by weight relative to the polyamic acid or a derivative thereof. 〜4〇% by weight, further selected as 1% by weight to 20% by weight. Alternatively, in view of the above, the content of the oxazoline compound is preferably such that when the oxindole structure in the oxazoline compound is converted to an oxazoline, the poly-proline or a derivative thereof is It is from 0.1% by weight to 40% by weight. The oxazoline compound may have only one oxazoline structure in one compound, or may have two or more octopus structures in one compound. Further, the oxetan compound may have one oxazoline structure in one compound, but preferably has two or more oxazoline structures. Further, the oxazoline compound may be a polymer having an oxazoline ring structure on the side or a copolymer. The polymer having a smectic structure on the side chain may be a homopolymer of a monomer having a morphine structure on the side chain, or may have a wickiness on the side chain. A copolymer of a monomer of a stand-up structure and a monomer having no oxazoline structure. The copolymer having an oxazoline structure on the side chain may be a copolymer of two or more kinds of early forms having an oxazoline structure in a side chain, or may be a rain species having a sputum structure on a side bond or Copolymerization of two or more kinds of monomers with a monomer having no oxazoline structure; 201022331 32945pif.doc The preferred cavity structure towel can be inversely related to the filament of the polyamic acid (Car-) = The structure exists in the structure of the oxazoline compound. As the sputum compound, for example, it can be: =?; (2. sinensis 2 _ base) · stupid, 'biting -2- quinone quinone 嗤 5 ketone, M, (4, 5 _ Dioxane_2_Evil silk) Benzene, ^ (4,5_一虱_2' ° ° 坐 基) benzene, 2,3- bis (4-isopropyl dil _2 _ 唾 ^ ^ Shuang Na-2 - Ester (tetra), 2,6-bis(isopropyl)pyrene, 2,2-isopropylidene bis(4-tert-butyl-2-oxoline), 2 2 =ylbis(4-phenyl _2_mum), 2,2'-methylene double (4_tert-butyl oxo and 2,2-methylene bisphenyl. b: in addition to, for example, Ep_s (trade name, A polymer or oligomer having an oxazolyl group, such as manufactured by Riken Co., Ltd.: In addition, for example, in terms of long-term stability of electrical properties in a liquid crystal display element, the liquid crystal alignment agent of the present invention can be further advanced. The epoxy compound may be a compound, or may be a compound of two or more. From the viewpoint of the above, the content of the epoxy compound is relative to the poly-proline or its The derivative, σ% by weight to 5 g% by weight, more preferably 7% by weight to 4%, preferably 1% by weight to 20% by weight. There are various compounds having one or two or more epoxy rings in the molecule. As a compound having an epoxy ring in the molecule, for example, phenyl glycidyl ether can be cited (phenyi 101 201022331 32945pif.doc §1&gt; 〖611^), butyl glycidyl ether, 3,3,3-trifluoro propylene oxide, styrene oxide, hexafluoropropylene oxide, Oxycyclohexene oxide, 3-glycidoxy propyl trimethoxysilane, 2-(3,4-epoxycyclohexyl)ethyltrimethoxy sulphur, N-shrinkage N-glycidyl phthalimide, (nonafluoro-N-butyl) epoxide, perfluoroethyl glycidyl ether, epichlorohydrin Epichlorohydrin, epibr〇mohydrin, hydrazine, hydrazine-diglycidylaniline, and 3·[2-(perfluorohexyl)ethoxy propylene oxide. As a molecule, there are two epoxy rings. Examples of the compound include ethylene glycol diglycidyl ether: polyethylene glycol II. Glycidyl ether, propylene glycol diglycidyl ether, tripropylene = alcohol diglycidyl shunt, polypropylene glycol diglycidyl (tetra), neopentyl glycol - glycosaminoglycan (tetra), hydrazine, 6 hexanediol diglycidyl ether, glycerol condensate甘/ from ether 2,2 odor neopentyl glycol diglycidyl ether, π epoxide cyclohexane methyl oxime epoxy 5 hexamethylene broth and 3_(N,N- diglycidyl)aminopropyl Dimethoxydecane. iSi . λ r/i is a compound having two epoxy rings in the knife, for example, it can be listed as a two-epoxy two-oxyl) stupid base]-2 pieces [1,1-double [4_([2,3 _Ethylene acrylate vr^1〇1 ,]]ethyl]phenyl]propane (trade name "Techmore VG31〇1L / manufactured by Mitsui Chemicals Co., Ltd.") = compound with four epoxy rings in korai, for example Can be listed as: glycidyl · 2,4-hexanediol, n, n, military-tetraglycidyl meta-diamine, hydrazine, 3 · bis (take diglycidyl amino fluorenyl) cyclohexane 102 201022331 32945pif.doc Phenylmethane and, in addition to the compound, as an oligomer having an epoxy ring or Si in the molecule, ===: for example, (10)) acrylonitrile: alkane , condition; ^, 1 ^ tetraglycidyl _4, 4, _ diamino 3 _ (Ν · propyl propyl - Ν 'glycidyl) aminopropyl three;:: Roller insurance department, , Μ J Shi Xi Xuan's example ester (four) ddy! (meth) a Crylate), (meth) propyl _ and (meth) methacrylate methyl glycidyl ester. Nyle hexanone as a single with an epoxy ring Other examples of the copolymerization of the body include (meth)acrylic acid, (methyl) Methyl enoate, (propane N-based\propylene 5 butyl hydrazine, (methyl) propyl acetoacetate t-butyl vinegar, (¥ base} propyl _ cyclohexanol, (methyl) acrylic acid vinegar, (A Acetyl acid · 2 old ethyl vinegar, (meth) acrylic acid · 2 · thiopropyl S, styrene, methyl stupyl, chlorophenyl styrene, (meth) acrylate (3_Ethyl_3_epoxypropyl)methanil cyclohexylmaleimide and N-phenylmaleimide.

作為具有環氧環的單體的聚合物的優選具體例,可以 列舉聚曱基丙烯酸縮水甘油酯等。另外,作為具有環氧環 的單體與其他單體的共聚物的優選具體例,可以列舉:N_ 苯基馬來醯亞胺_甲基丙烯酸縮水甘油酯共聚物、N_環己基 馬來醯亞胺-甲基丙烯酸縮水甘油酯共聚物、甲基丙烯酸苄 酉旨-甲基丙細酸縮水甘油g旨共聚物、曱基丙稀酸丁醋-甲基 丙烯酸縮水甘油酯共聚物、曱基丙烯酸_2-羥基乙酯-曱基 丙烯酸縮水甘油酯共聚物、曱基丙烯酸(3-乙基-3-環氧丙基) 曱酯-曱基丙烯酸縮水甘油酯共聚物以及苯乙烯-甲基丙烯 103 201022331 32945pif.doc . 酸縮水甘油酯共聚物。 這些例子中,特別優選Ν,Ν,Ν’,Ν,_四縮水甘油基間苯 二甲胺、1,3-雙(Ν,Ν-二縮水甘油基胺基甲基)環己烷、 Ν,Ν,Ν',Ν’-四縮水甘油基_4,4,_二氨基二苯基甲烷、商品名 “Techmore VG3101L”、3,4-環氧環己烯甲酸-3,,4,-環氧環己 稀基甲酯、N-苯基馬來酿亞胺_甲基丙稀酸縮水甘油酯共聚 物以及2-(3,4-環氧環己基)乙基三甲氧基矽烷。 、 更加系統地來說,作為所述環氧化合物,例如可以列 舉:縮水甘油醚、縮水甘油酯、縮水甘油胺、含有環氧基 0 的丙烯酸系樹脂、縮水甘油醯胺、異氰尿酸縮水甘油酯、 鏈狀脂肪族型環氧化合物以及環狀脂肪族型環氧化合物。 此外,環氧化合物是指具有環氧基的化合物,環氧樹脂是 指具有環氧基的樹脂。 作為所述縮水甘油醚’例如可以列舉:雙盼A型環氧 化合物、雙酚F型環氧化合物、雙酚s型環氧化合物衣雙 紛^環氧化合物、氫化雙紛A型環氧化合物、氫化雙齡F 型環氧化合物、氫化雙盼S型環氧化合物、氫化雙紛型環 氧化合物、溴化雙酚A型環氧化合物、溴化雙酚F型環氧 ^ 化合物、苯酚酚醛清漆(phenol novolac)型環惫彳卜人铷m 酚酚醛清漆(cresol novolac)型環氧化合物、溴苯酚酚醛、生 漆型環氧化合物、溴甲盼祕清漆型環氧化合物、雙紛1 酚醛清漆型環氧化合物、含有萘骨架的環氧化合物、芳香 族聚縮水甘_化合物、雙環戊二晞盼型環氧化合物、於 環式二縮水甘油醚化合物、脂肪族聚縮水甘油醚化合物、9 104 201022331 32945pif.doc 型二縮水甘她合物《及彻 合物及縮水如可以列舉二縮水甘油醋化 合物。 作為所述縮水甘油胺,例如可以列舉聚縮 水甘油胺化Preferable specific examples of the polymer having a monomer having an epoxy ring include polyglycidyl acrylate and the like. Further, preferred examples of the copolymer of the monomer having an epoxy ring and another monomer include N-phenylmaleimide-glycidyl methacrylate copolymer and N-cyclohexylmalanium. Imine-glycidyl methacrylate copolymer, benzyl methacrylate-methylpropionic acid glycidol g-copolymer, mercapto-acrylic acid butyl vinegar-glycidyl methacrylate copolymer, sulfhydryl 2-hydroxyethyl acrylate-glycidyl methacrylate copolymer, (3-ethyl-3-epoxypropyl) decyl acrylate-glycidyl methacrylate copolymer and styrene-methyl Propylene 103 201022331 32945pif.doc . Acid glycidyl ester copolymer. Among these examples, particularly preferred are ruthenium, osmium, iridium, osmium, _tetraglycidyl metaxylylenediamine, 1,3-bis(indole, fluorene-diglycidylaminomethyl)cyclohexane, hydrazine ,Ν,Ν',Ν'-tetraglycidyl_4,4,-diaminodiphenylmethane, trade name "Techmore VG3101L", 3,4-epoxycyclohexenecarboxylic acid-3,,4,- Epoxycyclohexane methyl ester, N-phenyl maleimide-methyl methacrylate glycidyl ester copolymer and 2-(3,4-epoxycyclohexyl)ethyltrimethoxydecane. More specifically, examples of the epoxy compound include glycidyl ether, glycidyl ester, glycidylamine, acrylic resin containing epoxy 0, glycidylamine, and glycidol isocyanurate. An ester, a chain aliphatic epoxy compound, and a cyclic aliphatic epoxy compound. Further, the epoxy compound means a compound having an epoxy group, and the epoxy resin means a resin having an epoxy group. Examples of the glycidyl ethers include a double-presence A type epoxy compound, a bisphenol F type epoxy compound, a bisphenol s type epoxy compound, a double epoxy compound, and a hydrogenated double A type epoxy compound. , hydrogenation double age F type epoxy compound, hydrogenated double expectation S type epoxy compound, hydrogenated double condensed epoxy compound, brominated bisphenol A type epoxy compound, brominated bisphenol F type epoxy compound, phenol novolac Phenol novolac type 惫彳 铷 phenol phenol novolac type epoxide, bromo phenol phenol, lacquer type epoxy compound, bromine smear varnish type epoxy compound, double scent 1 novolac Epoxy compound, epoxy compound containing naphthalene skeleton, aromatic polycondensation compound, dicyclopentadienyl epoxy compound, cyclic diglycidyl ether compound, aliphatic polyglycidyl ether compound, 9 104 201022331 32945pif.doc type dihydrated glycoside compound "and condensed water and shrinkage can be cited as diglycidyl vinegar compound. As the glycidylamine, for example, polyglycidyl amination can be mentioned.

夹有環氧基的丙婦酸系化合物,例如可以列 牛/、有%軋乙基(oxiranyl)的單體的均聚物及共聚物。 型環1=縮水甘細,例如爛舉縮水甘油酿胺 作為所述鏈狀脂肪族型環氧化合物,例如可以列舉將 烯烴(alkene)化合物的碳-碳雙鍵氧化而獲得的含有環氧基 的化合物。 作為所述環狀脂肪族型環氧化合物,例如可以列舉將 環烯烴化合物的碳-碳雙鍵氧化而獲得的含有環氧基的化 合物。 作為所述雙酚A型環氧化合物,例如可以列舉:828、 1001、1002、1〇〇3、1〇〇4、1007、1010(均為曰本環氧樹脂 (Japan Epoxy Resins)(股)製造),Epot〇hto yD_128(東都化成 (股)製造)’ DER-331、DER-332、DER-324(均為 Dow Chemical Japan(股)製造)’Epiclon 840、Epiclon 85〇、Epiclon 1050(均為 DIC(股)製造),Epomic R-140、Epomic R-301 及The bupropionic acid-based compound having an epoxy group may, for example, be a homopolymer or a copolymer of a monomer having a oxiranyl group. Ring 1 = shrinkage, for example, rotten glycidylamine as the chain aliphatic epoxy compound, and examples thereof include an epoxy group obtained by oxidizing a carbon-carbon double bond of an alkene compound. compound of. The cyclic aliphatic epoxy compound may, for example, be an epoxy group-containing compound obtained by oxidizing a carbon-carbon double bond of a cyclic olefin compound. Examples of the bisphenol A type epoxy compound include 828, 1001, 1002, 1〇〇3, 1〇〇4, 1007, and 1010 (all of which are Japan Epoxy Resins). Manufactured, Epot〇hto yD_128 (made by Tohto Kasei Co., Ltd.) 'DER-331, DER-332, DER-324 (all manufactured by Dow Chemical Japan) 'Epiclon 840, Epiclon 85〇, Epiclon 1050 (both Manufactured for DIC, Epomic R-140, Epomic R-301 and

EpomicR-304(均為三井化學(股)製造)。 作為所述雙酚F型環氧化合物,例如可以列舉:806、 105 201022331 32945pif.doc 807、4004P(均為曰本環氧樹脂(股)製造),Ep〇t〇ht〇 YDF-170、Epotohto YDF-175S、Epotohto YDF-2〇01(均為 東都化成(股)製造),DER-354(D0W Chemical Japan(股)製 造)’ Epiclon 830 及 Epiclon 835(均為 DIC(股)製造)。 作為所述雙酚型環氧化合物,例如可以列舉2,2_雙(4_ 經基苯基)-1,1,1,3,3,3-六氟丙烷的環氧化物。 作為所述氫化雙酚A型環氧化合物,例如可以列舉:EpomicR-304 (all manufactured by Mitsui Chemicals Co., Ltd.). As the bisphenol F-type epoxy compound, for example, 806, 105 201022331 32945 pif. doc 807, 4004P (all manufactured by Epoxy Epoxy Co., Ltd.), Ep〇t〇ht〇YDF-170, Epotohto YDF-175S, Epotohto YDF-2〇01 (both manufactured by Tohto Kasei Co., Ltd.), DER-354 (manufactured by D0W Chemical Japan Co., Ltd.) Epiclon 830 and Epiclon 835 (both manufactured by DIC). As the bisphenol type epoxy compound, for example, an epoxide of 2,2-bis(4-diphenyl)-1,1,1,3,3,3-hexafluoropropane can be mentioned. As the hydrogenated bisphenol A type epoxy compound, for example,

Simtohto ST-3000(東都化成(股)製造)、趾啦咖 HBE-100(新曰本理化(股)製造)以及Denac〇1 Θ EX_252(Nagase chemtex(股)製造)。 作為所述氫化雙酚型環氧化合物,例如可以列舉氫化 2,2-雙(4-羥基苯基)-ΐ,ι,ι,3,3,3-六氟丙烷的環氧化物。 作為所述溴化雙酚A型環氧化合物,例如可以列舉: 5050、5051(均為曰本環氧樹脂(股)製造),Ep〇t〇ht〇 YDB-360、Epotohto YDB-400(均為東都化成(股)製造), DER-530、DER-538(均為 Dow Chemical Japan(股)製造),Simtohto ST-3000 (manufactured by Tohto Kasei Co., Ltd.), Toka Coffee HBE-100 (manufactured by Shin Sakamoto Chemical Co., Ltd.), and Denac 〇1 Θ EX_252 (manufactured by Nagase Chemtex). The hydrogenated bisphenol type epoxy compound may, for example, be an epoxide of hydrogenated 2,2-bis(4-hydroxyphenyl)-fluorene, iota, 3,3,3-hexafluoropropane. Examples of the brominated bisphenol A type epoxy compound include 5050 and 5051 (all manufactured by Enamel Epoxy Resin Co., Ltd.), Ep〇t〇ht〇YDB-360, and Epotohto YDB-400 (both Manufactured for Dongdu Chemical (share), DER-530, DER-538 (all manufactured by Dow Chemical Japan)

Epiclon 152 及 Epiclon 153(均為 DIC(股)製造)。 〇 作為所述本盼盼搭清漆型環氧化合物,例如可以列 舉.152、154(均為日本環氧樹脂(股)製造),ydpN_638(東 都化成(股)製造),DEN431、DEN438(均為 Dow Chemical Japan(股)製造),Epiclon N-770(DIC(股)製造),EPPN-201 及EPPN-202(均為日本化藥(股)製造)。 作為所述曱酚酚醛清漆型環氧化合物,例如可以列 舉:180S75(曰本環氧樹脂製造),YDCN-701、YDCN-702(^ 106 201022331 32945pif.doc 為東都化成(股)製造)’ EpiclonN-665、EpiclonN-695(均為 DIC(股)製造),EOCN-102S、EOCN-103S、EOCN-104S、 EOCN-1020、EOCN-1〇25 及 EOCN-1027(均為日本化藥(股) 製造)。 作為所述雙盼A齡酸·清漆型環氧化合物,例如可以列 舉157S70(曰本環氧樹脂(股)製造)以及Epiclon N-880(DIC(股)製造)。 @ 作為所述含有萘骨架的環氧化合物,例如可以列舉Epiclon 152 and Epiclon 153 (both manufactured by DIC). 〇 〇 N 152 152 152 152 152 152 152 152 152 152 152 152 152 152 152 152 152 152 152 152 152 152 152 152 152 152 152 152 152 152 152 152 152 152 152 152 152 152 152 152 152 152 152 152 152 152 152 152 152 152 152 152 Dow Chemical Japan (manufactured by Dow Chemical Japan), Epiclon N-770 (manufactured by DIC), EPPN-201 and EPPN-202 (all manufactured by Nippon Kayaku Co., Ltd.). Examples of the nonylphenol novolak-type epoxy compound include 180S75 (manufactured by Sakamoto Epoxy Resin), YDCN-701, YDCN-702 (^106 201022331 32945pif.doc manufactured by Tohto Kasei Co., Ltd.) EpiclonN -665, Epiclon N-695 (all manufactured by DIC), EOCN-102S, EOCN-103S, EOCN-104S, EOCN-1020, EOCN-1〇25 and EOCN-1027 (both Japanese chemical companies) Manufacturing). As the bismuth A-age acid/varnish-type epoxy compound, for example, 157S70 (manufactured by Enamel Epoxy Co., Ltd.) and Epiclon N-880 (manufactured by DIC) can be listed. @ As the epoxy compound containing a naphthalene skeleton, for example,

Epiclon HP-4032、Epiclon HP-4700、Epiclon HP-4770(均為 DIC(股)製造)以及NC-7000(曰本化藥(股)製造)。 作為所述方香族聚縮水甘油鍵化合物,例如可以列 舉·對本一紛,一縮水甘油轉(hydroquinone diglycidyl ether)(下述結構式E101) ’鄰苯二酚二縮水甘油醚(catech〇1 diglycidyl ether)(下述結構式E1〇2),間苯二酚二縮水甘油 醚(resorcinol diglycidyl ether)(下述結構式 E103),三(4-縮 水甘油基氧基苯基)曱烷(下述結構式E105),1031S、 豢 1032H60(均為曰本環氧樹脂(股)製造),TACTIX-742(DowEpiclon HP-4032, Epiclon HP-4700, Epiclon HP-4770 (both manufactured by DIC) and NC-7000 (manufactured by Sakamoto Chemical Co., Ltd.). As the scented polyglycidyl bond compound, for example, hydroquinone diglycidyl ether (the following structural formula E101) catechol diglycidyl ether (catech〇1 diglycidyl) can be exemplified. Ether) (structure E1〇2 below), resorcinol diglycidyl ether (structure E103 below), tris(4-glycidyloxyphenyl)decane (described below) Structural Formula E105), 1031S, 豢1032H60 (all manufactured by Epoxy Epoxy Resin), TACTIX-742 (Dow)

Chemical Japan(股)製造),Denac〇i EX-20 l(Nagase chemtex(股)製造)’ DPPN_5〇3、DPPN-502H、DPPN-501H、 NC6000(均為日本化藥(股)製造),Techm〇re VG31〇1L(三井 化學(股)製造),以下述結構式El〇6所表示的化合物以及 以下述結構式E107所表示的化合物。 107 201022331 32945pif.doc [化 70] (Ε101) (Ε102) (Ε103)Chemical Japan (manufactured by Chemical Japan), Denac〇i EX-20 l (manufactured by Nagase chemtex) 'DPPN_5〇3, DPPN-502H, DPPN-501H, NC6000 (all manufactured by Nippon Kayaku Co., Ltd.), Techm 〇re VG31〇1L (manufactured by Mitsui Chemicals Co., Ltd.), a compound represented by the following structural formula El〇6, and a compound represented by the following structural formula E107. 107 201022331 32945pif.doc [化70] (Ε101) (Ε102) (Ε103)

作為所述雙環戊二烯酚型環氧化合物,例如可以列舉 TACTIX-556(Dow Chemical Japan(股)製造)以及 Epiclon HP_72〇〇(DIC(股)製造)。 作為所述脂環式一縮水甘油鱗化合物,例如可以列舉 環己一曱醇一縮水甘油醚化合物以及Rikaresin DME-100(新曰本理化(股)製造)。 作為所述脂肪族聚縮水甘油醚化合物,例如可以列 108 201022331 32945pif.doc 舉:乙二醇二縮水甘油醚(下述結構式E108),二乙二醇二 縮水甘油醚(下述結構式E1〇9),聚乙二醇二縮水甘油醚, 丙二醇二縮水甘油醚(下述結構式E110),三丙二醇二縮水 甘油醚(下述結構式Bill),聚丙二醇二縮水甘油醚,新戊 二醇二縮水甘油醚(下述結構式E112),14-丁二醇二縮水 甘油鱗(下述結構式E113),1,6-己二醇二縮水甘油醚(下述 結構式E114),二漠新戊二醇二縮水甘油醚(下述結構式 參 E115) ’ Denacol EX-810、Denacol EX-851、Denacol EX-8301、Denacol EX-911、Denacol EX-920、Denacol EX-931、Denacol EX-211、Denacol EX-212、Denacol EX-313(均為 Nagase chemtex(股)製造)’ DD-503(ADEKA(股)製造),Rikaresin W-100(新日本理化 (股)製造),1,3,5,6-四縮水甘油基-2,4-己二醇(下述結構式 E116) ’ 甘油聚縮水甘油謎(glycerin polyglycidyl ether) ’ 山 梨糖醇聚縮水甘油謎(sorbitol polyglycidyl ether),三經甲基 丙烧聚縮水甘油趟(trimethylolpropane polyglycidyl β ether),季戊四醇聚縮水甘油醚(pentaerythritol polyglycidyl ether),Denacol EX-313、Denacol EX-611、Denacol EX-321 [化 71]Examples of the biscyclopentadiene phenol type epoxy compound include TACTIX-556 (manufactured by Dow Chemical Japan Co., Ltd.) and Epiclon HP_72® (manufactured by DIC Co., Ltd.). Examples of the alicyclic monoglycidyl scale compound include a cyclohexanone-glycidyl ether compound and Rikaresin DME-100 (manufactured by Shin Sakamoto Chemical Co., Ltd.). As the aliphatic polyglycidyl ether compound, for example, it can be listed as 108 201022331 32945 pif. doc: ethylene glycol diglycidyl ether (the following structural formula E108), diethylene glycol diglycidyl ether (the following structural formula E1) 〇9), polyethylene glycol diglycidyl ether, propylene glycol diglycidyl ether (the following structural formula E110), tripropylene glycol diglycidyl ether (the following structural formula Bill), polypropylene glycol diglycidyl ether, neopentyl Alcohol diglycidyl ether (structure E112 below), 14-butanediol diglycidil scale (structure E113 below), 1,6-hexanediol diglycidyl ether (structure E114 below), Dimethylpentanediol diglycidyl ether (the following structural formula E115) ' Denacol EX-810, Denacol EX-851, Denacol EX-8301, Denacol EX-911, Denacol EX-920, Denacol EX-931, Denacol EX -211, Denacol EX-212, Denacol EX-313 (all manufactured by Nagase Chemtex) 'DD-503 (made by ADEKA), Rikaresin W-100 (made by New Japan Physical and Chemical Co., Ltd.), 1, 3,5,6-tetraglycidyl-2,4-hexanediol (Structure E116 below) 'Glycerol polyglyc Idyl ether) 'sorbitol polyglycidyl ether, trimethylolpropane polyglycidyl beta ether, pentaerythritol polyglycidyl ether, denacol EX-313, Denacol EX-611, Denacol EX-321 [71]

(E108) (E109)(E108) (E109)

(E110) 109 201022331 32945pif.doc(E110) 109 201022331 32945pif.doc

作為所述多硫化物型二縮水甘油醚化合物,例如可以 列舉 FLDP-50 及 FLDP-6〇(均為 T〇ray Thi〇kol㈤製造)。 作為所述聯笨酚型環氧化合物,例如可以列舉: YX-4000、YL-6121H(均為日本環氧樹脂(股)製造), NC-3000P及NC-3〇OOS(均為日本化藥(股)製造)。As the polysulfide type diglycidyl ether compound, for example, FLDP-50 and FLDP-6(R) (all manufactured by T〇ray Thi〇kol (5)) can be cited. Examples of the biphenol-based epoxy compound include YX-4000 and YL-6121H (all manufactured by Japan Epoxy Resin Co., Ltd.), NC-3000P and NC-3〇OOS (all of which are Japanese chemical drugs). (share) manufacturing).

作為所述二縮水甘油酯化合物,例如可以列舉:對笨 二甲酸二縮水甘油酯(下述結構式Π7)、鄰苯二曱酸二縮水 甘油酯(下述結構式E118)、鄰苯二甲酸雙(2-曱基環氧乙烷 基甲基)酯(下述結構式EH9)、以下述結構式E12i所表示 的化合物、以下述結構式E122所表示的化合物以及以下 述結構式E123所表示的化合物。 110 201022331 32945pif.doc [化 72]Examples of the diglycidyl ester compound include bisglycidyl benzoate (the following structural formula Π7), diglycidyl phthalate (the following structural formula E118), and phthalic acid. Bis(2-fluorenyloxiranylmethyl)ester (the following structural formula EH9), a compound represented by the following structural formula E12i, a compound represented by the following structural formula E122, and represented by the following structural formula E123 compound of. 110 201022331 32945pif.doc [Chem. 72]

(E117)(E117)

(E118)(E118)

(E119)(E119)

Ο (E123)Ο (E123)

作為所述縮水甘油醋環氧化合物’例如可以列舉·· Wl、872(均為曰本環氧樹脂(股)製造)’Epicl〇n200、EPicl〇n 4〇〇(均為 dic(股)製造),Denacol EX-711 及 DenacolAs the glycidol vinegar epoxy compound, for example, Wl, 872 (all manufactured by 曰本环氧树脂 epoxy resin) can be used as 'Epicl〇n200, EPicl〇n 4〇〇 (all manufactured by dic). ), Denacol EX-711 and Denacol

Ex·721 (均為 Nagase chemtex(股)製造)。 一作為所述聚縮水甘油胺化合物,例如可以列舉·· Nn 結構式_、N,N-二縮水甘油基 (下述結構)、聯二料料基Μ笨胺 述結構式£127)、Wxr,Ν_一縮水甘油基_2,4,6·三溴苯胺(下 ,Ν'二縮水甘油基)胺基丙基三甲氧基 111 201022331 32945pif.doc 梦烷(下述結構式E128)、Ν,Ν,0_三縮水甘油基對氨基笨盼 (下述結構式E129)、N,N,0-三縮水甘油基間氨基苯酚(下述 結構式E130)、N,N,N,,N,-四縮水甘油基間苯二甲胺 (TETRAD-X(三菱氣體化學(股)),下述結構式E132)、n 雙(Ν,Ν·二縮水甘油基胺基甲基)環己烷(TETRAD-C(三菱 氣體化學(股)),下述結構式Ε133)、1,4·雙(Ν,Ν-二縮水甘 油基胺基甲基)環己烷(下述結構式E134)、l,3-雙(Ν,Ν-二縮 水甘油基胺基)環己烷(下述結構式Ε135)、1,4-雙(Ν,Ν-二$ 水甘油基胺基)環己烷(下述結構式E136)、l,3-雙(Ν,Ν-二縮 水甘油基胺基)苯(下述結構式Ε137)、1,4-雙(Ν,Ν-二縮水甘 油基胺基)苯(下述結構式Ε138)、2,6-雙(Ν,Ν-二縮水甘油基 胺基甲基)雙環Ρ.2.1]庚烷(下述結構式Ε139)、Ν,Ν,Ν,,&gt;^ 四縮水甘油基-4,4·-二氨基二環己基曱烷(下述結構式 Ε140)、2,2’-二曱基-(1^凡:^’,:^-四縮水甘油基)-4,4,-二氨基 聯苯(下述結構式Ε141)、Ν,Ν,Ν’,Ν’-四縮水甘油基_44,--氨基二苯基醚(下述結構式Ε142)、1,3,5·三(4-(Ν,Ν-二縮水 甘油基)胺基苯氧基)苯(下述結構式Ε143)、2,4,4,-三(Ν,ν_ 二縮水甘油基胺基)二苯基醚(下述結構式Ε144)、三 (4-(Ν,Ν-二縮水甘油基)胺基苯基)曱烷(下述結構式 Ε145)、3,4,3’,4’-四(Ν,Ν-二縮水甘油基胺基)聯苯(下述結構 式迟146)、3,4,3,,4,-四(队&gt;1-二縮水甘油基氨基)二笨基醚(下 述結構式Ε147)、以下述結構式Ε148所表示的化合物以及 以下述結構式Ε149所表示的化合物。 112 201022331 32945pif.doc [化 73]Ex·721 (both manufactured by Nagase Chemtex). As the polyglycidylamine compound, for example, Nn structural formula, N,N-diglycidyl group (structure described below), bipartite material base, stupid amine structure formula (127), Wxr , Ν_-glycidyl 2,4,6·tribromoaniline (lower, Ν' diglycidyl) aminopropyltrimethoxy 111 201022331 32945pif.doc montane (the following structural formula E128), Ν , hydrazine, 0_triglycidyl-p-amino (hereinafter, the structural formula E129), N,N,0-triglycidyl-m-aminophenol (the following structural formula E130), N,N,N,,N ,-tetraglycidyl metaxylylenediamine (TETRAD-X (Mitsubishi Gas Chemical Co., Ltd.), the following structural formula E132), n bis(Ν,Ν·diglycidylaminomethyl)cyclohexane (TETRAD-C (Mitsubishi Gas Chemical Co., Ltd.), the following structural formula Ε133), 1,4·bis(indole, fluorene-diglycidylaminomethyl)cyclohexane (the following structural formula E134), l,3-bis(indole, fluorene-diglycidylamino)cyclohexane (formula 135 below), 1,4-bis(indole, fluorene-di-glycidylamino)cyclohexane ( The following structural formula E136), l,3-bis(indole, fluorene-diglycidylamino)benzene (the following structural formula Ε137) 1,4-Bis(Ν,Ν-diglycidylamino)benzene (the following structural formula Ε138), 2,6-bis(indole, fluorene-diglycidylaminomethyl)bicycloindole.2.1] Heptane (structure Ε 139 below), hydrazine, hydrazine, hydrazine, &gt;^ tetraglycidyl-4,4·-diaminodicyclohexyldecane (structure formula Ε140 below), 2,2'- Dimercapto-(1^凡:^',:^-tetraglycidyl)-4,4,-diaminobiphenyl (the following structural formula Ε141), Ν, Ν, Ν', Ν'-four shrinkage Glyceryl-44,-aminodiphenyl ether (formula 142 below), 1,3,5·tris(4-(anthracene, Ν-diglycidyl)aminophenoxy)benzene (described below) Structural formula Ε143), 2,4,4,-tris(Ν,ν_ diglycidylamino)diphenyl ether (the following structural formula Ε144), tris(4-(Ν,Ν-diglycidyl) Aminophenyl)decane (the following structural formula Ε145), 3,4,3',4'-tetrakis(Ν,Ν-diglycidylamino)biphenyl (the following structural formula is delayed 146), 3 , 4, 3, 4, -4 (team &gt; 1- diglycidylamino) diphenyl ether (the following structural formula Ε 147), a compound represented by the following structural formula Ε 148, and the following structural formula Ε 149 Compound represented112 201022331 32945pif.doc [Chem. 73]

(E124)(E124)

(E126)(E126)

(E128) (E129)(E128) (E129)

(E136) (E137) 113 201022331 32945pif.doc [化 74](E136) (E137) 113 201022331 32945pif.doc [Chem. 74]

(E138)(E138)

(E141)(E141)

(E144)(E144)

Ο 114 201022331 32945pif.docΟ 114 201022331 32945pif.doc

[化 75][化75]

(E148)(E148)

作為所述具有環氧乙基的單體 舉聚甲基丙賊縮水甘油醋。作為所= 體的共聚物,例如可以列舉:Ν-苯基馬來醯亞胺-甲基丙^ 酸縮水甘油酯共聚物、Ν-環己基馬來酿亞胺_甲基丙烯酸縮 水甘油酯共聚物、甲基丙烯酸苄酯-甲基丙烯酸縮水甘油醋 共聚物、甲基丙婦酸丁酯-甲基丙稀酸縮水甘油酯共聚物、 115 201022331 32945pif.doc 甲基丙烯酸-2-羥基乙醋-甲基丙烯酸 甲基丙輝乙基-3·環氧丙基)甲醋由:酸: 你氣路、+、目:基烯縮水甘油酯共聚物。 作為所述具有環氧乙基的單體,例如 某 基)丙烯酸曱基縮水甘油酯。 …衣己酉曰以及(甲 且右===有魏6基的單_料财的除所述 /、有魏乙基的早體以外的其他單體,例如可以列舉 基)丙烯酸、(甲基)丙晞酸甲醋、(曱基)丙烯酸乙醋、(甲基) 丙烯酸異丙醋、(甲基)丙稀酸丁醋、(甲基)丙稀酸異丁醋、 (一甲基)丙烯酸叔丁醋、(甲基)丙烯酸環己醋、(甲基)丙烯酸 卞酯:(曱基)丙烯酸-2·經基乙醋、(甲基)丙烯酸_2•經基丙 醋、苯乙烯、甲基苯乙烯、氯甲基苯乙烯、(曱基)丙烯酸 (3-乙基-3-環氧丙基)曱醋、队環己基馬來醯亞胺以及n-笨 基馬來醯亞胺。 作為所述異氰尿酸、%水甘油目旨,例如可以列舉:1 '5_ 三縮水甘油基-1,3,5-三嗪-2,4,6-(1氏3氏511)-三酮(下述結構 式E150)、l,3-二縮水甘油基_5_烯丙基_丨,3,5_三嗪 -2,4,6·(1Η,3Η,5Η)-三酮(下述結構式£151)以及異氰尿酸縮 水甘油酯型環氧樹脂。 [化 76]As the monomer having an epoxy group, polymethyl propyl thief glycidol vinegar is used. Examples of the copolymer of the compound include a fluorene-phenylmaleimide-methyl propyl glycidyl ester copolymer, fluorene-cyclohexylmaleimine-glycidyl methacrylate copolymerization. , benzyl methacrylate-glycidyl methacrylate copolymer, butyl methacrylate-glycidyl methacrylate copolymer, 115 201022331 32945pif.doc 2-hydroxyethyl methacrylate -Methylpropoxyethyl methacrylate -3 -epoxypropyl) methyl acetonate: Acid: Your gas path, +, mesh: styrene glycidyl ester copolymer. As the monomer having an epoxy group, for example, a certain group of decyl glycidyl acrylate.克 酉曰 酉曰 酉曰 ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( 酉曰 酉曰 酉曰 酉曰 酉曰 酉曰 酉曰 酉曰 酉曰 酉曰 酉曰 酉曰 酉曰 酉曰 酉曰 酉曰 酉曰 酉曰 酉曰 酉曰 酉曰Methyl acrylate, ethyl acetonate, isopropyl methacrylate, butyl acetonate, butyl acetonate, (meth) acrylate Tert-butyl vinegar, cyclomethicone (meth) acrylate, decyl (meth) acrylate: (mercapto) acrylate - 2. ethyl acetonate, (meth) acrylate _2 propyl acetonide, styrene, Methylstyrene, chloromethylstyrene, (mercapto)acrylic acid (3-ethyl-3-epoxypropyl) vinegar, cycline hexamethylene quinone imine, and n-stupyl maleimide . Examples of the isocyanuric acid and the % chloroglycerin include 1 '5_triglycidyl-1,3,5-triazine-2,4,6-(1's 3 511)-trione. (Strong formula E150 below), l,3-diglycidyl-5-allyl-indole, 3,5-triazine-2,4,6·(1Η,3Η,5Η)-trione (under The structural formula is £151) and the isocyanuric acid glycidyl ester type epoxy resin. [化76]

201022331 32945pif.doc ^作為所述鏈狀脂肪族型環氧化合物,例如可以列舉環 氧化聚丁二烯以及Ep〇lead pB36〇〇(Daicd化學工業(股)製 造)。 作為所述環狀脂肪族型環氧化合物,例如可以列舉: 2:甲基-3,4-環氧環己甲酸_2,_甲基_3,,4,_環氧環己基甲醋(下 述結構式E153) ’ 2,3-環氧環戊基·2,,3,_環氧環戊基趟(下述 結構式Ε154),ε-己内酯改性3,4_環氧環己甲酸_3,,4,_環氧 ❺ 環己基曱酉曰,1,2.8,9-二環氧檸檬稀(cell〇xide 3000(Daicel 化學工業(股)製造)),3,4_環氧環己烯曱酸_3,,4,_環氧環己烯 基甲醋(Cell〇xide2021P(Daicel化學工業(股)製造),下述結 構式E155),以下述結構式E156所表示的化合物, CY-175、CY-177、CY-179(均為 CIBA-GEIGY 公司製造), EHPD-3150(Daicel化學工業(股)製造)以及環狀脂肪族型 環氧樹脂。 [化 77]201022331 32945pif.doc ^ As the chain aliphatic epoxy compound, for example, epoxidized polybutadiene and Ep〇lead pB36〇〇 (manufactured by Daicd Chemical Industries Co., Ltd.) can be cited. As the cyclic aliphatic epoxy compound, for example, 2: methyl-3,4-epoxycyclohexanecarboxylic acid 2,_methyl_3,4,-epoxycyclohexylmethine ( The following structural formula E153) '2,3-epoxycyclopentyl·2,3,_epoxycyclopentyl hydrazine (the following structural formula Ε154), ε-caprolactone modified 3,4_epoxy Cyclohexanoic acid _3,,4,_epoxy oxime Cyclohexyl hydrazine, 1,2.8,9-diepoxy lemon dilute (cell 〇xide 3000 (Daicel Chemical Industry Co., Ltd.)), 3, 4_ Epoxycyclohexene decanoic acid _3,, 4, epoxycyclohexenyl methyl vinegar (Cell® xide 2021P (manufactured by Daicel Chemical Industry Co., Ltd.), the following structural formula E155), represented by the following structural formula E156 The compounds, CY-175, CY-177, CY-179 (both manufactured by CIBA-GEIGY Co., Ltd.), EHPD-3150 (manufactured by Daicel Chemical Industry Co., Ltd.), and cyclic aliphatic epoxy resins. [化77]

(E155) (E156) 另外,例如本發明的液晶配向劑可以進一步含有各種 添加劑。作為各種添加劑,例如可以列舉聚醢胺酸及其衍 生物以外的高分子化合物及低分子化合物,可以根據各自 117 201022331 32945pif.doc 目的來選擇使用。 例如’作為所述高分子化合物,可以列舉可溶於有機 溶媒的商分子化合物。就控制所形成的液晶配向膜的電性 能或配向性的觀點而言,優選將此種高分子化合物添加到 本發明的液晶配向劑中。作為此高分子化合物 ,例如可以 歹】舉t酿胺、t氣醋、聚腺(p〇lyUrea)、聚 S曰(polyester)、聚環氧化物(p〇iyep〇xide)、聚酯多元醇 (polyester p〇ly〇i)、矽酮改性聚氨酯以及矽酮改性聚酯。 另外,作為所述低分子化合物,例如:1)當期望提高 Θ 塗布性時可以列舉符合此目的介面活性劑,2)當必須提高 抗靜電性時可以列舉抗靜電劑,3)當期望提高與基板的密 接性或耐摩擦性時可以列舉矽烷偶合劑(silane e〇upli% agent)或鈦(titanium)系的偶合劑,另外,4)當在低温下進行 醯亞胺化時可以列舉醯亞胺化催化劑。 作為所述矽烷偶合劑,例如可以列舉:乙烯基三甲氡 基矽烷(vinyl trimethoxysilane)、乙烯基三乙氧基矽烷、 N_(2-氨基乙基)_3_氨基丙基曱基二曱氧基矽烷、N_(2_氨基 乙基)-3-氨基丙基曱基三甲氧基石夕烧、對氨基苯基三甲 〇 基石夕烧、對氨基苯基三乙氧基石夕貌、間氨基苯基三曱氧義 石夕院、間氨基笨基三乙氧基石夕烧、3_氨基丙基三甲氧基^ ,、3-氨基丙基三乙氧基石夕燒、3·縮水甘油氧基丙基三甲 氧基矽烷、3-縮水甘油氧基丙基甲基二甲氧基矽烷、 %氧年己基)乙基三曱氧基石夕烧、3_氯丙基曱基二曱氧基矽 烧、3-氯丙基三甲氧基魏、3_曱基丙烤醯氧基丙基三甲 118 201022331 32945pif.doc 氧基矽烷、3-巯基丙基三甲氧基矽烷、n_(1,3_二甲基亞丁 基)-3-(三乙氧基曱石夕烧基)-1·丙胺以及雙[3_(三甲氧 基甲矽烷基)丙基]乙二胺。 作為所述酿亞胺化催化劑,例如可以列舉:二曱胺 (trimethylamine)、三乙胺、三丙胺、三丁胺等脂肪族^類; N,N-二甲基苯胺、N,N-二乙基苯胺、甲基取代苯胺、羥基 取代苯胺等芳香族胺類;吡啶、甲基取代吡咬、經基取代 0 吼°定、啥琳(quinoline)、甲基取代喹淋、羥基取代喹^、異 喹啉、曱基取代異喹啉、羥基取代異喹啉、咪^坐 (imidazole)、甲基取代咪唑、羥基取代咪唑等環式胺類。 所述醯亞胺化催化劑優選選自N,N_二甲基笨胺、鄰羥基苯 胺、間羥基苯胺、對羥基苯胺、鄰羥基吡啶、間羥基吡啶、 對經基°比咬以及異喹琳中的一種或者兩種或兩種以上。 矽烷偶合劑的添加量通常為聚醯胺酸或者其衍生物 的總重量的0.1重量%〜50重量%,優選為〇丨重量%〜2〇 重量%。 ® 醯亞胺化催化劑的添加量通常相對於聚酿胺酸或者 其衍生物的羰基為0.01當量〜5當量,優選為〇 〇5當量〜 3當量。 其他添加劑的添加量根據其用途而有所不同,通常為 聚醯胺酸或者其衍生物的總重量的0重量%〜3〇重量%, 優選為0.1重量%〜1〇重量%。 另外,例如本發明的液晶配向劑可以在不損及本發明 效果的範圍(優選為所述聚醯胺酸或者其衍生物的2〇重量 119 201022331 32945pif.doc %以内的量)内進-步含有π烯酸聚合物,丙烯酸醋聚合 物,以及作為四羧酸二酐、二綾酸或者其衍生物與二胺的 反應生成物的聚醯胺醯亞胺等其他聚合物成分。 另外,例如就調整液晶配向劑的塗布性或者所述聚醯 胺酸或者其衍生物的濃度的觀點而言,本發明的液晶配向 劑可以進一步含有溶劑。所述溶劑只要是具有溶解高分子 成分的能力的溶劑,那麼可以無特別限制地使用。所述溶 劑廣泛地包括聚醯胺酸、可溶性聚醯亞胺等高分子成分的 製造步驟或用途方面通常所使用的溶劑,可以根據使用目 〇 的而適當選擇。所述溶劑可以是一種溶劑,也可以是兩種 或兩種以上溶劑的混合溶劑。 作為所述溶劑’可以列舉所述聚醯胺酸或者其衍生物 的良溶劑、或者以改善塗布性為目的之其他溶劑。(E155) (E156) Further, for example, the liquid crystal alignment agent of the present invention may further contain various additives. Examples of the various additives include polymeric compounds other than polyglycine and derivatives thereof, and low molecular weight compounds, which can be selected and used according to the purpose of each of 117 201022331 32945 pif.doc. For example, as the polymer compound, a quotient molecular compound which is soluble in an organic solvent can be mentioned. From the viewpoint of controlling the electrical properties or the alignment properties of the liquid crystal alignment film formed, it is preferred to add such a polymer compound to the liquid crystal alignment agent of the present invention. As the polymer compound, for example, t-amine, t-gas vinegar, polyp (p〇lyUrea), poly-S-polyester, polyepoxide (p〇iyep〇xide), polyester polyol (polyester p〇ly〇i), anthrone modified polyurethane and anthrone modified polyester. Further, as the low molecular compound, for example, 1) when it is desired to improve the coating property, an surfactant suitable for this purpose may be mentioned, 2) an antistatic agent may be mentioned when it is necessary to improve the antistatic property, and 3) when it is desired to improve The adhesion between the substrate and the rubbing resistance may be exemplified by a silane coupling agent or a titanium coupling agent, and 4) when the hydrazine imidization is carried out at a low temperature, Amination catalyst. Examples of the decane coupling agent include vinyl trimethoxysilane, vinyl triethoxy decane, and N-(2-aminoethyl)_3_aminopropyl decyl decyloxydecane. , N_(2_aminoethyl)-3-aminopropyl decyl trimethoxy sulphur, p-aminophenyl trimethyl decyl sulphate, p-aminophenyl triethoxy sulphate, m-aminophenyl triterpene Oxygen sylvestre, m-amino-p-butyl triethoxy sulphate, 3-aminopropyltrimethoxy^, 3-aminopropyltriethoxy sulphur, 3, glycidoxypropyltrimethoxy Base decane, 3-glycidoxy propyl methyl dimethoxy decane, % oxonyl hexyl) ethyl trimethoxy oxanthine, 3- chloropropyl decyl decyloxy oxime, 3-chloro Propyltrimethoxywei, 3_mercaptopropanyloxypropylpropyl 118, 201022331 32945pif.doc Oxydecane, 3-mercaptopropyltrimethoxydecane, n_(1,3-dimethylbutylene) -3-(triethoxycarbosulfanyl)-1·propylamine and bis[3_(trimethoxycarbamidyl)propyl]ethylenediamine. Examples of the brewing imidization catalyst include aliphatic compounds such as trimethylamine, triethylamine, tripropylamine, and tributylamine; N,N-dimethylaniline, N,N-di Aromatic amines such as ethyl aniline, methyl substituted aniline, hydroxy substituted aniline; pyridine, methyl substituted pyridine, transsubstituted 0 吼 °, quinoline, methyl substituted quinone, hydroxy substituted quinolin a cyclic amine such as an isoquinoline, a mercapto-substituted isoquinoline, a hydroxy-substituted isoquinoline, an imidazole, a methyl-substituted imidazole, or a hydroxy-substituted imidazole. The ruthenium amide catalyst is preferably selected from the group consisting of N,N-dimethyl phenylamine, o-hydroxyaniline, m-hydroxyaniline, p-hydroxyaniline, o-hydroxypyridine, m-hydroxypyridine, p-aminopyrylene, and isoquine. One or two or more of them. The amount of the decane coupling agent to be added is usually 0.1% by weight to 50% by weight based on the total weight of the polyamic acid or a derivative thereof, preferably 〇丨% by weight to 2% by weight. The amount of the ruthenium imidization catalyst to be added is usually 0.01 to 5 equivalents, preferably 5 to 3 equivalents, per gram of the carbonyl group of the poly-aracine or its derivative. The amount of the other additives to be added varies depending on the use thereof, and is usually 0% by weight to 3% by weight based on the total weight of the polyaminic acid or a derivative thereof, preferably 0.1% by weight to 1% by weight. Further, for example, the liquid crystal alignment agent of the present invention can be carried out in a range which does not impair the effects of the present invention (preferably, the amount of the polyacrylic acid or a derivative thereof is 119 201022331 32945 pif. doc %) It contains a pienoic acid polymer, an acrylic vinegar polymer, and other polymer components such as polyamidoximine which is a reaction product of tetracarboxylic dianhydride, dicarboxylic acid or a derivative thereof and a diamine. Further, for example, from the viewpoint of adjusting the coatability of the liquid crystal alignment agent or the concentration of the polyamic acid or a derivative thereof, the liquid crystal alignment agent of the present invention may further contain a solvent. The solvent is not particularly limited as long as it has a solvent having the ability to dissolve a polymer component. The solvent widely includes a solvent which is usually used in the production step or use of a polymer component such as polyaminic acid or soluble polyimine, and can be appropriately selected depending on the intended use. The solvent may be a solvent or a mixed solvent of two or more solvents. The solvent 'is a good solvent for the polyamic acid or a derivative thereof, or another solvent for the purpose of improving coatability.

對於所述聚醯胺酸或者其衍生物為良溶劑的奍質子 性極性有機溶劑可以列舉:Ν-曱基-2-吡咯啶酮 (N-methyl-2-pyrrolidone)、二曱基咪唾琳酮(dimethyl imidazolidinone) 、N-曱基己内酿胺(N-methyl Q caprolactam)、N_ 曱基丙醯胺(N-methyl propionamide)、N,N- 二曱基乙酿胺、二甲基亞石風(dimethyl sulfoxide)、N,N-二甲 基曱醯胺(N,N-dimethylformamide)、N,N-二乙基曱酸胺、 二乙基乙醯胺、γ-丁内醋(γ-butyrolactone)等内醋。 作為所述以改善塗布性等為目的之其他溶劑的例 子,可以列舉:乳酸烷基酯,3-甲基-3-甲氧基丁醇 (3-methyl-3-me1;hoxybutanol),四氳化萘(tetralin),異彿爾 120 201022331 32945pif.doc 酮(isophorone),乙二醇單丁醚(她作狀§1外〇1 monobutylether)等乙二醇單烷基醚,二乙二醇單乙峻等二 乙二醇單烧基驗,乙二醇單燒基或苯基乙酸酯,三乙土醇 單烷基醚,丙二醇單甲醚、丙二醇單丁醚等丙二醇單烷基 醚,丙二酸二乙酯(diethyl malonate)等丙二酸二烷基酯,二 丙一醇單曱醚等二丙二醇單烧基趟,這些的乙酸酯類等醋 化合物。 這些化合物中,所述溶劑特別優選N_甲基_2_吡洛咬 酮、二曱基咪唑琳酮、γ-丁内酯、乙二醇單丁趟、二乙二 醇單乙醚、丙二醇單丁醚、丙二醇單甲醚以及二丙二醇單 甲鍵。 于本發明中,液晶配向劑中的包含所述聚醯胺酸或者 其竹生物的南分子成分的濃度沒有特別限定,優選為〇.1 重量%〜40重量%。將此液晶配向劑塗布在基板上時,有 時為了調整膜厚而必須進行預先利用溶劑來將所含有的高 分子成分稀釋的操作。此時,就將液晶配向劑的粘度調整 ® 成適合在液晶配向劑中容易地混合溶劑的粘度的觀點而 έ ’所述兩分子成分的濃度優選小於等於40重量%。 另外,液晶配向劑中的所述高分子成分的濃度有時也 要根據液晶配向劑的塗布方法來調整。當液晶配向劑的塗 布方法為旋塗法或印刷法時,為了良好地保持膜厚,通常 大多使所述高分子成分的濃度小於等於10重量%。對於其 他塗布方法,例如浸潰法或喷墨法來說,可能要進一步降 低》辰度。另一方面,如果所述高分子成分的濃度大於等於 121 201022331 32945pif.doc 0.1重量%,那麼所獲得的液晶配向膜的膜厚容易成為最佳 尽度。因此’在通常的旋塗法或印刷法等中,所述$分子 成分的濃度大於等於〇 1重量%,優選為〇 5重量% 重量%。但是’通過液晶配向劑的塗布方法,有時也可以 在更低的濃度下使用。 此外The protonic polar organic solvent in which the polylysine or the derivative thereof is a good solvent may, for example, be N-methyl-2-pyrrolidone or dimercapto Dimethyl imidazolidinone, N-methyl Q caprolactam, N-methyl propionamide, N,N-dimercaptoamine, dimethyl Dimethyl sulfoxide, N,N-dimethylformamide, N,N-diethyl decanoic acid, diethyl acetamide, γ-butyrolactone (γ -butyrolactone) and other vinegar. Examples of the other solvent for the purpose of improving coatability and the like include alkyl lactate, 3-methyl-3-methoxybutanol (3-methyl-3-me1; hoxybutanol), tetraterpene. Tetralin, isophor 120 201022331 32945pif.doc ketone (isophorone), ethylene glycol monobutyl ether (she § 1 outer 〇 1 monobutylether) and other ethylene glycol monoalkyl ether, diethylene glycol single Ethylene glycol single-burning test, such as ethylene glycol monobutyl or phenyl acetate, triethyl alcohol monoalkyl ether, propylene glycol monomethyl ether, propylene glycol monobutyl ether and other propylene glycol monoalkyl ether, A dipropylene glycol monoalkyl ester such as diethyl malonate or a dipropylene glycol monoalkyl sulfonate such as dipropanol monoterpene ether or an acetate compound such as an acetate. Among these compounds, the solvent is particularly preferably N-methyl-2-pyrrolidone, dinonylimidazolidinone, γ-butyrolactone, ethylene glycol monobutyl hydrazine, diethylene glycol monoethyl ether, propylene glycol single Butyl ether, propylene glycol monomethyl ether and dipropylene glycol monomethyl bond. In the present invention, the concentration of the south molecular component containing the polyamic acid or the bamboo organism thereof in the liquid crystal alignment agent is not particularly limited, and is preferably from 0.1% by weight to 40% by weight. When the liquid crystal alignment agent is applied onto a substrate, in some cases, it is necessary to perform an operation of diluting the contained high molecular component with a solvent in advance in order to adjust the film thickness. In this case, the viscosity of the liquid crystal alignment agent is adjusted to a viscosity suitable for easily mixing the solvent in the liquid crystal alignment agent. The concentration of the two molecular components is preferably 40% by weight or less. Further, the concentration of the polymer component in the liquid crystal alignment agent may be adjusted depending on the method of applying the liquid crystal alignment agent. When the coating method of the liquid crystal alignment agent is a spin coating method or a printing method, in order to maintain the film thickness favorably, the concentration of the polymer component is usually usually 10% by weight or less. For other coating methods, such as dipping or ink jetting, it is possible to further reduce the "length". On the other hand, if the concentration of the polymer component is 0.1% by weight or more, the film thickness of the obtained liquid crystal alignment film is likely to be the best. Therefore, in the usual spin coating method, printing method, or the like, the concentration of the molecular component is 大于 1% by weight or more, preferably 〇 5% by weight. However, the coating method by the liquid crystal alignment agent may be used at a lower concentration. In addition

將本發明的液晶配向劑用於製作液晶配向辟 時,本發明的液晶配向劑的粘度可以根據形成此液晶配戌 劑的膜的|置或者方絲蚊。例如當制印職來形成 液晶配向劑的膜時,就獲得足夠的膜厚的觀點而言,^ 明的液晶配向劑的粘度優選為大於等於5mPa.s,另外,韵 抑制印刷不均的觀點而言,本發明的液晶配向劑_^ 選為小於等於l〇0mPa.s ’更優選為1〇mPa.s〜8〇mPa s。 當利用旋塗法(spin e㈣㈣布液晶配向劑而形成液晶哉 向劑的膜時,就相同的觀點而言,本發明的液晶配向劑_ 粘度優選為5mPa.s〜200mPa.s,更優選為1〇mPa.s〜1〇( mPa.s。液晶配向劑的粘度可以通過溶劑的稀釋或伴隨著 拌的熟化而減小。When the liquid crystal alignment agent of the present invention is used for the production of a liquid crystal alignment, the viscosity of the liquid crystal alignment agent of the present invention can be determined according to the film forming the liquid crystal compound or the silkworm. For example, when the film is formed to form a film of a liquid crystal alignment agent, the viscosity of the liquid crystal alignment agent is preferably 5 mPa·s or more from the viewpoint of obtaining a sufficient film thickness, and the viewpoint of suppressing uneven printing is suppressed. In other words, the liquid crystal alignment agent of the present invention is selected to be 1 〇 mPa.s' or more, more preferably 1 〇 mPa.s to 8 〇 mPa s. When a liquid crystal aligning agent film is formed by a spin coating method (spin e) liquid crystal alignment agent, the liquid crystal alignment agent _ viscosity of the present invention is preferably 5 mPa·s to 200 mPa·s, and more preferably 1 〇 mPa.s~1 〇 (mPa.s. The viscosity of the liquid crystal alignment agent can be reduced by dilution of the solvent or accompanying aging of the mixture.

本發明的液晶配向劑可以是含有一種聚醯胺酸或者 其何生物的形態,也可以是混合了兩種或兩種以上聚釅胺 酸或者其衍生物的所謂聚合物摻合物的形態。聚合物摻合 物的形態的液晶配向劑可以列舉如下的液晶配向劑:此液 晶配向劑含有聚醯胺酸或者其衍生物八及8,聚醯胺酸或 者其衍生物A的二胺包含所述具有側鏈結構的二胺,且聚 酿胺酸或者其衍生物A及B的四賴二酐的一方或雙方包 122 201022331 32945pif.doc 含以所述通式(TC-1)〜通式(TC-14)所表示的四羧酸二酐。 聚醯胺酸或者其衍生物A是含有所述具有側鏈結構 的二胺的聚醯胺酸或者其衍生物。聚醯胺酸或者其衍生物 B是含有除具有侧鏈結構的二胺以外的二胺的聚酿胺酸或 者其衍生物。以所述通式(TC-1)〜通式(TC-14)所表示的二 胺只要包含於聚合物摻合物中所混合的至少一種聚醯胺酸 或者其衍生物中即可,可以包含於聚醯胺酸或者其衍生物 φ A及B雙方中’也可以包含於聚合物摻合物中所混合的所 有聚醯胺酸或這些的衍生物中。 本發明的液晶配向膜是對所述本發明的液晶配向劑 的塗膜進行加熱而形成的膜。本發明的液晶配向膜可以使 用由液晶配向劑來製作液晶配向膜的通常方法而獲得,例 如,本發明的液晶配向膜可以通過形成本發明液晶配向劑 的塗膜的步驟、以及對此塗膜進行加熱並煆燒的步驟而獲 得。對於本發明的液晶配向膜來說,視需要可以對所述煆 燒步驟中所獲得的膜進行摩擦處理。 ® 與製作通常的液晶配向膜相同,所述塗膜可以通過在 液晶顯示元件的基板上塗布本發明的液晶配向劑而形成。 所述基板可以列舉:可以設置氧化銦錫(Indium Tin Oxide ’ ITO)電極等電極或彩色濾光片(c〇1〇r fllter)等的玻璃 制基板。 作為將液晶配向劑塗布在基板上的方法,通常已知有 旋塗法、印刷法、次潰法、洛滴法method)、 喷墨法等。這些方法在本發明中也同樣可以應用。 123 201022331 32945pif.doc 所述塗膜的烺燒可以在所述聚酿胺酸或者其 進行脫水、閉環反應所需要的條件下進行。所述塗膜的煆 燒通常已知有在烘箱(oven)或紅外爐中進行加熱處理的方 法、在加熱板上(h〇tpiate)進行加熱處理的方法等。這此方 法在本發明中也同樣可以應用。通常優選在15(TC〜3〇0。(: 左右的溫度下進行〗分鐘〜3小時。The liquid crystal alignment agent of the present invention may be in the form of a polyglycine or a living organism thereof, or a form of a so-called polymer blend in which two or more kinds of polyaminic acid or a derivative thereof are mixed. The liquid crystal alignment agent of the form of the polymer blend may, for example, be a liquid crystal alignment agent containing polylysine or derivatives thereof 8 and 8, and a polyamine containing polyamine or its derivative A. One or both of the diamines having a side chain structure, and the poly-branched acid or the derivatives of the derivatives A and B, the tetrahydro dianhydride 122 201022331 32945 pif.doc contains the formula (TC-1) to the formula Tetracarboxylic dianhydride represented by (TC-14). Polylysine or a derivative thereof A is a polyamine or a derivative thereof containing the diamine having a side chain structure. Polylysine or a derivative thereof B is a poly-tantoic acid or a derivative thereof containing a diamine other than a diamine having a side chain structure. The diamine represented by the above formula (TC-1) to formula (TC-14) may be contained in at least one polyphthalic acid or a derivative thereof mixed in the polymer blend. Included in the poly-proline or its derivatives φ A and B ' can also be included in all of the polyamines or derivatives of these blends in the polymer blend. The liquid crystal alignment film of the present invention is a film formed by heating the coating film of the liquid crystal alignment agent of the present invention. The liquid crystal alignment film of the present invention can be obtained by a usual method for producing a liquid crystal alignment film from a liquid crystal alignment agent, for example, a step of forming a coating film of the liquid crystal alignment agent of the present invention by the liquid crystal alignment film of the present invention, and a coating film therefor It is obtained by the step of heating and calcining. For the liquid crystal alignment film of the present invention, the film obtained in the calcining step can be subjected to rubbing treatment as needed. ® is the same as the usual liquid crystal alignment film which can be formed by applying the liquid crystal alignment agent of the present invention on the substrate of the liquid crystal display element. The substrate may be a glass substrate such as an electrode such as an Indium Tin Oxide ITO electrode or a color filter (c〇1〇r fllter). As a method of applying a liquid crystal alignment agent onto a substrate, a spin coating method, a printing method, a secondary collapse method, a drop method, an inkjet method, and the like are generally known. These methods are equally applicable in the present invention. 123 201022331 32945pif.doc The calcination of the coating film can be carried out under the conditions required for the polyamic acid or the dehydration and ring closure reaction. As the sinter of the coating film, a method of heat-treating in an oven or an infrared furnace, a method of heat-treating on a hot plate, and the like are generally known. This method is equally applicable in the present invention. It is usually preferably carried out at 15 (TC to 3 〇 0. (: at a temperature of about ~ minutes to 3 hours).

所述摩擦處理能夠以與通常用來對液晶配向膜進行 配向處理的摩擦處理相同的方式來進行,只要是可以在本 發明的液晶配向財獲得充分的輯(i*etaniatiGn)的條件 即可。特別優選的條件是毛刷壓入量為0.2 mm〜0.8 mm, 平臺移動速度為5 mm/see〜25G mm/see,滾㈣速為· P rpm。作為液晶配向膜的配向處理方法,除摩 擦法以外’ it常已知有光配向法或轉印法等。在可以獲得 本發明效果的範_ ’可以在所述摩擦處理巾顧這 他配向處理方法。 一八The rubbing treatment can be carried out in the same manner as the rubbing treatment which is usually used for the alignment treatment of the liquid crystal alignment film, as long as it can satisfy the conditions of the liquid crystal alignment of the present invention (i* etaniatiGn). Particularly preferred conditions are a brush press-in amount of 0.2 mm to 0.8 mm, a platform moving speed of 5 mm/see to 25 Gmm/see, and a roll (four) speed of · P rpm. As a method of aligning the liquid crystal alignment film, a photo-alignment method, a transfer method, and the like are often known in addition to the rubbing method. The method of obtaining the effect of the present invention can be used in the rubbing treatment method. one eight

^發明的液晶配向膜可關用進—步包括除所述步 1卜的其他步驟的方法㈣宜地獲得。作為此種其他步 摩捧使所㈣膜賴的频、或者使用清洗輯 ①处理則後的膜進行清洗的步驟等。 h ΪΓ魏燒步驟彳目同,所述乾燥步料常已知有在烘 二二ί爐中進行加熱處理的方法、在加熱板上進行加 法等。這些方法在所述乾燥步驟中也同樣可以 絲,步驟優選在溶劑能夠蒸發的範圍内的溫度下實 選在低於所述煆燒步驟的溫度的溫度下實施。 124 201022331 32945pif.docThe inventive liquid crystal alignment film can be suitably used, including the method (IV) of the other steps of the step 1 described above. As such another step, the frequency of the film (4) is used, or the film after the cleaning process 1 is used for cleaning. The procedure of h ΪΓ Wei burning is the same, and the drying step is often known as a method of heat treatment in a baking furnace, addition on a hot plate, and the like. These methods may also be carried out in the drying step, and the step is preferably carried out at a temperature lower than the temperature of the calcining step at a temperature within a range in which the solvent can evaporate. 124 201022331 32945pif.doc

作為使用清洗液對配向處理前後的液晶配向骐 清洗的清洗方法,可以列舉:刷洗(bmshing)、喷霧;^ spmy)、魏清洗或麟波m這些枝可以單I 行,也可以並用。作為清洗液,可以使用:純水,或者 醇(mehtyl alcohol)、乙醇、異丙醇等各種醇類,苯、甲 (toluene)、二甲苯(Xylene)等芳香族烴類,二氯曱广 (methylene chloride)等齒素系溶劑,丙 _cet〇ne)、甲基= 基酮(methyl ethyl 1^的狀)等_類,但並不限定於這些ς洗 液。當然’這些清絲可崎用經充分純麵雜質^清 洗液。此種清洗方法在形成本發明的液晶配向膜的 ^ 洗步驟中也可以應用。 本發明的液晶配向膜的膜厚沒有特別限定,優選為ι〇 nm〜300nm ’更優選為3〇nm〜150nm。本發明的液晶配 向膜的膜厚可以使用表面輪廓儀或橢偏儀(ellips〇meter)等 眾所周知的膜厚測定裝置來測定。 本發明的液晶顯示元件具有:一對基板;含有液晶分 子並形成于所述-對基板之間的液晶層;對液晶層施加電 壓的電極;以及將所述液晶分子配向在預定的方向上的液 晶配向膜;所述液晶配向膜是使用所述本發明的液晶配向 膜。 所述基板可以使用上文中針對本發明的液晶配向膜 所描述的玻璃制基板,所述電極可以使用上文中針對本發 明的液晶配向膜所描述的形成在玻璃制基板上的IT〇電 極0 125 201022331 32945pif.doc 所述液晶層是由被密封在相對向的一對基板間的間 隙中的液晶組成物形成,此相對向的一對基板是以使所述 一對基板中的一方的基板的形成有液晶配向膜的面朝向另 一方的基板的方式而對向的。 所述液晶組成物沒有特別限制,可以使用介電常數各 向異性為正或者負的各種液晶組成物。介電常數各向異性 為正的優舰晶喊物可間舉在以下公報巾所揭示的液 晶組成物.日本專利第3〇86228號公報、曰本專利第 2635435號公報、日本專利特表平5_5〇1735號公報、日本 專利特開平8·157826號公報、日本專利制平8_23觸 號公報、日本專利特開平9_241644號公報(Ερ觀說 明書)、日本專利特開平ΜΟΒ46號公報(Ερ8祕⑷說 明書)、日本專利特開平㈣咖號公報(肥创嫩 〇 明書)、日本專利特開平㈣邱號公報、日本專利特開 平9-255956號公報、日本專利特開平9_241643號公報 (ΕΡ885271Α1說明書)、日本專利特開平1〇_2〇4_號公報 (ε·4229αι說明書)、日本專利特開平1〇2〇鄕號公 報、日本專利特開平1〇-231482號公報、日本專利特開 2000-087040公報、日本專利特開2〇〇Μ8822公報等。 介電常數各向異性為貞的優驗晶 57==揭示的液晶組成物:曰本專利特上 本專利特開平2.號公報、曰本 專^制平4_22娜L日本相制平8•彻 么報、日本專職開平8·购69號公報、日 = 126 201022331 32945pif.doc 10-168076號公報、日本專利 本專利特開平1〇·236989^千他麵3號公報、日 -誦罐報、日本專利;=平報二二=特開平 本專利特開平10-236993 #八4 號么報、日 10-236994號公報、日本專二 ':日本專利特開平 ^ ^ l〇-237〇t ^lt1〇-237〇〇〇;&quot;&quot;V^ ' 9 10-237024號公報、日本專利^ 、日本專利特開平The cleaning method for cleaning the liquid crystal alignment before and after the alignment treatment using the cleaning liquid may be, for example, bmshing, spraying, spuming, Wei washing or lining m, and the branches may be used in a single row or in combination. As the cleaning liquid, pure water, various alcohols such as alcohol (mehtyl alcohol), ethanol, and isopropyl alcohol, aromatic hydrocarbons such as benzene, toluene, and xylene may be used. Methylene chloride) is a solvent such as a dentate solvent, a propyl group, a methyl group or a methyl ketone, but is not limited to these mash liquids. Of course, these cleansing yarns can be thoroughly cleaned with a pure surface impurity. This cleaning method can also be applied in the step of forming the liquid crystal alignment film of the present invention. The film thickness of the liquid crystal alignment film of the present invention is not particularly limited, but is preferably from 10 nm to 300 nm, more preferably from 3 nm to 150 nm. The film thickness of the liquid crystal alignment film of the present invention can be measured by a known film thickness measuring device such as a surface profiler or an ellips meter. A liquid crystal display element of the present invention has: a pair of substrates; a liquid crystal layer containing liquid crystal molecules and formed between the pair of substrates; an electrode for applying a voltage to the liquid crystal layer; and aligning the liquid crystal molecules in a predetermined direction A liquid crystal alignment film; the liquid crystal alignment film is a liquid crystal alignment film of the present invention. The substrate may use the glass substrate described above for the liquid crystal alignment film of the present invention, and the electrode may use the IT germanium electrode 0 125 formed on the glass substrate described above for the liquid crystal alignment film of the present invention. 201022331 32945pif.doc The liquid crystal layer is formed of a liquid crystal composition sealed in a gap between a pair of opposing substrates, and the pair of opposing substrates is a substrate of one of the pair of substrates The surface on which the liquid crystal alignment film is formed faces the other substrate. The liquid crystal composition is not particularly limited, and various liquid crystal compositions having positive or negative dielectric anisotropy can be used. The liquid crystal composition disclosed in the following publications can be used for the liquid crystal composition disclosed in the following publication. Japanese Patent No. 3,862, 528, Japanese Patent No. 2635435, Japanese Patent Special Table Japanese Laid-Open Patent Publication No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. No. Hei. , Japanese Patent Laid-Open (four) Coffee No. (Fei Chuang Nen Ming Ming), Japanese Patent Laid-Open (four) Kyu, Japanese Patent Laid-Open No. Hei 9-255956, Japanese Patent Laid-Open No. Hei 9-241643 (ΕΡ 885 271 Α 1 specification), Japanese Patent Laid-Open No. 1〇_2〇4_ (Japanese Patent Application Laid-Open No. Hei No. Hei No. Hei. No. 2, No. 2, No. 2, No. 2, No. 2, No. 231, 482, Japanese Patent Laid-Open No. Hei No. Hei No. 2000-087040 Bulletin, Japanese Patent Laid-Open No. 2882882, and the like. The dielectric constant anisotropy is 优 优 晶 57 = = = = = = = = = 揭示 揭示 揭示 揭示 揭示 揭示 揭示 揭示 揭示 揭示 揭示 揭示 揭示 揭示 揭示 揭示 揭示 揭示 揭示 揭示 揭示 揭示 揭示 揭示 揭示 揭示 揭示 揭示 揭示 揭示 揭示 揭示 揭示 揭示 揭示The newspaper, the Japanese full-time Kaiping 8 · the purchase of the 69th bulletin, the day = 126 201022331 32945pif.doc 10-168076, the Japanese patent this patent special Kaiping 1〇 · 236989 ^ Thousands of No. 3 bulletin, the day - cans , Japanese patent; = Pingwen 22 = special open patents, special Kaiping 10-236993 #八四号, newspaper, Japanese 10-236994 bulletin, Japanese special two ': Japanese patent special Kaiping ^ ^ l〇-237〇t ^lt1〇-237〇〇〇;&quot;&quot;V^ ' 9 10-237024, Japanese patent ^, Japanese patent special Kaiping

本專利特開… 10-237076號公報、日本專^、日本專利特開平 (EP967261A1說明書)、日本真^平1〇_237448號公報 ^ 曰J曰本專利特開平10-287874號公 報、日本專利特開平10-287875號公報、日本專利牲^ 10-291945號公報、曰太直名丨Λ± 特開平 土奎咖 報曰本專利特開平11-〇29581號公報、日 i主μ開平11_〇80049號公報、特開2000-256307公報、 寺開2〇01-019965公報、特開2〇_脳公報 2001-192657 公報等。 ’ 即使向所述介電常數各向異性為正或貞的液晶組成 ^添加—種或—種以上的光學活性化合物來使用也沒有 絲亳影響。 本發明的液晶顯示元件是通過下述方式而獲得的:在 曰對基板中的至少一方上形成本發明的液晶配向膜,使液 曰曰配向膜朝内而使所獲得的一對基板經由間隔物(spacer) 相對向,在形成於基板間的間隙中封入液晶組成物而形成 液曰曰層。于本發明的液晶顯示元件的製造過程中,視需要 可以進一步包含對基板貼附偏光膜等的步驟。 127 201022331 32945pif.doc 本發明的液晶顯示元件可⑽成各種電場方式 液晶顯示元件。此種電場方式用的液晶顯示元件可以 舉:所述電極在與所述基板的表面水準的方向上對所 晶層施加電壓的橫向電場方式用的液晶顯示元件、或者戶^ 述電極在與所述基板的表面垂直的方向上對所述液^曰 加電壓的縱向電場方式用的液晶顯示元件。 θ 橫向電場方式用的液晶顯示元件即使不表現出較大 的預傾角也無妨,因此,由本發明的液晶配向劑所形^ © 液晶配向膜翻於橫向電場方式用的液晶顯示元件,其中 本發明的液晶配向劑含有如由不含具有側鏈結構的二ς 二胺所得的雜舰或者其衍生物之類的不具有側 的聚醯胺酸或者其衍生物。 ''σ 縱向電場方式用的液晶顯示元件需要表現出較大的 =角,因此,由本發_液晶配向劑所形成的液晶配向 膜適用於縱向電場方式用的液晶顯示元件,其中本發 液晶配向劑含有如由包含具有侧鏈結構的二胺的二ς 〇 的聚酿胺酸或者其衍生物的之類的具有 ς 酸或者其衍生物。 酬㈣胺 、、如上所述,將本發明的液晶配向劑作為原料而製 液晶配向膜可輯輯它的原料即聚合物騎 而應用於各麵㈣動对㈣晶齡元件中。、 本發_液晶顯示元件可以進—步具有所述構成要 此種其他構成要素,在本發明的液晶 顯不疋件中可μ裝偏紐(偏細)、波長板、光散射膜、 128 201022331 32945pif.doc 驅動電路等液晶顯示元件中通常使用的構成要素。 [實施例] 以下,利用實施例來說明本發明,但本發明並不限定 於這些實施例。實施例中所使用的化合物如不所述。 &lt;四羧酸二酐&gt; EDDA:乙二胺四乙酸二酐 PhDDA : 1,4-苯二胺四乙酸二酐 ❹ PMDA .均本四甲酸二酐(PyromeiHtie Dianhydride) CBDA .環 丁四甲酸二針(CyCi〇butane tetracarb〇xylic dianhydride) PSQ1 : 18,21-雙(3·(2,5-二氧四氫呋喃_3·基)丙 基)-18,21-二甲基-1,3,5,7,9,11,13,15-辛苯基-五環 [10.5.1·25,13.17,11·19,15]十石夕氧燒 NPDA :萘-1,4,5,8-四甲酸二酐 NTCA :萘-2,3,6,7-四曱酸二酐 &lt;二胺&gt; 〇 DDM : 4,[二氨基二苯基曱烷 DDET · 4,4 -一氣基二苯基乙院 DATA . 1,3,5-二氨基_1,2,4_三嗤 5HHP1PDA : 5·{4-[4-(4-正戊基環己基)]環己基}苯基 甲基-1,3-二氨基苯 25P1PDA : 2-(笨基甲基)-Μ_二氨基苯 5HPlPDA:5-{4-(4-戊基環己基)}苯基曱二氨基 129 201022331 32945pif.doc 7H2HP1PDA : 5-{4-[2-(4-正己基環己基)乙基]環己基} 苯基曱基-1,3-二氨基苯 3HHPEPDA :笨甲酸_3,5_二氨基苯基-4-(4,-丙基二(環 己烧)-4-基)酉旨 16DAB :苯甲醆_3,5_二氨基十六烷基酯 &lt;溶劑&gt; NMP : N-曱基比洛咬酮 BC : 丁基溶纖劑(乙二醇單丁醚) &lt;1.聚酿胺酸的合成&gt; ❾ [合成例1] 在具備溫度計、攪拌機、原料投入口和氮氣導入口的 100 mL 的四 口燒瓶中加入 0.7420 g 的 5HHP1PDA、0.7934 g的DDM以及37.0 g的脫水NMP,在乾燥氮氣流下進行 擾拌溶解。接著,添加1.4646 g的EDDA,反應30小時 後,加入10.0 g的BC而合成濃度為6重量%的聚醯胺酸 溶液(PA 1)。當於原料的反應中因反應溫度而導致溫度上升 時,將反應溫度抑制在約70°C或7(TC以下而進行反應。此 〇 外,所獲得的PA1中的聚醯胺酸的重量平均分子量為 72,600。 聚醯胺酸的重量平均分子量是以如下方式求出的:以 使聚醯胺酸濃度達到約1重量%的方式,利用磷酸七mf 混合溶液(填酸/DMF = 0.6/100,重量比)來稀釋所獲得的聚 醢胺酸,然後使用2695分離模組(separation module)、2414 差示折射計(Waters製造)’將所述混合溶液作為展開溶劑 130 201022331 32945pif.doc 並使用GPC法進行測定,再進行聚苯乙婦換算。此外,管 柱是使用HSPgelRTMB-M(Waters製造),並在管柱溫度為 40 C、流速為0.35 mL/min的條件下進行測定。 [合成例2〜合成例11] 除如表1所示般變更四羧酸二酐以及二胺以外,依據 合成例1來製備聚醯胺酸溶液(PA2〜PA11)。將包括合成例 1在内的結果匯總於表i。 ^ [比較合成例1〜比較合成例3] 除如表1所示般變更四羧酸二酐以及二胺以外,依據 合成例1來製備聚醯胺酸溶液(PA12〜PA14)。將結果匯總 於表1。 131 201022331 132 比較合成例 3 比較合成例 2 比較合成例 1 合成例11 合成例10 I合成例9 I合成例8 I合成例7 合成例6 合成例5 合成例4 I合成例3 合成例2 合成例l | 5 u&gt; &gt; to涿 l-&gt;^ o歹 *—k SO oo On Κ) i 配向 劑 o O EDD A 酸二酐(mol%) PhDD A 1 1—^ o (-Λ -! PMD .A j CBD A NPD A NTC A g sB 無側鏈的二胺(mo】%) DDE T DATA U) o 5H HP1PD A 帶有側鏈的二胺(mol%) U) 1 5H PI PDA | 7H2H P1PD A 3HH PEPDA ® ^ Os C o y\ o 47,200 o -4 oo o so o o U) o o 89,200 o 91,800 | n&gt;* 1—· c o g V o 72,600 ϋ&gt; 14 ^&quot;4 *U)· ΙΦ 32945pif.doc ο 201022331 32945pif.doc [合成例12〜合成例16] 除如表2所示般變更四羧酸二酐和二胺以外,依據合 成例1來製備聚醯胺酸溶液(B1〜B5)。 [比較合成例4、比較合成例5] 除以表2所示的比例變更四羧酸二酐及二胺以外,依 據合成例1來合成聚醯胺酸溶液(B6、B7)。 [表2] 清漆 酸二針(mol%) 二胺(mol0/〇) 重量平均分 子量 EDDA PMDA CBDA PSQ1 NTCA DDM DDET 合成例12 B1 50 50 100 70,700 合成例13 B2 50 50 100 66,100 合成例14 B3 20 60 20 100 32,400 合成例15 B4 50 50 100 74,100 合成例16 B5 50 50 100 108,000 比較合成 例4 B6 50 50 100 51,500 比較合成 例5 B7 50 50 100 83,300Japanese Patent Laid-Open No. 10-237076, Japanese Patent No., Japanese Patent Laid-Open (EP967261A1), Japanese Patent No. _237448, 曰J曰, Japanese Patent Laid-Open No. Hei 10-287874, Japanese Patent Japanese Patent Publication No. 10-287875, Japanese Patent Publication No. 10-291945, 曰太直名丨Λ± 特开平土奎咖报曰本专利公开平11-〇29581号,日 i主μ开平11_ Japanese Laid-Open Patent Publication No. Hei. No. Hei. No. Hei. No. 2000-256. Even when an optically active compound having a positive or negative dielectric constant anisotropy is added or used, there is no effect on the silk. The liquid crystal display device of the present invention is obtained by forming a liquid crystal alignment film of the present invention on at least one of the ruthenium-based substrates, and causing the liquid yam alignment film to face inward to pass the obtained pair of substrates via the spacer. The spacers are opposed to each other, and a liquid crystal composition is sealed in a gap formed between the substrates to form a liquid helium layer. In the manufacturing process of the liquid crystal display element of the present invention, a step of attaching a polarizing film or the like to the substrate may be further included as needed. 127 201022331 32945pif.doc The liquid crystal display element of the present invention can be (10) formed into various electric field type liquid crystal display elements. In the liquid crystal display device for the electric field method, a liquid crystal display element for a lateral electric field method in which a voltage is applied to a crystal layer in a direction parallel to a surface level of the substrate, or an electrode of the household electrode is used. A liquid crystal display element for a vertical electric field method in which a voltage is applied to the liquid in a direction perpendicular to the surface of the substrate. The liquid crystal display element for the θ lateral electric field method may not exhibit a large pretilt angle. Therefore, the liquid crystal alignment film of the present invention is formed by a liquid crystal display element in which the liquid crystal alignment film is turned over to the transverse electric field mode, wherein the present invention The liquid crystal aligning agent contains a polyglycine having no side or a derivative thereof such as a miscellaneous ship obtained from a diterpene diamine having a side chain structure or a derivative thereof. The ''s liquid crystal display element for the vertical electric field method needs to exhibit a large = angle. Therefore, the liquid crystal alignment film formed by the present invention is suitable for a liquid crystal display element for a vertical electric field mode, in which the present liquid crystal alignment The agent contains citric acid or a derivative thereof such as polyacrylic acid or a derivative thereof comprising diterpenoids having a diamine having a side chain structure. As described above, the liquid crystal alignment film of the present invention can be used as a raw material to prepare a liquid crystal alignment film, and the raw material, that is, the polymer ride, can be applied to each surface (four) moving pair (four) crystal age element. The liquid crystal display element can further have the other constituent elements of the above configuration, and the liquid crystal display element of the present invention can be equipped with a bias (thinness), a wavelength plate, a light scattering film, and 128. 201022331 32945pif.doc A component commonly used in liquid crystal display devices such as driver circuits. [Examples] Hereinafter, the present invention will be described by way of Examples, but the present invention is not limited to these Examples. The compounds used in the examples are not described. &lt;tetracarboxylic dianhydride&gt; EDDA: ethylenediaminetetraacetic acid dianhydride PhDDA: 1,4-phenylenediaminetetraacetic acid dianhydride DA PMDA. PyromeiHtie Dianhydride CBDA. Cyclobutanetetracarboxylic acid Two needles (CyCi〇butane tetracarb〇xylic dianhydride) PSQ1 : 18,21-bis(3·(2,5-dioxotetrahydrofuran-3-yl)propyl)-18,21-dimethyl-1,3, 5,7,9,11,13,15-octylphenyl-pentacyclic [10.5.1·25,13.17,11·19,15] Ten Shixi Oxygen Burning NPDA: Naphthalene-1,4,5,8- Tetracarboxylic acid dianhydride NTCA: naphthalene-2,3,6,7-tetradecanoic acid dianhydride &lt;diamine&gt; 〇DDM : 4,[diaminodiphenyl decane DDET · 4,4- oxadiphenyl乙乙院DATA . 1,3,5-Diamino-1,2,4_三嗤5HHP1PDA : 5·{4-[4-(4-n-pentylcyclohexyl)]cyclohexyl}phenylmethyl- 1,3-diaminobenzene 25P1PDA : 2-(stylmethyl)-indole-diaminobenzene 5HP1PDA: 5-{4-(4-pentylcyclohexyl)}phenylindolediamino129 201022331 32945pif.doc 7H2HP1PDA : 5-{4-[2-(4-n-hexylcyclohexyl)ethyl]cyclohexyl}phenylphenyl-1,3-diaminobenzene 3HHPEPDA: benzoic acid _3,5-diaminophenyl-4 -(4,-propylbis(cyclohexane)-4-yl)酉16DAB: benzamidine_3,5 _Diaminohexadecyl ester &lt;solvent&gt; NMP : N-methylpyrrolidone BC : butyl cellosolve (ethylene glycol monobutyl ether) &lt;1. Synthesis of poly-bristine &gt; ❾ [ Synthesis Example 1 In a 100 mL four-necked flask equipped with a thermometer, a stirrer, a raw material inlet, and a nitrogen inlet, 0.7420 g of 5HHP1PDA, 0.7934 g of DDM, and 37.0 g of dehydrated NMP were placed, and the mixture was dissolved under a dry nitrogen stream. . Next, 1.4646 g of EDDA was added, and after reacting for 30 hours, 10.0 g of BC was added to synthesize a polyglycine solution (PA 1) having a concentration of 6% by weight. When the temperature rises due to the reaction temperature in the reaction of the raw material, the reaction temperature is suppressed to about 70 ° C or 7 (TC or less) to carry out the reaction. In addition, the weight average of the polylysine in the obtained PA1 is obtained. The molecular weight is 72,600. The weight average molecular weight of polylysine is determined in such a manner that a mixed solution of seven mf of phosphoric acid is used in such a manner that the polyglycine concentration is about 1% by weight (filling acid / DMF = 0.6/100) , the weight ratio) to dilute the obtained polyamic acid, and then use the 2695 separation module, 2414 differential refractometer (manufactured by Waters)' to use the mixed solution as a developing solvent 130 201022331 32945pif.doc and use The GPC method was used for the measurement, and the polystyrene conversion was performed. Further, the column was measured using HSPgel RTMB-M (manufactured by Waters) under the conditions of a column temperature of 40 C and a flow rate of 0.35 mL/min. Example 2 - Synthesis Example 11 A polyphthalic acid solution (PA2 to PA11) was prepared according to Synthesis Example 1 except that the tetracarboxylic dianhydride and the diamine were changed as shown in Table 1. The synthesis example 1 was included. The results are summarized in Table i. ^ [Comparative Example 1 to Comparative Synthesis Example 3 A polyglycine solution (PA12 to PA14) was prepared according to Synthesis Example 1 except that the tetracarboxylic dianhydride and the diamine were changed as shown in Table 1. The results are summarized in Table 1. 131 201022331 132 Comparative Synthesis Example 3 Comparative Synthesis Example 2 Comparative Synthesis Example 1 Synthesis Example 11 Synthesis Example 10 Synthesis Example 9 I Synthesis Example 8 Synthesis Example 7 Synthesis Example 6 Synthesis Example 5 Synthesis Example 4 Synthesis Example 3 Synthesis Example 2 Synthesis Example 1 | 5 u&gt;&gt;to涿l-&gt;^ o歹*-k SO oo On Κ) i Directional Agent o O EDD A Acid dianhydride (mol%) PhDD A 1 1—^ o (-Λ -! PMD .A j CBD A NPD A NTC A g sB Diamine without side chain (mo)%) DDE T DATA U) o 5H HP1PD A Diamine with side chain (mol%) U) 1 5H PI PDA | 7H2H P1PD A 3HH PEPDA ® ^ Os C oy\ o 47,200 o -4 oo o so oo U) oo 89,200 o 91,800 | n&gt;* 1—· cog V o 72,600 ϋ&gt; 14 ^&quot;4 *U)· ΙΦ 32945pif.doc ο 201022331 32945pif.doc [Synthesis Example 12 to Synthesis Example 16] A polyaminic acid solution (B1 to B5) was prepared according to Synthesis Example 1, except that the tetracarboxylic dianhydride and the diamine were changed as shown in Table 2. [Comparative Synthesis Example 4 and Comparative Synthesis Example 5] A polyaminic acid solution (B6, B7) was synthesized according to Synthesis Example 1, except that the tetracarboxylic dianhydride and the diamine were changed in the ratio shown in Table 2. [Table 2] Two-needle (mol%) diamine (mol%) diamine (mol0/〇) Weight average molecular weight EDDA PMDA CBDA PSQ1 NTCA DDM DDET Synthesis Example 12 B1 50 50 100 70,700 Synthesis Example 13 B2 50 50 100 66,100 Synthesis Example 14 B3 20 60 20 100 32,400 Synthesis Example 15 B4 50 50 100 74,100 Synthesis Example 16 B5 50 50 100 108,000 Comparative Synthesis Example 4 B6 50 50 100 51,500 Comparative Synthesis Example 5 B7 50 50 100 83,300

[合成例17、合成例18] 除如表3所示般變更四羧酸二酐和二胺以外,依據合 成例1來製備聚醯胺酸溶液(C卜C2)。 [比較合成例6、比較合成例7] 除以表3所示的比例變更四羧酸二酐及二胺以外,依 據合成例1來合成聚醯胺酸溶液(C3、C4)。 133 201022331 32945pif.doc 酸二酐(mol%;) 二胺(mol%) 帶側鏈θ二胺 (mol%) 重量平均 分子量 EDDA CBDA PSQ1 25P1PDA 5HP1PDA 合成例17 C1 20 80 50 50 77,700 合成例18 C2 20 40 40 50 50 32,200 比較合成例6 C3 100 50 50 58,300 比較合成例7 C4 60 40 50 50 25,600 將合成例12〜合成例16及比較合成例4、比較合成 例5中所合成的濃度為6重量%的聚醯胺酸溶液(B1〜B7) 與合成例17、合成例18及比較例6、比較例7中所合成的 濃度為6重量%的聚醯胺酸溶液(C1〜C4)以重量比 90/10(前者/後者)混合,從而製成液晶配向劑(PA15〜 PA28)。將PA15〜PA28的組成比匯總於表4。 [表4] 配向劑 清漆 清漆重量比 PA15 B1 C3 B1/C3-9/1 PA16 B2 C3 B2/C3 = 9/l PA17 B6 C1 B6/C 1=9/1 PA18 B1 ~~ci B1/C1=9/1 PA19 B2 B2/C 1=9/1 PA20 B3 C4 B3/C4 = 9/l PA21 B3 B3/C2 = 9/l PA22 B6 ~~cT~~^ B6/C3 = 9/l PA23 B4 ci B4/C1=9/1 PA24 B5 B5/C 1=9/1 PA25 B7 Cl B7/C 1=9/1 PA26 B4 C3 B4/C3 = 9/l PA27 B5 C3 B5/C3 = 9/l PA28 B7 C3 B7/C3 = 9/l 134 201022331 32945pif.doc 向合成例3、比較合成例2中所合成的濃度為6重量 %的聚醯胺酸溶液(A3、A13)中,相對於聚合物重量分別添 加10重量%的雙{4-(烯丙基雙環[2,2,1]庚-5-稀-2,3-二曱醯 亞胺)本基}曱院、2-(3,4-環氧環己基)乙基三曱氧基石夕烧及 N,N-(1,2-二經基乙烯)雙丙烯醯胺,而製成液晶配向劑 (PA29〜PA32)。將PA29〜PA32的組成示於表5。 配向劑 清漆 添加劑 添加量(wf%) PA29 PA3 雙{4_(稀丙基雙環[2,2,1]庚-5-稀_2,3_二曱醯亞 胺)苯基}曱烷 ’— 10 PA30 PA3 2-(3,4-環氧環己基)乙基二甲氧基矽烷 10 PA31 PA3 N,N-(1,2-二羥基乙烯)雙丙烯酼眩 10 PA32 PA13 雙{4_(烯丙基雙環[2,2,1]庚-^^:二曱_醯亞 胺)苯基}曱烷 10 &lt;2.液晶顯示元件的製作&gt; [實施例1] 0 向合成例1中所合成的濃度為6重量%的聚醯胺酸溶 液(PA1)中添加NMP/BC=1/1(重量比)的混合溶媒並將整體 稀釋成4重量%,而製成液晶配向劑。使用所獲得的液晶 配向劑,以如下方式製作液晶顯示元件。 &lt; VA型液晶顯示元件的製作方法&gt; 通過旋塗法將所獲得的液晶配向劑塗布在一對附有 ITO透明電極的基板上,並於加熱板上於8代下乾燥$分 鐘二然後,在設定為220°C的烘箱中加熱瑕燒20分鐘,而 獲仟形成有液晶配向膜的基板。使形成有液晶配向膜的面 135 201022331 32945pif.doc 為内側,在一方的基板上殘留液晶的注入孔並利用環氧系 轉劑密封周邊’在另-方的基板上散佈並貼附4 25啤 的間隙材料(gap material)。向所獲得的單元(edl)中真空注 所示的液晶組成物,使用光密來密封注入孔並 =travi^ Uv)來使注入孔硬化。最後在ιι〇 得VA 。理(各向_論_)處理),而獲[Synthesis Example 17 and Synthesis Example 18] A polyaminic acid solution (C, C2) was prepared according to Synthesis Example 1, except that the tetracarboxylic dianhydride and the diamine were changed as shown in Table 3. [Comparative Synthesis Example 6 and Comparative Synthesis Example 7] A polyaminic acid solution (C3, C4) was synthesized according to Synthesis Example 1, except that the tetracarboxylic dianhydride and the diamine were changed in the ratio shown in Table 3. 133 201022331 32945pif.doc Acid dianhydride (mol%;) Diamine (mol%) with side chain θ diamine (mol%) Weight average molecular weight EDDA CBDA PSQ1 25P1PDA 5HP1PDA Synthesis Example 17 C1 20 80 50 50 77,700 Synthesis Example 18 C2 20 40 40 50 50 32,200 Comparative Synthesis Example 6 C3 100 50 50 58,300 Comparative Synthesis Example 7 C4 60 40 50 50 25,600 The concentration synthesized in Synthesis Example 12 to Synthesis Example 16 and Comparative Synthesis Example 4 and Comparative Synthesis Example 5 was 6 The polyglycine solution (C1 to C7) having a concentration of 6% by weight and the polyamine solvent (C1 to C4) having a concentration of 6 wt% synthesized in Synthesis Example 17, Synthesis Example 18, Comparative Example 6, and Comparative Example 7 were used. The weight ratio of 90/10 (the former/the latter) was mixed to prepare a liquid crystal alignment agent (PA15 to PA28). The composition ratios of PA15 to PA28 are summarized in Table 4. [Table 4] Directional agent varnish varnish weight ratio PA15 B1 C3 B1/C3-9/1 PA16 B2 C3 B2/C3 = 9/l PA17 B6 C1 B6/C 1=9/1 PA18 B1 ~~ci B1/C1= 9/1 PA19 B2 B2/C 1=9/1 PA20 B3 C4 B3/C4 = 9/l PA21 B3 B3/C2 = 9/l PA22 B6 ~~cT~~^ B6/C3 = 9/l PA23 B4 ci B4/C1=9/1 PA24 B5 B5/C 1=9/1 PA25 B7 Cl B7/C 1=9/1 PA26 B4 C3 B4/C3 = 9/l PA27 B5 C3 B5/C3 = 9/l PA28 B7 C3 B7/C3 = 9/l 134 201022331 32945pif.doc To the polyglycine solution (A3, A13) having a concentration of 6% by weight synthesized in Synthesis Example 3 and Comparative Synthesis Example 2, respectively, with respect to the weight of the polymer Add 10% by weight of bis{4-(allylbicyclo[2,2,1]hept-5-thin-2,3-diimineimine) base 曱 、, 2-(3,4- Epoxycyclohexyl)ethyltrimethoxyxanthene and N,N-(1,2-divinylethene)bispropenylamine were used to prepare a liquid crystal alignment agent (PA29 to PA32). The composition of PA29 to PA32 is shown in Table 5. Additive varnish additive addition amount (wf%) PA29 PA3 double {4_(dilylbiscyclo[2,2,1]hept-5-diluted-2,3_diimideimine)phenyl}decane'- 10 PA30 PA3 2-(3,4-epoxycyclohexyl)ethyldimethoxydecane 10 PA31 PA3 N,N-(1,2-dihydroxyethylene) bispropene oxime 10 PA32 PA13 double {4_(ene Propylbicyclo[2,2,1]heptane-^^:dioxin-p-imine)phenyl}decane 10 &lt;2. Preparation of liquid crystal display element&gt; [Example 1] 0 Synthesis Example 1 A mixed solvent having a concentration of NMP/BC = 1/1 (weight ratio) was added to a polyglycine solution (PA1) having a concentration of 6% by weight and the whole was diluted to 4% by weight to prepare a liquid crystal alignment agent. Using the obtained liquid crystal alignment agent, a liquid crystal display element was produced in the following manner. &lt;Method for Producing VA Type Liquid Crystal Display Element&gt; The obtained liquid crystal alignment agent was applied onto a pair of substrates with ITO transparent electrodes by spin coating, and dried on a hot plate for 8 minutes under 8 days. The substrate was heated and calcined in an oven set at 220 ° C for 20 minutes to obtain a substrate on which a liquid crystal alignment film was formed. The surface 135 on which the liquid crystal alignment film is formed is 201022331 32945pif.doc is the inner side, and the injection hole of the liquid crystal remains on one of the substrates, and the periphery is sealed with an epoxy-based agent to spread and attach the 4 25 beer on the other substrate. Gap material. The liquid crystal composition shown in the obtained unit (edl) was vacuum-filled, and the injection hole was sealed using a light seal to seal the injection hole and =travi^Uv). Finally, I got VA in ιι〇. Management (different _ theory _) processing)

136 201022331 32945pif.doc [化 78]136 201022331 32945pif.doc [Chem. 78]

5wi% 7wt%5wi% 7wt%

Bwf% 8wt% 14wt% 14wt% 10wi% 10wl% 12wt%Bwf% 8wt% 14wt% 14wt% 10wi% 10wl% 12wt%

12wt% [實施例2〜實施例26、比較例1〜比較例6] 向在合成例2〜合成例26及比較合成例1〜比較合成 例6中進行合成並視需要混合而成的濃度為6重量%的聚 醯胺酸溶液(PA2〜PA32)中加入NMP/BC=1/1(重量比)的 137 201022331 32945pif.doc 混合溶媒,將整體稀釋成4重量%而製成液晶配向劑。使 用所獲得的液晶配向劑,以與實施例1相同的方式製作液 晶顯示元件。 &lt;電壓保持率(voltage holding ratio ’ VHR)的長時間熱 可靠性的評價&gt; 對於實施例1〜實施例26、比較例1〜比較例6中所 製作的液晶顯示元件,以如下方式進行VHR的長時間熱 可靠性的評價。 (1 .VHR的測定) © 使用Toyo Corporation製造的液晶物性評價裝置6254 型對VA型液晶顯示元件的電壓保持率進行測定。測定條 件為:柵極寬度為60 ps,頻率為30Hz,波高為±5 V,測 定溫度為60°C。 (2.VHR的長時間熱可靠性的計算) 針對實施例1〜實施例26、比較例1〜比較例6中所 製作的液晶顯示元件’將元件製作後2 4小時以内所測定的 VHR的值設為VHR(初始)。另外,將VHR測定後的液晶 〇 顯示元件在保持於l〇(TC的烘箱中保存5〇〇小時,並將在 所述記載的條件下測定的VHR的值設為VHR(5〇〇小時)。 根據下式由所獲得的兩個VHR計算出VHR降低率。此值 越小VHR的長時間熱可靠性越良好。將結果示於表6。 VHR降低率=[{VHR(初始)一 VHR(5⑻小 時)}xl〇0]/VHR(初始) 138 20102233112% by weight [Example 2 to Example 26, Comparative Example 1 to Comparative Example 6] The concentration obtained by combining in Synthesis Example 2 to Synthesis Example 26 and Comparative Synthesis Example 1 to Comparative Synthesis Example 6 was carried out as needed. To a 6 wt% polyproline solution (PA2 to PA32), a mixed solvent of 137 201022331 32945 pif.doc of NMP/BC = 1/1 (weight ratio) was added, and the whole was diluted to 4 wt% to prepare a liquid crystal alignment agent. A liquid crystal display element was produced in the same manner as in Example 1 using the obtained liquid crystal alignment agent. &lt;Evaluation of long-term thermal reliability of voltage holding ratio 'VHR&gt;&gt; The liquid crystal display elements produced in Examples 1 to 26 and Comparative Examples 1 to 6 were subjected to the following manner. Evaluation of the long-term thermal reliability of VHR. (1. Measurement of VHR) The voltage holding ratio of the VA liquid crystal display element was measured using a liquid crystal physical property evaluation device 6254 manufactured by Toyo Corporation. The measurement conditions are: gate width of 60 ps, frequency of 30 Hz, wave height of ±5 V, and measurement temperature of 60 °C. (2. Calculation of long-term thermal reliability of VHR) For the liquid crystal display elements produced in Examples 1 to 26 and Comparative Examples 1 to 6, the VHR measured within 24 hours after the fabrication of the device The value is set to VHR (initial). In addition, the liquid crystal display device after the VHR measurement was stored in an oven at TC for 5 hours, and the value of VHR measured under the conditions described above was VHR (5 hours). The VHR reduction rate is calculated from the two VHRs obtained according to the following formula. The smaller the value, the better the long-term thermal reliability of VHR. The results are shown in Table 6. VHR reduction rate = [{VHR (initial) - VHR (5 (8) hours)}xl〇0]/VHR (initial) 138 201022331

[表6] 配向劑 VHR(初 始)(%) VHR(500 小時)(%) VHR降低率(%) 實施例1 PA1 96.99 96.46 0.5 實施例2 PA2 99.02 97.17 1.9 實施例3 PA3 95.55 93.70 1.9 實施例4 PA4 98.49 95.39 3.1 實施例5 PA5 94.47 91.41 3.2 實施例6 PA6 97.02 96.21 0.8 實施例7 PA7 95.26 95.16 0.1 實施例8 PA8 97.00 96.33 0.7 實施例9 PA9 97.81 97.04 0.8 實施例10 PA10 96.20 95.11 1.1 實施例11 ΡΑ11 96.33 95.40 1.0 比較例1 ΡΑ12 98.86 91.05 7.9 比較例2 ΡΑ13 98.31 91.61 6.8 比較例3 ΡΑ14 98.05 91.73 6.4 實施例12 ΡΑ15 98.98 97.72 1.3 實施例13 ΡΑ16 98.99 94.73 4.3 實施例14 ΡΑ17 99.47 96.36 3.1 實施例15 ΡΑ18 99.18 98.96 0.2 實施例16 ΡΑ19 99.23 98.05 1.2 實施例17 ΡΑ20 99.33 94.82 4.5 實施例18 ΡΑ21 99.40 98.06 1.3 比較例4 ΡΑ22 99.26 90.83 8.5 實施例19 ΡΑ23 99.30 98.20 1.1 實施例20 ΡΑ24 99.20 98.40 0.8 實施例21 ΡΑ25 99.49 96.72 2.9 實施例22 ΡΑ26 99.06 94.98 4.1 實施例23 ΡΑ27 99.49 96.72 2.8 比較例5 ΡΑ28 99.18 88.57 10.7 實施例24 ΡΑ29 98.78 97.59 1.2 實施例25 ΡΑ30 99.03 98.54 0.5 實施例26 ΡΑ31 99.16 98.16 1.0 比較例6 ΡΑ32 99.01 91.49 7.6 139 201022331 如表6所示,使用由含有單體中包含edda的聚醯胺 酸的液晶配向劑所獲得的液晶配向膜的液晶顯示元件具有 VHR長期熱可靠性極其高的效果。 雖然本發明已以實施例揭露如上,然其並非用以限定 本發明’任何所屬技術領域中具有通常知識者,在不脫離 本發明之精神和範圍内’當可作些許之更動與潤錦,故本 發明之保護範圍當視後附之申請專利範圍所界定者 【圖式簡單說明】 / 無。 【主要元件符號說明】 無。[Table 6] Excipient VHR (initial) (%) VHR (500 hours) (%) VHR reduction rate (%) Example 1 PA1 96.99 96.46 0.5 Example 2 PA2 99.02 97.17 1.9 Example 3 PA3 95.55 93.70 1.9 Example 4 PA4 98.49 95.39 3.1 Example 5 PA5 94.47 91.41 3.2 Example 6 PA6 97.02 96.21 0.8 Example 7 PA7 95.26 95.16 0.1 Example 8 PA8 97.00 96.33 0.7 Example 9 PA9 97.81 97.04 0.8 Example 10 PA10 96.20 95.11 1.1 Example 11 ΡΑ11 96.33 95.40 1.0 Comparative Example 1 ΡΑ12 98.86 91.05 7.9 Comparative Example 2 ΡΑ13 98.31 91.61 6.8 Comparative Example 3 ΡΑ14 98.05 91.73 6.4 Example 12 ΡΑ15 98.98 97.72 1.3 Example 13 ΡΑ16 98.99 94.73 4.3 Example 14 ΡΑ17 99.47 96.36 3.1 Example 15 ΡΑ18 99.18 98.96 0.2 Example 16 ΡΑ19 99.23 98.05 1.2 Example 17 ΡΑ20 99.33 94.82 4.5 Example 18 ΡΑ21 99.40 98.06 1.3 Comparative Example 4 ΡΑ22 99.26 90.83 8.5 Example 19 ΡΑ23 99.30 98.20 1.1 Example 20 ΡΑ24 99.20 98.40 0.8 Example 21 ΡΑ25 99.49 96.72 2.9 Example 22 ΡΑ26 99.06 94.98 4.1 Example 23 ΡΑ27 99.49 96. 72 2.8 Comparative Example 5 ΡΑ28 99.18 88.57 10.7 Example 24 ΡΑ29 98.78 97.59 1.2 Example 25 ΡΑ30 99.03 98.54 0.5 Example 26 ΡΑ31 99.16 98.16 1.0 Comparative Example 6 ΡΑ32 99.01 91.49 7.6 139 201022331 As shown in Table 6, the use of monomer A liquid crystal display element of a liquid crystal alignment film obtained by a liquid crystal alignment agent containing poly-lysine of edda has an effect of extremely high VHR long-term thermal reliability. The present invention has been disclosed in the above embodiments, and it is not intended to limit the invention to those of ordinary skill in the art, and the invention may be modified and exemplified without departing from the spirit and scope of the invention. Therefore, the scope of protection of the present invention is defined by the scope of the appended patent application [Simple Description] / None. [Main component symbol description] None.

140140

Claims (1)

201022331 七、申請專利範圍: 1.一種液晶配向劑,其含有作為四羧酸二酐與二胺的 反應生成物的聚醯胺酸或者其衍生物,其中所述四羧酸二 酐含有以下述通式(TC-1)〜通式(TC-14)所表示的四羧酸 二酐,所述二胺含有以下述通式(VIII)及通式(X)〜通式(XI) 所表示的具有侧鏈結構的二胺, [化1]201022331 VII. Patent application scope: 1. A liquid crystal alignment agent containing polyamic acid or a derivative thereof as a reaction product of a tetracarboxylic dianhydride and a diamine, wherein the tetracarboxylic dianhydride contains the following a tetracarboxylic dianhydride represented by the formula (TC-1) to the formula (TC-14), wherein the diamine is represented by the following formula (VIII) and formula (X) to formula (XI) Diamine having a side chain structure, [Chemical 1] 141 201022331 [化2]141 201022331 [Chemical 2] 142 201022331 通式(TC-1)中,X表示-(CH2)n-,至多兩個-CH2-可以 獨立地被-0- ’但此處-0-並非連續、-S-、-COO-、-OCO-、 -CO- 、-CONH- &gt; -CnH2nN(CmH2mCOOH)CnH2n- &gt; _CH(CmH;2ni〇H)-、-CH(CnH2n+i)-、-CH=CH-或-C=C-取代, 上述通式(TC-1)中X的m表示〇〜30的整數,n獨立地表 示1〜30的整數;通式(TC-4)〜通式(TC-7)中,Υ獨立地 表示單鍵、-0-、-S-、-S-S-、-S〇2-、-CO-、-CONH-、-NHCO-、 0 -NH-、-N(CH3)-(CH2)m-N(CH3)-、-C(CH3)2_、-C(CF3)2-、 -(CH2)m-、-0-(CH2)m-0-、-S-(CH2)m_S-,上述通式(TC-4) 〜通式(TC-7)中Y的m表示1〜6的整數;通式(TC-5)中, Z表示單鍵或不存在;通式(TC-9)中,R33及R34分別獨立 地表示碳數為1〜3的烧基或苯基,A3獨立地表示亞曱基、 •^本基或經烧基取代的次苯基,1表示1〜6的整數,m表 示1〜10的整數;通式(TC·2)〜通式(TCV7)中,鍵結在環 己烧環或苯環上的氫可以獨立地被_F、_CH3、-CF3、-OH、 -C00H、-S〇3H、-p〇A取代,通式(TC-3)中的鍵結在苯 ® 環上的氫可以被苄基取代;通式(TC-2)〜通式(TC_8)中, R1獨立地表示-(CH2)m-,至多兩個_ch2-可以獨立地被_〇_, 但此處·0-並非連續、-8-、-(:00-、-0(:0-、_(:0_、_&lt;:01^_、 -CH(CmH2mOH)-、-CH(CmH2m+1)-、-CH=CH-或-OC-取代, 上述通式(TC-2)〜通式(TC_8)中Ri的m獨立地表示〇〜3〇 的整數;通式(TC-8)中,A1獨立為碳數為的烷基, 碳數為1〜1G 氧基、乙醯胺、氣、氯或演,a2獨立地 表示碳數為1〜3的烷基,m表示0〜3的整數,n表示〇 143 201022331 〜4的整數;通式(TC_1〇)中,A3表示單鍵、…C〇〇·、 -(^CO-、-CO-、-C0NH_ 或 _(CH2)m_,上述通式(TC1〇)中 A的m表不1〜6的整數,Rl表示具有類固醇骨架的基或 以下述通式(B)所表示的基,當鍵結在笨環上的兩個氨基的 位置關係為對位時Ri進一步包含碳數為丨〜孙的烷基,當 此位置關係為間位時Ri進一步包含碳數為1〜3〇的烷基或 苯基’此烧基中任意的_CH2_可以獨立地被_Cf2_、_CHF_、 -Ο-,但此處-〇_並非連續、_ch=ch-或-OC-取代,-CH3 可以被-CHsF、-CHF2或-CF3取代,此苯基的氫可以獨立地 〇 被-F、-CH3、-〇CH3、-0CH2F、-0CHF2 或-ocf3 取代; [化3]142 201022331 In the formula (TC-1), X represents -(CH2)n-, and at most two -CH2- may be independently -0-' but here -0 is not continuous, -S-, -COO- , -OCO-, -CO-, -CONH- &gt; -CnH2nN(CmH2mCOOH)CnH2n- &gt;_CH(CmH; 2ni〇H)-, -CH(CnH2n+i)-, -CH=CH- or -C =C-substitution, in the above formula (TC-1), m of X represents an integer of 〇30, and n independently represents an integer of 1 to 30; in the formula (TC-4) to (TC-7) , Υ independently represents a single bond, -0-, -S-, -SS-, -S〇2-, -CO-, -CONH-, -NHCO-, 0-NH-, -N(CH3)-( CH2)mN(CH3)-, -C(CH3)2_, -C(CF3)2-, -(CH2)m-, -0-(CH2)m-0-, -S-(CH2)m_S-, In the above formula (TC-4) to formula (TC-7), m of Y represents an integer of 1 to 6; in the formula (TC-5), Z represents a single bond or does not exist; In the above, R33 and R34 each independently represent a decyl group or a phenyl group having a carbon number of 1 to 3, and A3 independently represents a fluorenylene group, a benzyl group or a pyridyl group substituted with a phenyl group, and 1 represents 1 to 6 The integer, m represents an integer from 1 to 10; in the formula (TC·2) to the formula (TCV7), the hydrogen bonded to the cyclohexane ring or the benzene ring may be independently _F, _CH3, -CF3 , -OH, - Substituting C00H, -S〇3H, -p〇A, the hydrogen bonded to the benzene® ring in the formula (TC-3) may be substituted by a benzyl group; the formula (TC-2) to the formula (TC_8) Where R1 independently represents -(CH2)m-, at most two _ch2- can be independently _〇_, but here 0- is not continuous, -8-, -(:00-,-0(: 0-, _(:0_, _&lt;:01^_, -CH(CmH2mOH)-, -CH(CmH2m+1)-, -CH=CH- or -OC-substitution, the above formula (TC-2) m in the general formula (TC_8) independently represents an integer of 〇~3〇; in the general formula (TC-8), A1 is independently an alkyl group having a carbon number, and the carbon number is 1 to 1 G oxy group, acetamidine Amine, gas, chlorine or chlorine, a2 independently represents an alkyl group having a carbon number of 1 to 3, m represents an integer of 0 to 3, n represents an integer of 〇143 201022331 〜4; in the formula (TC_1〇), A3 represents a single bond, ... C〇〇·, -(^CO-, -CO-, -C0NH_ or _(CH2)m_, wherein m of A in the above formula (TC1〇) is not an integer of 1 to 6, and R1 represents a group of a steroid skeleton or a group represented by the following formula (B), when the positional relationship of two amino groups bonded to the acyclic ring is para-position, Ri further contains an alkyl group having a carbon number of 丨~sun, when Positional relationship In the meta position, Ri further contains an alkyl group having a carbon number of 1 to 3 Å or a phenyl group. Any _CH2_ in this alkyl group may be independently _Cf2_, _CHF_, -Ο-, but here -〇_ is not continuous , _ch=ch- or -OC-substitution, -CH3 may be substituted by -CHsF, -CHF2 or -CF3, and the hydrogen of the phenyl group may be independently deuterated by -F, -CH3, -〇CH3, -0CH2F, -CHF2 Or -ocf3 substituted; [Chemical 3] 通式(B)中,A4及A5分別獨立地表示單鍵、-〇-,但 此處-0-並非連續、_C〇〇---OCO---CONH-、-CH=CH· 或碳數為1〜12的烷烯基,R2及R3分別獨立地表示-F或 -CH3,環S獨立地表示丨,4_次苯基、1,4-環己烯、1,3-二惡 烷_2,5_二基、嘧啶-2,5-二基、吡啶-1,4-二基、萘-1,5-二基、 萘-2,7-二基或蒽·9,1〇-二基,R4表示-H、-F、碳數為1〜30 的烷基、碳數為1〜30的氟取代烷基、碳數為1〜30的烷 氧基、-ON、-OCH2F、-〇CHF2 或-OCF3,a 及 b 分別表示 0〜4的整數’ c、d及e分別表示0〜3的整數,f及g分別 獨立地表示0〜2的整數,且c + d + e21 ;通式(TC-11)及 通式(TC-12)中,R5獨立地表示-H或-CH3,R6表示-H、或 144 201022331 者碳數為1〜20的烧基或碳數為2〜20的烯基,A6獨立地 表示單鍵、-CO-或-CH2-;通式(TC-12)中,R7及R8分別獨 立地表示-H、碳數為1〜20的烷基或苯基;通式(TC_13) 及通式(TC-14)中,A7獨立地表示_〇_或碳數為1〜6的烧烯 基;通式(TC-13)中,R9表示-H或碳數為1〜3〇的烷基, 此烧基中碳數為2〜30的烧基的任意-CH2-可以被-〇_,但 此處-0-並非連續、-CH=CH-或-C=C·取代,A8表示單鍵或 碳數為1〜3的院烯基’環T表示1,4-次苯基或1,4_環己 〇 烯,h表示〇或1 ;通式(TC-14)中,R10表示碳數為6〜22 的炫基,R表不·Η或碳數為1〜22的烧基, [化4]In the general formula (B), A4 and A5 each independently represent a single bond, -〇-, but here -0- is not continuous, _C〇〇---OCO---CONH-, -CH=CH· or carbon The number is 1 to 12 alkenyl groups, R2 and R3 each independently represent -F or -CH3, and ring S independently represents fluorene, 4_phenylene, 1,4-cyclohexene, 1,3-dioxin Alkano-2,5-diyl, pyrimidine-2,5-diyl, pyridine-1,4-diyl, naphthalene-1,5-diyl, naphthalene-2,7-diyl or 蒽·9,1 〇-diyl, R4 represents -H, -F, an alkyl group having 1 to 30 carbon atoms, a fluorine-substituted alkyl group having 1 to 30 carbon atoms, an alkoxy group having 1 to 30 carbon atoms, -ON, - OCH2F, -〇CHF2 or -OCF3, a and b respectively represent integers of 0~4 'c, d and e respectively represent integers of 0~3, f and g respectively represent integers of 0~2, respectively, and c + d + e21 ; in the formula (TC-11) and the formula (TC-12), R5 independently represents -H or -CH3, and R6 represents -H, or 144 201022331, a carbon or carbon having a carbon number of 1 to 20 The number is 2 to 20 alkenyl groups, and A6 independently represents a single bond, -CO- or -CH2-; in the formula (TC-12), R7 and R8 each independently represent -H and have a carbon number of 1 to 20; Alkyl or phenyl; in the formula (TC_13) and formula (TC-14), A7 is independent The ground represents _〇_ or an alkylene group having a carbon number of 1 to 6; in the formula (TC-13), R9 represents -H or an alkyl group having a carbon number of 1 to 3 Å, and the carbon number in the alkyl group is 2 Any -CH2- of the decyl group of -30 may be -〇_, but here -0 is not continuous, -CH=CH- or -C=C.substitution, and A8 represents a single bond or a carbon number of 1-3. The alkenyl group 'ring T represents 1,4-phenylene or 1,4-cyclohexene, h represents hydrazine or 1; in the formula (TC-14), R10 represents a stimulus having a carbon number of 6 to 22 , R is not Η or a carbon number of 1 to 22, [Chemical 4] 通式(VIII)中,Α3 表示單鍵、-〇-、-COO-、-OCO-、 -CO-、-CONH-或-(CH2)m-,上述通式(VIII)中 Α3 的 m 表示 參 1〜6的整數,R1表示具有類固醇骨架的基或以下述通式 (IX)所表示的基,當鍵結在苯環上的兩個氨基的位置關係 為對位時R1進一步包含碳數為1〜30的烷基,當此位置關 係為間位時R1進一步包含碳數為1〜30的烷基或苯基,此 烷基中任意的-CHr·可以獨立地被-CF2-、-CHF-、-0-,但 此處-0-並非連續、-CH_CH-或-C^C-取代,-CH3可以被 -CH2F、-CHF2或-CF3取代’此苯基的氫可以獨立地被&gt;F、 -CH3、-OCH3、-OCH2F、-OCHF2 或-〇CF3 取代;其中,當 145 201022331 所述四綾酸二酐僅包含以通式(TC-1)〜通式(TC-14)所表 示的四緣酸一酐時,R1進一步包含的所述烧基的碳數為23 [化5] 「A3)gl 十π C 十5V d -R4 (IX) e 通式(IX)中’ A4及A5分別獨立地表示單鍵、_〇_,但 此處^並非連續、-COO-、-OCO- &gt; -CONH- &gt; -CH=CH-❹ ,者碳數為1〜丨2的烧稀基’ R2及R3分別獨立地表示-F f CH3 ’環S獨立地表示ι,4-次苯基、i,4_環己烯、丨,3_二 惡烷^,5_二基、嘧咬-2,5-二基、吡啶-1,4-二基、萘_1,5-二 土二2’7-—基或蒽-9,1〇_二基,R4表示_h、-F、碳數為1 〜3〇,烷基、碳數為1〜3〇的氟取代烷基、碳數為1〜30 的烷氧基、-〇ΞΝ、-0CH2F、-OCHF2 或-0(^3,a 及 b 分別 表示0〜4的整數’ c、d及e分別表示〇〜3的整數,f及g 分別獨立地表示〇〜2的整數’且c + d+egl ;其中,當c Q + d + e=l時’ R4表示碳數為卜邓的院基、碳數為卜刈 的氟取代烧基或碳數為1〜3〇的烧氧基,通式(vm)的a3 表示碳數大於等於1的基, 146 201022331 [化6]In the formula (VIII), Α3 represents a single bond, -〇-, -COO-, -OCO-, -CO-, -CONH- or -(CH2)m-, and m of Α3 in the above formula (VIII) represents In the integer of 1 to 6, R1 represents a group having a steroid skeleton or a group represented by the following formula (IX), and R1 further contains a carbon number when the positional relationship of two amino groups bonded to the benzene ring is para Is an alkyl group of 1 to 30, and when the positional relationship is meta-position, R1 further contains an alkyl group or a phenyl group having a carbon number of 1 to 30, and any -CHr· in the alkyl group may be independently -CF2-, - CHF-, -0-, but here -0- is not a continuous, -CH_CH- or -C^C-substitution, -CH3 can be replaced by -CH2F, -CHF2 or -CF3. The hydrogen of this phenyl group can be independently &gt;F, -CH3, -OCH3, -OCH2F, -OCHF2 or -〇CF3 are substituted; wherein, when 145 201022331, the tetraruthenic dianhydride comprises only the formula (TC-1) to the formula (TC-14) In the case of the tetragonal acid monoanhydride, the carbon number of the alkyl group further contained in R1 is 23 [Chemical 5] "A3" gl Ten π C 十 5V d - R4 (IX) e In the general formula (IX) 'A4 and A5 each independently represent a single bond, _〇_, but here ^ is not continuous, -COO-, -OCO- &Gt; -CONH- &gt; -CH=CH-❹ , a burnt base having a carbon number of 1 to 丨 2 ' R 2 and R 3 each independently represent -F f CH 3 'ring S independently represents ι, 4- benzene Base, i, 4_cyclohexene, anthracene, 3_dioxane^,5-diyl, pyrimidine-2,5-diyl, pyridine-1,4-diyl, naphthalene_1,5-di Earth 2'7--yl or 蒽-9,1〇-diyl, R4 represents _h, -F, carbon number is 1 to 3 〇, alkyl, fluorosubstituted alkyl having 1 to 3 carbon atoms Alkoxy group having a carbon number of 1 to 30, -〇ΞΝ, -0CH2F, -OCHF2 or -0 (^3, a and b each represent an integer of 0 to 4', c, d and e respectively represent 〇~3 Integer, f and g respectively represent the integer ' of 〇~2' and c + d+egl; where, when c Q + d + e = l ' R4 denotes the carbon number is the base of Bu Deng, the carbon number is a fluorine-substituted alkyl group of hydrazine or an alkoxy group having a carbon number of 1 to 3 Å, and a3 of the formula (vm) represents a group having a carbon number of 1 or more, 146 201022331 [Chem. 6] 通式(X)及(XI)中,R5獨立地表示-Η或-CH3,R6表示 -Η、或者碳數為1〜20的烷基或碳數為2〜20的烯基,A6 獨立地表示單鍵、-CO-或-CH2-,通式(XI)中,R7及R8分 別獨立地表示-H、碳數為1〜20的烷基或苯基。 2.如申請專利範圍第1項所述之液晶配向劑,其中所 述具有側鏈結構的二胺是以所述通式(VIII)所表示的二 胺,R1是以所述通式(IX)所表示的基。 ® 3.如申請專利範圍第2項所述之,其中所述具有側鏈 結構的二胺是以通式(VIII)所表示的二胺,R1是以如下通 式(RM)〜通式(1^-7)所表示的基, 147 201022331In the general formulae (X) and (XI), R5 independently represents -Η or -CH3, R6 represents -Η, or an alkyl group having 1 to 20 carbon atoms or an alkenyl group having 2 to 20 carbon atoms, and A6 independently In the formula (XI), R7 and R8 each independently represent -H, an alkyl group having 1 to 20 carbon atoms or a phenyl group. 2. The liquid crystal alignment agent according to claim 1, wherein the diamine having a side chain structure is a diamine represented by the above formula (VIII), and R1 is the above formula (IX) ) the base represented. 3. The invention as described in claim 2, wherein the diamine having a side chain structure is a diamine represented by the formula (VIII), and R1 is a formula (RM) to a formula ( 1^-7) The base represented, 147 201022331 通式(R-1)中,R表示碳數為卜如的院基、碳數為】 〜30的氟取代烷基或碳數為的烷氧基,當通式(rLi) 的R是碳數為1的基時,通式(VIII)的A3表示碳數大於等 於1的基,通式(R〗-2)〜通式(RL7)中,R表示_h、-F、碳 數為1〜30的烷基、碳數為1〜30的氟取代烷基、碳數為 1 〜30 的烷氧基、_〇N、-OCH2F、-OCHF2 或-OCF3,A 表 示-O-或碳數為1〜6的烧稀基。 4.如申請專利範圍第3項所述之液晶配向劑,其中所 述具有側鏈結構的二胺是選自以下述通式(VIII-2)〜通式 (VIII-8)所表示的化合物中的至少一種: 148 201022331 [化8]In the formula (R-1), R represents a group having a carbon number of ruthenium, a fluorine-substituted alkyl group having a carbon number of -30 or an alkoxy group having a carbon number, and R of the formula (rLi) is carbon. When the number is 1, the A3 of the formula (VIII) represents a group having a carbon number of 1 or more, and in the formula (R)-2 to (RL7), R represents _h, -F, and the carbon number is An alkyl group of 1 to 30, a fluorine-substituted alkyl group having 1 to 30 carbon atoms, an alkoxy group having 1 to 30 carbon atoms, _〇N, -OCH2F, -OCHF2 or -OCF3, and A represents -O- or carbon. The number is 1 to 6 of the burnt base. 4. The liquid crystal alignment agent according to claim 3, wherein the diamine having a side chain structure is a compound selected from the group consisting of the following formula (VIII-2) to formula (VIII-8) At least one of: 148 201022331 [Chem. 8] 所述通式中’ R52表示碳數為16〜30的烷基,R53表 示碳數為1〇〜3〇的烷基,R54表示碳數為4〜3〇的烷基, R55表示礙數為2〜30的燒基。 參 5.如申請專利範圍第1項所述之液晶配向劑,其中所 述具有侧鏈結構的二胺是以所述通式所表示的 二胺。 6. 如申請專利範圍第1項至第5項中任一項所述之液 晶配向劑’其中所述四羧酸二酐包含芳香族四羧酸二酐。 7. 如申請專利範圍第6項所述之液晶配向劑,其中所 述芳香族四羧_酸二軒是以下述結構式(1)、結構式(2)、結構 式(5)〜結構式(7)、結構式(11)、結構式(12)及結構式(14) 所表不的化合物中的至少一種. 149 201022331In the above formula, 'R52 represents an alkyl group having a carbon number of 16 to 30, R53 represents an alkyl group having a carbon number of 1 〇 to 3 Å, R54 represents an alkyl group having a carbon number of 4 to 3 Å, and R55 represents a hindrance number. 2 to 30 bases. The liquid crystal alignment agent according to claim 1, wherein the diamine having a side chain structure is a diamine represented by the above formula. 6. The liquid crystal alignment agent according to any one of claims 1 to 5 wherein the tetracarboxylic dianhydride comprises an aromatic tetracarboxylic dianhydride. 7. The liquid crystal alignment agent according to claim 6, wherein the aromatic tetracarboxylic acid is the following structural formula (1), structural formula (2), structural formula (5) to structural formula. (7) at least one of the compounds represented by the structural formula (11), the structural formula (12), and the structural formula (14). 149 201022331 8. 如申請專利範圍第1項至第5項中任一項所述之液 晶配向劑,其中所述四羧酸二酐包含脂環式四羧酸二酐及 脂肪族四羧酸二酐中的一方或雙方。 9. 如申請專利範圍第8項所述之液晶配向劑,其中所 述脂環式四羧酸二酐及脂肪族四羧酸二酐是以下述結構式 (19)、結構式(23)、結構式(25)、結構式(35)〜結構式(39)、 結構式(44)及結構式(49)所表示的化合物中的至少一種: ❹ 150 201022331 [化 ίο]8. The liquid crystal alignment agent according to any one of claims 1 to 5, wherein the tetracarboxylic dianhydride comprises an alicyclic tetracarboxylic dianhydride and an aliphatic tetracarboxylic dianhydride. One or both parties. 9. The liquid crystal alignment agent according to claim 8, wherein the alicyclic tetracarboxylic dianhydride and the aliphatic tetracarboxylic dianhydride are the following structural formula (19), structural formula (23), At least one of the compounds represented by the structural formula (25), the structural formula (35) to the structural formula (39), the structural formula (44), and the structural formula (49): ❹ 150 201022331 [Chemical] 10.如申請專利範圍第1項至第5項中任一項所述之液 晶配向劑,其中所述二胺進一步包含以下述通式⑴〜通式 (VII)、通式(XV)、通式(N)及通式⑻所表示的不具有側鏈 結構的二胺, 151 201022331 [化 11] H2N—X—NH2 ( i )The liquid crystal alignment agent according to any one of the items 1 to 5, wherein the diamine further comprises the following general formula (1) to general formula (VII), general formula (XV), and a diamine having no side chain structure represented by the formula (N) and the formula (8), 151 201022331 [11] H2N-X-NH2 (i) H2NOy-〇NH2 (i,,)H2NOy-〇NH2 (i,,) 通式(I)中,X表示-(CH2)m-,上述通式⑴中X的表示 1〜6的整數,通式(III)及通式(V)〜通式(VII)中,Y獨立地 表示單鍵、-〇-、-s-、-S-S-、-S02-、-CO-、·&lt;:ΟΝΗ-、-NHCO-、 ΝΗ_、-N(CH3)-(CH2)m-N(CH3)_、_C(CH3)2-、_C(CF3)2·、 152 201022331 -(CH2)m-、-0-(0^0…S_(CH2)m各,上述通式㈢及通 式(V)〜通式(VII)中丫的„1表示卜6的整數,通式(v)中, Z表示單鍵或不存在,通式(XV)中,R33&amp;R34分別獨立地 表示碳數為1〜3的烷基或苯基,A3獨立地表示亞甲基、 次苯基或經烷基取代的次笨基,丨表示〗〜6的整數,二表 示1〜10的整數;通式(Π)〜通式(VII)中,鍵結在環己烷環 或苯環上的氫可以獨立地被_F、_CH3、_CF3、_〇H、_c〇〇I1、 ❺ _S〇3H、-p〇3H2取代,通式(IV)中的苯環上所鍵結的氫可 以被节基取代;通式(N)中,A〗獨立地表示碳數為1〜4的 烷基、碳數為1〜4的烷氧基、乙醯胺、氟、氯或溴,A2 獨立地表示碳數為1〜3的烷基,m表示0〜3的整數,η 表示0〜4的整數;通式⑻中,L1表示氫、碳數為1〜4的 烧基、笨基或节基。 11.如申請專利範圍第10項所述之液晶配向劑’其中 所述不具有側鏈結構的二胺是選自以下述結構式(IV-1)、結 構式(IV-2)、結構式(IV_15)〜結構、結構式(V-1) &amp;〜結構式(V-13)、結構式(V-33)、結構式(V-35)〜結構式 (V-37)、結構式(νπ_2)、結構式(χν_丨)、結構式(Ν)-卜(Ν)-2、 結構式(N)-i4、結構式(a-1)及結構式(a-2)所表示的化合物 中的至少一種: 153In the formula (I), X represents -(CH2)m-, and X in the above formula (1) represents an integer of 1 to 6, and in the formula (III) and the formula (V) to the formula (VII), Y Independently means a single bond, -〇-, -s-, -SS-, -S02-, -CO-, ·&lt;:ΟΝΗ-, -NHCO-, ΝΗ_, -N(CH3)-(CH2)mN( CH3)_, _C(CH3)2-, _C(CF3)2·, 152 201022331 -(CH2)m-, -0-(0^0...S_(CH2)m each, the above formula (3) and formula ( V)~ 通式 in the general formula (VII) represents an integer of hexa. In the general formula (v), Z represents a single bond or does not exist, and in the general formula (XV), R33 &amp; R34 independently represent the carbon number Is an alkyl group or a phenyl group of 1 to 3, and A3 independently represents a methylene group, a phenylene group or a sub-phenyl group substituted with an alkyl group, 丨 represents an integer of 〜6, and 2 represents an integer of 1 to 10; (Π)~ In the general formula (VII), the hydrogen bonded to the cyclohexane ring or the benzene ring may be independently _F, _CH3, _CF3, _〇H, _c〇〇I1, ❺ _S〇3H, - Substituted by p〇3H2, the hydrogen bonded to the benzene ring in the formula (IV) may be substituted by a benzyl group; in the formula (N), A represents independently an alkyl group having a carbon number of 1 to 4 and a carbon number. Is a 1 to 4 alkoxy group, acetamide, fluorine, chlorine or A2 independently represents an alkyl group having a carbon number of 1 to 3, m represents an integer of 0 to 3, and η represents an integer of 0 to 4; in the formula (8), L1 represents hydrogen, and a carbon group having a carbon number of 1 to 4, 11. A liquid crystal alignment agent according to claim 10, wherein the diamine having no side chain structure is selected from the following structural formula (IV-1), structural formula (IV) -2), structural formula (IV_15) ~ structure, structural formula (V-1) &amp;~ structural formula (V-13), structural formula (V-33), structural formula (V-35) ~ structural formula (V -37), structural formula (νπ_2), structural formula (χν_丨), structural formula (Ν)-Bu (Ν)-2, structural formula (N)-i4, structural formula (a-1) and structural formula ( At least one of the compounds represented by a-2): 153 η2ν^〇κνη2 201022331 [化 12-1] H2N~〇&quot; (IV-1) (IV-2)Η2ν^〇κνη2 201022331 [Chemical 12-1] H2N~〇&quot; (IV-1) (IV-2) h2nH2n (V-10)(V-10) (V-11)(V-11) HO OHHO OH (V-33) H2N-hQ-°N〇-NH2 (V-13) h2n (\Λ35)(V-33) H2N-hQ-°N〇-NH2 (V-13) h2n (\Λ35) (V-36) 154 201022331(V-36) 154 201022331 [化 12-2][化 12-2] (VII-2) 9H3 ?H3 Η2Ν-〇3Η6-έί—Ο-έ 卜 C3H6-NH2 ch3 ch3 (XV-1)(VII-2) 9H3 ?H3 Η2Ν-〇3Η6-έί—Ο-έ Bu C3H6-NH2 ch3 ch3 (XV-1) (a_l) (a_2)(a_l) (a_2) 12. 如申請專利範圍第1項至第5項中任一項所述之液 晶配向劑,其中所述四羧酸二酐包含矽倍半氧烷二酐衍生 物。 13. 如申請專利範圍第12項所述之液晶配向劑,其中 所述矽倍半氧烷二酐衍生物是以下述結構式(S-1)所表示 的化合物: 155 201022331 [化 13]12. The liquid crystal alignment agent according to any one of the preceding claims, wherein the tetracarboxylic dianhydride comprises a sesquiterpoxy dianhydride derivative. The liquid crystal alignment agent according to claim 12, wherein the sesquiterpoxy dianhydride derivative is a compound represented by the following structural formula (S-1): 155 201022331 [Chem. 13] (S-l) 14.如申請專利範圍第1項至第5項中任一項所述之液 晶配向劑,盆中 所逃聚酿胺酸或者其衍生物包含兩種聚醯胺酸或者 其衍生物A及B, 所述聚醯胺酸或者其衍生物A包含所述二胺中的所 述具有側鏈結構的二胺,且所述聚醯胺酸或者其衍生物A 及B的四羧酸二酐的一方或雙方包含以通式(TC-1)〜通式 (TC-14)所表示的四叛酸二針。 15·如申請專利範圍第1項至第5項中任一項所述之液 晶配向劑,更含有選自烯基取代納迪克醯亞胺化合物、具 有自由基聚合性不飽和雙鍵的化合物、惡嗪化合物、惡唑 琳化合物及環氧化合物申的一種或一種以上。 16. —種液晶配向膜,其中其是對如申請專利範圍第工 項至第15項中任一項所述的液晶配向劑的塗膜進行加熱 而形成。 17. —種液晶顯示元件,其具有一對基板、含有液晶分 子並形成于所述一對基板之間的液晶層、對液晶層施加電 壓的電極、以及將所述液晶分子配向于預定方向上的液晶 配向膜,此液晶顯示元件的特徵在於: 201022331 所述液晶配向膜是根據如申請專利範圍第16項所述 的液晶配向膜。(Sl) 14. The liquid crystal alignment agent according to any one of claims 1 to 5, wherein the fumed chiral acid or derivative thereof comprises two polylysines or derivatives thereof A and B, the polyperuric acid or derivative A thereof comprises the diamine having a side chain structure in the diamine, and the polycarboxylic acid or a derivative thereof and a tetracarboxylic acid of the derivatives A and B One or both of the dianhydrides include four needles of tetrazolium represented by the general formula (TC-1) to the general formula (TC-14). The liquid crystal alignment agent according to any one of the items 1 to 5, further comprising a compound selected from an alkenyl-substituted nadic ylidene compound and having a radical polymerizable unsaturated double bond, One or more of an oxazine compound, an oxazoline compound, and an epoxy compound. A liquid crystal alignment film which is formed by heating a coating film of a liquid crystal alignment agent according to any one of the above claims. 17. A liquid crystal display element having a pair of substrates, a liquid crystal layer containing liquid crystal molecules and formed between the pair of substrates, an electrode for applying a voltage to the liquid crystal layer, and aligning the liquid crystal molecules in a predetermined direction The liquid crystal display element is characterized in that: the liquid crystal alignment film according to claim 16 is a liquid crystal alignment film according to claim 16. 157 201022331 32945pif.doc 四、 指定代表圖: (一) 本案之指定代表圖:無。 (二) 本代表圖之元件符號簡單說明:無。 五、 本案若有化學式時,請揭示最能顯示發明特徵 的化學式: 無。157 201022331 32945pif.doc IV. Designated representative map: (1) The designated representative of the case: None. (2) A brief description of the symbol of the representative figure: None. 5. If there is a chemical formula in this case, please disclose the chemical formula that best shows the characteristics of the invention: None.
TW098139996A 2008-11-25 2009-11-24 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display device TW201022331A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2008299607 2008-11-25

Publications (1)

Publication Number Publication Date
TW201022331A true TW201022331A (en) 2010-06-16

Family

ID=42360944

Family Applications (1)

Application Number Title Priority Date Filing Date
TW098139996A TW201022331A (en) 2008-11-25 2009-11-24 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display device

Country Status (4)

Country Link
JP (1) JP5482109B2 (en)
KR (1) KR20100059693A (en)
CN (1) CN101735826A (en)
TW (1) TW201022331A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8558973B2 (en) 2011-04-06 2013-10-15 Chunghwa Picture Tubes, Ltd. Liquid crystal mixture and liquid crystal display panel
TWI494292B (en) * 2010-08-19 2015-08-01 Jnc Corp Diamine, liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display device

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5994257B2 (en) * 2011-03-17 2016-09-21 Jsr株式会社 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
JP6079210B2 (en) * 2012-03-28 2017-02-15 Jsr株式会社 Liquid crystal aligning agent, liquid crystal aligning film, liquid crystal display element, polymer and compound
KR102135493B1 (en) * 2013-05-01 2020-08-26 닛산 가가쿠 가부시키가이샤 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
CN103484132B (en) * 2013-09-25 2016-01-06 深圳市华星光电技术有限公司 The making method of a kind of alignment film material and display panels
JP6337576B2 (en) * 2014-04-01 2018-06-06 Jsr株式会社 Liquid crystal aligning agent, liquid crystal alignment film, liquid crystal display element, and method for manufacturing liquid crystal display element
JP6805475B2 (en) * 2014-09-09 2020-12-23 Jsr株式会社 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TWI565756B (en) * 2015-03-04 2017-01-11 奇美實業股份有限公司 Composition for liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element having the same
TWI549992B (en) * 2015-09-14 2016-09-21 達興材料股份有限公司 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display
KR20170097552A (en) * 2016-02-18 2017-08-28 제이엔씨 주식회사 Liquid crystal aligning agents for forming liquid crystal alignment films, liquid crystal alignment films and liquid crystal display devices using the same
TWI763760B (en) * 2017-12-29 2022-05-11 奇美實業股份有限公司 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
KR102391473B1 (en) 2019-01-17 2022-04-26 주식회사 엘지화학 Liquid crystal alignment composition, method of preparing liquid crystal alignment film, and liquid crystal alignment film, liquid crystal display using the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5520845A (en) * 1993-12-02 1996-05-28 E. I. Du Pont De Nemours And Company Poly(2,6-piperazinedione) alignment layer for liquid crystal displays
JPH10197873A (en) * 1997-01-08 1998-07-31 Seiko Epson Corp Formation of oriented film as well as liquid crystal panel and electronic apparatus
JP4992436B2 (en) * 2006-03-24 2012-08-08 Jnc株式会社 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
JP4941120B2 (en) * 2006-09-01 2012-05-30 Jnc株式会社 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
JP5245329B2 (en) * 2006-09-15 2013-07-24 Jnc株式会社 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI494292B (en) * 2010-08-19 2015-08-01 Jnc Corp Diamine, liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display device
US8558973B2 (en) 2011-04-06 2013-10-15 Chunghwa Picture Tubes, Ltd. Liquid crystal mixture and liquid crystal display panel

Also Published As

Publication number Publication date
JP2010152332A (en) 2010-07-08
KR20100059693A (en) 2010-06-04
CN101735826A (en) 2010-06-16
JP5482109B2 (en) 2014-04-23

Similar Documents

Publication Publication Date Title
TW201022331A (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display device
TWI492966B (en) Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display
JP5556482B2 (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
TWI458754B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display device
TWI375095B (en)
TWI454529B (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
TWI606081B (en) Method of forming liquid crystal alignment film for photo-alignment, and liquid crystal displays
CN104910106B (en) Aligning agent for liquid crystal, liquid crystal orientation film, the manufacture method and polymerizable compound of liquid crystal display cells and liquid crystal display cells
CN101910929B (en) Liquid crystal aligning agent and liquid crystal display device using the same
TW201016751A (en) Liquid crystal aligning agent, liquid crystal alignment layer and liquid crystal display device
TW201209077A (en) Liquid-crystal alignment agent, liquid-crystal alignment film, and liquid-crystal display element
TW201434974A (en) Liquid crystal aligning agent, liquid crystal aligning film and liquid crystal display device
TW201125896A (en) Liquid crystal aligning agents, liquid crystal aligning layers and liquid crystal display devices
WO2012014898A1 (en) Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element
TW200923012A (en) Liquid crystal aligning agent, liquid crystal alignment layer and liquid crystal display device
TW200530712A (en) Composition for liquid crystal alignment film, liquid crystal alignment film, liquid crystal holding substrate and liquid crystal display device
TW201030095A (en) Alignment agent and liquid crystalline polyimide used therein
TW200940506A (en) Diamine compound, liquid crystal aligning agent, and liquid crystal display device using the same
TW200906914A (en) Liquid crystal aligning agent, liquid crystal alignment layer and liquid crystal display
TW201237068A (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element, and polyamic acid and polyimide for producing thereof
TW200909479A (en) Liquid crystal aligning agent, liquid crystal alignment layer and liquid crystal display device
TW201100463A (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display device
TWI499588B (en) Liquid crystal alignment film and a liquid crystal display element to the processing agent, with the liquid crystal
TW200914953A (en) Alignment material for liquid crystal display device and a preparing method of the same
KR20180061414A (en) Composition liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element